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Introduction
And when Rachel saw that she bore Jacob no children, Rachel envied her sister; and she 
said unto Jacob: ‘Give me children, or else I die.’ And Jacob’s anger was kindled against 
Rachel; and he said: ‘Am I in God’s stead, who hath withheld from thee the fruit of the 
womb?’ And she said: ‘Behold my maid Bilhah, go in unto her; that she may bear upon my 
knees, and I also may be builded up through her. And she gave him Bilhah her handmaid 
to wife; and Jacob went in unto her. And Bilhah conceived, and bore Jacob a son. And 
Rachel said: ‘God hath judged me, and hath also heard my voice, and hath given me a 
son.’ (Genesis 30:1-6)
The biblical tale about Rachel and Jacob, over 3500 years old, illustrates that involuntary 
childlessness can cause a broad range of emotions in couples. Furthermore, it shows us 
that partners may cope with their infertility in different ways and have different beliefs 
about the cause of their childlessness. The most important message of this story however, 
is that couples are willing to go to great lengths to fulfil their wish for a child of their 
own.
In the last 30 years, several Assisted Reproductive Technologies (ART) have been intro-
duced, including In Vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI), 
which enable sub-fertile couples to have a child that is genetically theirs. The first baby 
to be conceived from IVF treatment, Louise Brown, was born in 1978. Since then, over a 
million babies have been born around the world with the help of ART [1]. Between 1996 
and 2000, one out of every 61 children born in the Netherlands was conceived through 
IVF or ICSI [2].
IVF is a time-consuming and intrusive treatment. Current treatment protocols require 
the woman to begin injections with a gonadotropin-releasing hormone (GnRH) agonist 
to prevent premature ovulation in the mid-luteal phase of her pretreatment menstrual 
cycle. Two weeks later she must commence additional daily injections of follicle stimulat-
ing hormone (FSH) to stimulate the growth of multiple follicles. The aim is to produce 
multiple oocytes for fertilization in vitro. Frequent blood tests and ultrasound scans are 
performed to monitor the development of ovarian follicles. When enough follicles have 
sufficiently matured, the oocytes are aspirated from the ovaries under transvaginal ultra-
sound control. On the same day, sperm is produced by the father or sperm donor. The 
oocytes are then fertilised with the sperm outside the mother’s body. Two to five days 
later, one or more of the resulting embryos are transferred to the mother’s uterus. During 
the next twelve to fourteen days, the couple must wait until they can take a pregnancy 
test to determine whether treatment was successful, while the woman continues medica-
tion to support successful implantation of the embryos. The chance that a pregnancy will 
occur is approximately 1 in 5.
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Medical risks of IVF treatment
Standard IVF treatment, as briefly described above, is not without health risks. Ovarian 
suppression with the use of GnRH agonists can lead to menopausal symptoms, such as 
hot flushes, vaginal dryness, headaches and mood swings [3-5]. Furthermore, a small 
percentage (0.1-0.5%) of women receiving ovarian stimulation will develop ovarian hy-
perstimulation syndrome which can result in serious and even life-threatening medical 
complications [6]. The long-term maternal risks associated with ovarian stimulation re-
main unclear due to a lack of reliable studies [7]. The most important complication of IVF 
however, is multiple pregnancy, which is associated with a variety of maternal, foetal en 
neonatal complications. In 2003, about twenty-five percent of IVF deliveries in Europe 
were multiples [8].
One of the major maternal complications of multiple pregnancy is hypertension. Severe 
hypertension occurs 2-3 times more often in twin than in singleton pregnancies [9]. Pre-
eclampsia, or pregnancy toxemia, is about three times more common in twin than in 
singleton pregnancies [10]. Multiple pregnancies not only lead to an increased likelihood 
of medical problems in the carrying mothers, but also in the offspring themselves. Com-
pared with singletons, twins are at approximately 5-fold increased risk of foetal death. 
Additionally, neonatal death occurs 7 times more often in twins [11]. The major causes of 
perinatal mortality and morbidity in multiple pregnancies are preterm delivery and low 
birth weight. As a result of these problems, women carrying multiples are at increased 
risk of requiring treatment and extended hospitalisation.
Women’s experiences of IVF treatment
Despite the relatively low chance of achieving a pregnancy in one IVF cycle, many 
women embarking on treatment have unrealistic expectations about treatment success 
[12]. This is what Kalbian [13] calls ‘The hope narrative’: the infertile woman strongly 
believes that the fertility physicians are able to help her achieve a successful pregnancy. 
In order to achieve this goal, the woman feels she has to completely surrender her body 
to her physician. Indeed, many women report a lack of control during the process of 
infertility treatment [14]. They feel they have little choice but to succumb to the invasive 
investigations and procedures the doctors prescribe. A very private aspect of their lives, 
namely reproduction, becomes medicalised. As a result of this process, feelings of dep-
ersonalisation can emerge. Women may feel they are not a person anymore, but feel as 
if they are being reduced to body parts instead. Even after successful treatment, women 
retrospectively describe infertility treatment as being physically and emotionally painful, 
while some women even reported feeling ‘hurt’ or ‘damaged’ [14].
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Undergoing infertility treatment also has an impact on the woman’s social and profes-
sional life [12]. Social activities are often put on hold during a treatment cycle, as many 
women are not able or willing to share their experiences with others. Furthermore, the 
frequent hospital visits may result in absence from work. The demands of treatment also 
put pressure on the partner relationship. Partners often cope differently with treatment 
related strain and this may lead to disagreement about whether to continue treatment or 
not. Many couples find it difficult to make the final decision about ending IVF treatment 
[12]. Being diagnosed with infertility may evoke strong feelings of deficiency in a woman, 
who feels that motherhood is the norm. She may feel social pressure to reproduce from 
her family, friends or even society. According to Franklin [15], the paradoxical nature of 
IVF treatment itself makes it more difficult for women to come to terms with their infertil-
ity. There are always newer assisted reproductive technologies to try which makes the 
decision to end treatment a difficult one. As Franklin [15] puts it, ‘IVF is a choice, but not 
a choice. It is a resolution, but not a resolution’.
Psychological models of infertility
In lay aetiology, psychological problems are often believed to have a negative effect on 
fertility. The origin of this belief can be dated back to the 1950s. During this period, a 
number of psychodynamic writings were published, in which infertility was considered to 
be the result of unconscious conflicts in the infertile woman. These conflicts included the 
fear of motherhood and sexuality. The full psychogenic model of infertility has been the 
main perspective on the relationship between infertility and psychological functioning in 
biomedicine until the 1980s [16-18]. Even when a physiological defect could be identi-
fied, the primary origin of the infertility problems was still assumed to be psychogenic in 
nature. Furthermore, psychological functioning of the male partner was usually not taken 
into consideration. As more and more somatic causes of infertility were discovered, the 
full psychogenic model of infertility got replaced by the psychogenic model of unexplained 
infertility. According to this model, all infertility difficulties for which no organic cause 
can be found arise from psychogenic factors. However, the results of empirical research 
do not affirm this model. Patients with unexplained infertility usually do not have more 
psychological problems than patients with somatically explained infertility [19-21].
Gradually, the focus of psychological studies in the infertility field has shifted. Nowa-
days, psychological problems are considered to be an effect of infertility rather than a 
cause. Quantitative research has shown that infertile persons experience only slightly 
more distress than fertile persons [22-24]. These results support the psychological conse-
quences model of infertility rather than the psychogenic model of (unexplained) infertility, 
since it is highly unlikely that a moderate amount of distress can bring about infertility 
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problems. However, the causal relation between infertility and distress cannot be proven, 
since no longitudinal studies exist that follow infertile patients from before they start 
trying to conceive [16].
The psychological consequences of IVF treatment
Stress (or a stressor) is typically defined as a stimulus which produces mental tension or 
physiological arousal, whereas distress is the term used to describe the negative emotions 
that result from the stressor [25]. When a person appraises a situation as being stressful, 
they will classify it as a threat, a loss or a challenge [26]. IVF, with its painful and invasive 
procedures, is a burdensome treatment. Since IVF is usually the final treatment option for 
infertility, IVF patients have to face the possibility that they may never achieve the valu-
able life goal of parenthood. As such, IVF treatment poses a threat to the childless person, 
which may result in symptoms of anxiety. Moreover, IVF is a low-control stressor, since 
patients have little control over its progression and its outcome [27]. As treatment pro-
gresses and its uncontrollability continues, feelings of depression may emerge [28]. When 
IVF treatment fails, couples may grief over the loss of the child that was never born. The 
realization that their childlessness is irrevocable, may lead to the loss of an acceptable self 
or body image, and losses concerning self-esteem and self-confidence. Social losses may 
involve the ending of relationships and the loss of social status. These multiple losses 
related to treatment failure may evoke depressive symptoms and grief [29].
Results of quantitative research show that women who are about to start IVF may be 
more anxious than control populations [30-32], although in some studies no differences 
are found [33-35]. During treatment, women experience symptoms of anxiety, especially 
at oocyte pick-up and just before pregnancy testing [36, 37]. Distress levels are reported 
to be higher during the first and last IVF treatment cycles [31, 38, 39]. Although most 
women seem to adjust well to unsuccessful IVF treatment, up to 25% of women report 
clinically relevant levels of depression after failed IVF [40, 41]. Three years after unsuc-
cessful IVF treatment, women report less life satisfaction, but not more distress than 
women who did conceive via IVF [42]. Negative emotions seem to disappear after IVF 
pregnancy, which could suggest that depression related to IVF treatment results from 
the inability to become pregnant rather than treatment itself [43]. On the other hand, the 
excitement and happiness associated with pregnancy may neutralize negative treatment-
related emotions [See: 14].
In the Netherlands, only couples are usually eligible for IVF treatment, which makes it 
a dyadic stressor. Women are more likely to initiate infertility treatment than their male 
partners [44, 45]. Once they have started infertility treatment, women are less willing to 
stop treatment than men [46]. Even though men show the same pattern of emotional reac-
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tions during IVF treatment as women, their emotions are usually less intense [40, 47-50]. 
According to Stanton and colleagues [51], there are three possible explanations for this 
phenomenon. One possible explanation is that the female partner has to undergo most of 
the invasive procedures related to IVF, regardless of which partner is infertile. Moreover, 
as parenthood might be a more important life goal to women [48, 52], the perceived 
threat posed by IVF treatment might be greater to women than to men. Finally, Stanton 
and colleagues [51] argue that women show a general tendency to appraise negative 
events as more stressful than men.
Having twins: a blessing or a burden?
Results from studies on families with twins conceived with medical assistance are in line 
with studies on families with naturally conceived twins. Raising two children of the same 
age, places huge demands on the parents. Mothers with IVF twins seem to experience 
more parenting stress than mothers with either naturally conceived or IVF singletons 
[53]. The former group also reports more dysfunctional child-parent interactions, as well 
as more child behaviour difficulties. Furthermore, mothers of IVF twins are less likely 
to be working outside the home. With every increase in multiplicity, mothers are more 
likely to have difficulties with meeting material family needs, such as supplies, housing 
and health care needs. Parents of IVF multiples may have to face intrusive questions 
about their children’s conception status, which might cause feelings of social deviation. 
Moreover, mothers of IVF multiples are more likely to suffer from depression and a lower 
quality of life [54]. Although behavioural difficulties seem to disappear in later years, IVF 
twins show lower levels of cognitive functioning during their preschool years than IVF 
singletons [55].
Psychosocial counselling in IVF
Since the psychological consequences model of infertility became popular in the 1980’s, 
professionals in the infertility field have recommended the provision of psychosocial 
counselling interventions to infertile patients [56]. Infertility counselling helps patients 
explore, understand and cope with issues related to infertility and its treatment [57]. Ac-
cording to the Code of Practise of the Human Fertilisation and Embryology Authority [58], 
several tasks of counselling can be distinguished in the context of infertility treatment. A 
psychosocial counsellor may help patients to collect and comprehend all information that 
is needed to make treatment related decisions, as well as the emotional and social impli-
cations of these decisions (e.g. implications and decision-making counselling). When IVF 
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treatment is causing emotional distress in patients, counsellors can offer them emotional 
support to help them cope more effectively with treatment strain (e.g. support counsel-
ling). Therapeutic counselling can be offered, when specific issues concerning infertility 
or treatment need more working through.
Although many couples embarking on IVF may welcome some form of psychosocial 
counselling [59], studies addressing the effectiveness of psychosocial interventions for 
this population are scarce. The results of the few randomized controlled studies that 
have been conducted in this field suggest that psychosocial counselling before or after 
IVF treatment does not lead to fewer post-treatment symptoms of depression and anxiety 
in women [60, 61]. Counselling might be more effective, when offered to patients dur-
ing those stages of IVF treatment that are most stressful to them (e.g. waiting for the 
pregnancy test results). Furthermore, psychosocial counselling should be offered to both 
partners instead of individuals, as infertility is a shared problem (in the majority of cases). 
In this thesis, a psychosocial counselling intervention for couples undergoing their first 
cycle of IVF treatment was evaluated. Counselling was offered to both partners before the 
start of the first treatment cycle, during the waiting period and then again after comple-
tion of the first cycle.
Mild treatment strategies in IVF
Success in IVF is generally presented per cycle, which has led to complex and burden-
some ovarian stimulation protocols. Adopting term live birth per time period (e.g. one 
year) as a new primary endpoint may encourage clinicians and scientists to develop and 
apply simpler stimulation protocols. Mild ovarian stimulation is likely to result in fewer 
physiological and psychological side effects than standard long-protocol stimulation. The 
introduction of GnRH antagonists has facilitated the development of such ovarian stimu-
lation protocols for IVF [62]. In contrast to GnRH agonist treatment, the administration of 
GnRH antagonists can be limited to the mid to late follicular phase of the menstrual cycle. 
Moreover, exogenous FSH administration is limited to the mid-late follicular phase, since 
the endogenous inter-cycle FSH rise is exploited rather than suppressed.
Single embryo transfer (SET) offers the most reliable means of reducing the incidence 
of multiple pregnancies. Improved quality assessment of embryos has enhanced the ef-
fectiveness of this procedure [63]. However, the transfer of one embryo instead of two, 
results in a decrease in pregnancy rates per cycle. The implementation of IVF treatment 
strategies which combine single embryo transfer with milder ovarian stimulation proto-
cols may allow for more IVF cycles in the same period of time, resulting in similar term 
live birth rate per IVF treatment. A possible drawback of milder IVF strategies, however, 
is the higher cycle cancellation rate and the necessity of a greater number of treatment 
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cycles to achieve pregnancy [64]. Establishing a high-quality cryopreservation programme 
for surplus embryos can provide additional pregnancy chances after transfer in subse-
quent cycles [65, 66].
The use of GnRH antagonists in IVF might decrease the prevalence of symptoms of 
depression and anxiety, which seem to be side effects of GnRH agonist ovarian suppres-
sion, possibly associated with a decline in estrogen levels [67] or a decreased serotonin 
density [5]. Women treated with GnRH agonist may also report menopausal symptoms, 
such as hot flushes and headaches [3, 4]. Indeed, mild ovarian stimulation appears to 
result into a smaller increase in treatment burden over cycles than standard long ovarian 
stimulation [68]. However, couples who fail to conceive with minimal stimulation IVF are 
less likely to prefer the minimal stimulation in future than pregnant couples. Likewise, 
most couples show more concerns about the possible higher risk of treatment failure 
associated with SET than about potential risks related to multiple embryo transfer [69]. 
Moreover, many of these couples may actually consider multiple birth to be a favour-
able treatment outcome, as they consider having twins as the most cost-effective means 
to complete their family in terms of treatment-related distress [70, 71]. More scientific 
evidence on the possible psychological advantages and disadvantages of the use of mild 
IVF strategies might change patients’ preferences in favour of these strategies. This thesis 
describes the results of a comprehensive study of the psychological consequences of a 
mild IVF strategy during various stages of IVF treatment.
Stress and IVF outcome
Although nowadays most researchers would reject the psychogenic model of infertility, 
a modified version of this model is still popular in studies on IVF. The cyclical model 
of stress [16] or stress hypothesis [18] proposes that patients’ distress has a negative influ-
ence on pregnancy chance. According to this concept, distress has a direct effect on IVF 
pregnancy outcome through stress-related hormones [72] or immunological mechanisms, 
by modulating T cell activity [73]. Also, distress is believed to have an indirect negative 
effect on IVF outcome through adverse health-related behaviour, such as unhealthy eat-
ing habits, smoking and alcohol consumption [74]. Smoking and overweight are known 
to negatively influence pregnancy rates, live birth rates and other IVF outcomes [75-78]. 
Alcohol intake also seems to have a negative influence on IVF outcomes, but this rela-
tionship needs to be studied further [79].
Whereas several studies suggest that distress results in reduced pregnancy rates [80-84], 
others have failed to find a detrimental effect of negative emotional reactions on IVF 
outcomes [31, 85-87]. Some authors have claimed that psychosocial interventions aimed 
at reducing distress increase pregnancy rates in infertile people [88, 89]. However, psy-
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chosocial counseling during IVF treatment does not seem to influence IVF pregnancy 
rates [60, 61]. As most studies in this field show considerable limitations in study sample 
size and design, more large prospective studies are required. These studies should report 
live birth as the endpoint, as data relating to miscarriage and premature delivery are rare. 
In this thesis, the relationship between distress in women and live birth resulting from 
one cycle of IVF was studied.
Study aims and outline
This thesis focuses on the relationship between IVF treatment and associated psychologi-
cal distress in women. The main objectives of this thesis were to study patient distress 
both as a consequence of IVF treatment (Chapters 2-6), and as a predictor of IVF treat-
ment outcome (Chapter 7).
In Chapter 2, a study of the effect of a psychosocial counselling intervention for couples 
undergoing their first cycle of IVF treatment on women’s distress is presented. Women 
who received additional counselling by a social worker were compared with a routine-
care control group in a randomized controlled trial.
In Chapters 3 to 6, studies are presented which assess whether a mild IVF strategy 
which combined mild ovarian stimulation with single embryo transfer results in compa-
rable distress levels as standard IVF. In order to answer this research question, a random-
ized controlled trial was performed with 404 women. The methodology of this trial is 
described in Chapter 3. As each stage of IVF treatment might have different implications 
for women’s psychological adjustment [31, 36, 37], distress was measured several times 
during treatment. In Chapter 4, distress was studied in first-time IVF patients during six 
separate stages of one IVF treatment cycle: ovarian stimulation, oocyte retrieval, fertiliza-
tion, embryo transfer, waiting period and pregnancy testing. In Chapter 5, overall patient 
discomfort during a period of one year associated with both mild IVF was studied and 
compared with conventional treatment. Finally, Chapter 6 focuses on the impact of un-
successful IVF treatment on women’s psychological wellbeing.
Chapter 7 reports a study in which distress in women before and during a first IVF 
treatment cycle was prospectively examined, and its relationship to live birth delivery 
rates was studied. For this study, the same cohort of women was studied as in Chapters 
3 to 6.
The main findings of this thesis are summarized and discussed in Chapter 8. Finally, 
implications for future treatment and research are given.
2
Chapter 2
Effectiveness of a psychosocial 
counselling intervention for first-time IVF 
couples: a randomized controlled trial
C de Klerk, JAM Hunfeld, HJ Duivenvoorden, MA den Outer, 
BCJM Fauser, J Passchier & NS Macklon
Human Reproduction 2005; 20: 1333-8
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Abstract
BACKGROUND: The objective of this study was to evaluate a psychosocial counselling 
intervention for first-time IVF couples. In this article the results on women’s distress are 
presented.
METHODS: Two hundred sixty-five couples admitted to an IVF treatment programme at 
the Erasmus MC were asked to participate in this study. Eighty-four couples agreed and 
were randomized according to a computer-generated random-numbers table into either a 
routine-care control group or an intervention group. The intervention consisted of three 
sessions with a social worker trained in experiential psychosocial therapy: one before, 
one during and one after the first IVF cycle. Distress was measured daily during treatment 
by the Daily Record Keeping Chart. Depression and anxiety were measured before and 
after treatment by the Hospital Anxiety and Depression Scale.
RESULTS: No significant group differences were found.
CONCLUSIONS: The results of this study do not support the implementation of our 
counselling intervention for all first-time IVF couples. The low response rate suggests 
that there is little perceived need for psychosocial counselling among couples during a 
first IVF treatment cycle.
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Introduction
In-Vitro Fertilization (IVF) treatment can be a stressful experience to couples. The de-
mands of treatment—daily injections, semen analysis, scans, and invasive procedures—
may be a cause of distress to both partners. Additionally, many couples have to deal with 
treatment failure and are often confronted with emotionally difficult treatment choices, 
such as whether or not to freeze embryos [90]. There has been a number of clinical re-
ports on the emotional impact of IVF treatment. Common emotional responses to infertil-
ity and its treatment are depression, anger, guilt, frustration and sadness [91]. Prospective 
studies have shown that women demonstrate elevated anxiety levels during IVF treatment 
[92, 93]. Treatment failure appears to be associated with an increased prevalence of both 
mild and moderate depression in both women and men [40, 94]. Indeed, anxiety and 
depression are considered to be causes for the relatively high drop-out rate observed 
after the first failed IVF cycle [95, 96]. It has also been suggested that elevated anxiety 
and depression may cause lower pregnancy rates [83, 84]. Most authors agree that fertility 
clinics should not only address the medical needs of their patients, but also their emo-
tional needs. Boivin et al. [97] advocate that psychosocial counselling should be available 
during all stages of IVF treatment. According to the Human Fertilisation and Embryology 
Authority [58] the following tasks of counselling can be distinguished in the context of in-
fertility treatment: information gathering and analysis, implications and decision-making 
counselling, support counselling and therapeutic counselling. Laffont et al. [59] suggest 
that many couples undergoing IVF may welcome some form of psychosocial counselling. 
Seventy-five percent of the participants in this study, who had been through at least one 
IVF attempt, expressed a wish for pretreatment counselling, while almost half of the study 
group requested counselling during treatment.
Despite the high agreement on the necessity of counselling IVF patients, there is a lack 
of studies addressing the efficacy of psychological interventions for this population. To 
date, only a few randomized, controlled, prospective studies have been conducted to as-
sess the effect of counselling on distress related to infertility and its treatment. In a study 
by Domar et al. [98] infertile couples received 10 weekly sessions in either a cognitive-be-
havioural group or a support group. These intervention groups were not linked to an IVF 
programme. At six months follow-up, participants in both intervention groups showed 
healthier scores than the controls on several psychological variables: anxiety, marital 
distress, confusion, mood disturbance, stress management skills, health-promoting style 
and vigour. Another 6 months later, less group differences were found. Overall, the par-
ticipants in the cognitive-behavioural group showed more health-promoting behaviours, 
especially concerning interpersonal support and stress management. Surprisingly, both 
subjects in this group and the control group showed less depressive symptoms than did 
subjects in the support group.
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The study by Domar et al. [98] shows a long-term psychological approach to infertility. 
In other studies couples were offered specific support during IVF treatment. In a recent 
study by Emery et al. [61], couples were offered a pre-IVF counselling intervention in a 
couple format, which focused on their narrative capacities. Six weeks after the first IVF 
treatment cycle had ended, participation in counselling was not associated with fewer 
symptoms of depression and anxiety. Couples in a study by Connolly et al. [60] received 
not only a pretreatment counselling session, but also one counselling session after their 
first cycle of IVF treatment. Counselling was directed at difficulties associated with IVF 
treatment, like interpersonal and psychosexual problems. The authors concluded that 
counselling did not have an additional effect on anxiety or depression over information 
provision alone.
One possible explanation for the lack of effect of counselling in the latter two studies 
could be the use of general stress questionnaires as opposed to infertility-specific stress 
questionnaires. Furthermore, none of the above studies measured the effect of counsel-
ling on stress patients experienced during treatment, e.g. procedural stress. The aim of 
this study was therefore to evaluate a psychosocial counselling intervention for couples 
undergoing their first cycle of IVF treatment using an infertility-specific distress question-
naire. We hypothesized that counselling during the first IVF treatment cycle may reduce 
women’s procedural distress levels during IVF treatment.
Materials and methods
Subjects
Two hundred sixty-five couples admitted to an infertility treatment programme at the 
Erasmus MC (Rotterdam, The Netherlands) were asked to participate in this study be-
tween June 2001 and May 2003. Inclusion criteria for this programme were: indication for 
IVF treatment, women aged under 41, a stable relationship and no severe psychological 
problems, as assessed by a physician during the couples’ initial visit to the hospital. This 
information is gathered using a standardized protocol. Because there is some evidence 
that the first ever IVF treatment cycle is the most stressful to patients [31, 32], only first-
time IVF patients were recruited for this study. Both partners had to be able to complete 
the questionnaires in Dutch. Eighty-four couples agreed to participate (32%). Reasons for 
non-participation are displayed in Table 2.1.
Intervention
Couples in the intervention group received three counselling sessions, each of approxi-
mately one-hour duration. Similar to Connolly et al. [60], we offered couples a pretreat-
ment and a post-treatment counselling session. The pretreatment session took place 
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about one week before the first day of pituitary downregulation or the first day of 
ovarian stimulation (in case of GnRH antagonist co-treatment); the post-treatment session 
took place approximately two weeks after the day of the pregnancy test. Additionally, 
patients received a counselling session six to nine days after the embryo was transferred, 
because most IVF patients consider this stage of IVF treatment to be the most stressful. 
The waiting period is associated with more uncertainty and lack of control than other 
treatment stages [60]. All counselling sessions took place at the Erasmus MC. During the 
non-directive sessions couples were invited to discuss their feelings and thoughts on 
topics related to infertility and IVF treatment. Depending on the needs of the clients, 
the counsellor alternately used the four basic aspects of infertility counselling: infor-
mation gathering and analysis, implications and decision-making counselling, support 
counselling and therapeutic counselling. Counselling was provided by a social worker 
who had been trained in experiential psychosocial therapy [99], which has been derived 
from Kempler’s experiential family therapy [100]. According to this method, problems are 
believed to originate from an imbalance between the basic human needs autonomy and 
relatedness and should therefore be solved in the context of a relationship. The main 
goal of Experiential Psychosocial Therapy is teaching clients new (interpersonal) skills 
by forming not only a professional but also a personal relationship with them. Instead of 
being an objective observer, the counsellor expresses her own feelings and ideas about 
the client in order to create new interpersonal experiences for the client. It is assumed 
that through these personal experiences with the therapist clients learn how to cope with 
(inter)personal problems.
Measures
Demographics
Information on demographics and infertility history was gathered from all women by a 
standardized questionnaire.
Table 2.1 Reasons for non-participation
Motivation n %
No time for counselling 57 31.5
No need for counselling 16  8.8
Discontinuation of IVF treatment  7  3.9
Work in hospital  4  2.2
Too stressed  4  2.2
No interest in study participation  2  1.1
Unknown reason 91 50.3
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Daily Record Keeping Chart (DRK)
In contrast to previous intervention studies in this area, distress was measured with 
an infertility-specific questionnaire, e.g. the Daily Record Keeping Chart [93, 101]. This 
questionnaire consists of 21 items that represent emotional reactions common to women 
undergoing infertility treatment. Each item is rated on a 4-point-Likert scale (‘none’ to 
‘severe’). Scores on four subscales can be obtained: depression/anger, uncertainty, posi-
tive affect and anxiety (range 0–12). The DRK showed good criterion-related validity and 
good convergent validity with other conceptually related scales, like the Spielberger State 
Anxiety Inventory [101]. However, factor analysis showed overlap between the ‘negative’ 
subscales. We therefore decided to use the General Distress Scale for this study, which 
combines the depression/anger, uncertainty and anxiety subscales into one negative af-
fect scale (range 0–36). The DRK showed good internal consistency: Cronbach coefficient 
alpha varied from 0.76 to 0.88 for the individual subscales, while the coefficient alpha 
for the General Distress Scale was 0.87. The original items of the DRK were translated 
into Dutch.
Hospital Anxiety and Depression Scale (HADS)
To enable comparisons with other effect studies, a general stress questionnaire was 
also administered. The Hospital Anxiety and Depression Scale [102] was developed as a 
screening tool to detect anxiety and depression in medical patients. All fourteen items are 
scored on a 4-point-Likert scale from 0 to 3. Each of the two subscales consists of seven 
items (range 0–21). For this study, the Dutch version of the HADS by Spinhoven et al. 
[103] was used, which has shown good test-retest reliability, homogeneity and internal 
consistency. Cronbach alpha for the total scale and both subscales varied from 0.71 to 
0.90. Since the total HADS scale showed a better sensitivity and positive predictive value 
in detecting psychiatric disorder than the two subscales, the anxiety and depression 
scores were also combined in a total HADS score (0–42).
Study design
The couples were randomized according to a computer-generated random-numbers table 
into one of two groups. Forty-one couples were randomized in a routine-care control 
group, forty-three couples into an intervention group. All participants completed the 
HADS before the couples’ initial visit to the hospital (baseline). During the first week after 
that visit the DRK was completed daily by the women (baseline) and again daily during 
their first IVF cycle: depending on the ovarian stimulation protocol that was used, women 
started monitoring on either the first day of downregulation (GnRH agonist long protocol 
co-treatment) or the first day of ovarian stimulation (mild ovarian stimulation using GnRH 
antagonist co-treatment). Monitoring ended two weeks after the day of the pregnancy test 
and after the third counselling session. On that same day all participants completed the 
Effectiveness of a psychosocial counselling intervention for first-time IVF couples 27
HADS for the second time. Since previous studies have shown that men experience lower 
levels of distress during IVF treatment than women [50], male participants did not fill in 
the DRK. Results on the men’s HADS scores have been reported elsewhere [104].
Procedure
The study was reviewed and approved by the Erasmus MC Ethical Review Board. Couples 
were informed about this study during information evenings for couples about to start 
their first IVF cycle at the Erasmus MC. During these meetings all couples received written 
information with regard to the study and the baseline HADS. In the ensuing weeks, pa-
tients who met the study criteria received a telephone call and were invited to participate 
in the study. Couples who agreed to take part in this study met with one of the research-
ers before their first medical appointment at the hospital. After the objectives of the study 
were discussed, both partners signed an informed consent form. The completed baseline 
HADS was collected and all women received a diary with one DRK for every treatment 
day and they were instructed to complete the DRK on a fixed moment during the day. 
Finally, couples were informed whether they would receive additional counselling ses-
sions with a social worker. The questionnaire on demographics was sent by mail before 
the start of the first IVF treatment cycle. A second HADS was sent by mail two weeks after 
the first cycle had ended.
Statistical analyses
Demographical data were analysed using Student’s t-test for continuous variables and 
χ2-test for categorical variables. For the group analyses, a distinction was made between 
seven individual IVF treatment stages: stimulation, day of oocyte retrieval, fertilization, 
day of embryo transfer, waiting period, day of the pregnancy test and post-treatment. 
However, no results are available for the post-treatment stage, since most women dis-
continued monitoring with the DRK after the day of the pregnancy test. Stage scores for 
both positive and negative affect were calculated by averaging daily scores on the DRK 
within each treatment stage. In addition, the stage scores from the stimulation days until 
the day of the pregnancy test were averaged into two separate overall treatment scores: 
one for positive affect and one for negative affect. These overall treatment scores were 
used to get a rough estimate of the level of the overall distress of the women in our 
study during their first IVF treatment cycle. Due to cycle cancellation, not all women 
went through every of the previously mentioned treatment stages. Analyses of covari-
ance for group comparisons for overall treatment scores were therefore adjusted for the 
total number of treatment stages the women passed through during their first IVF cycle. 
Next, analyses of covariance were conducted for group comparisons of both positive and 
negative affect during each individual treatment stage, adjusting for baseline affect scores. 
Analyses for the day of the pregnancy test and the overall treatment were also statistically 
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controlled for pregnancy outcome. Finally, analyses of covariance were performed for 
the post-treatment HADS scores on both the subscales and the total scale, controlling for 
the baseline HADS scores. Data analysis was performed with the couples’ original group 
assignment (intent-to-treat design principle). Since we hypothesized that the intervention 
group would experience less procedural distress during the first IVF treatment cycle 
than controls, significance testing on all outcome measures was done at 0.05 level of 
significance (one-tailed). Effect sizes were measured using Cohen’s d [105]. The standard 
deviation of the control group was used as the denominator of Cohen’s d.
Results
Demographics
Non-respondents did not differ in age from women who participated in this study. Of the 
eighty-four couples who were recruited, forty couples (48%) discontinued participation 
during the study (See Figure 2.1). Twenty-four women did not return their diary, 3 couples 
did not want counselling anymore, 11 couples did not proceed with IVF treatment, and 
2 couples required extensive counselling. The couples who completed the programme 
did not differ significantly from the couples who dropped out in demographics and stress 
as measured by the HADS at baseline. The biochemical pregnancy rate after the first IVF 
treatment cycle was 27% for the intervention group and 32% for the control group. This 
difference was not significant. Table 2.2 shows the demographic characteristics for both 
intervention and control groups. No significant differences were found for any of the 
demographic variables between groups. Six couples were not able to attend all three 
counselling sessions due to practical reasons.
Positive and negative affect during the first IVF cycle
Table 2.3 shows the means and 95% confidence intervals (CIs) of the DRK scores in both 
groups for all treatment stages individually as well as overall treatment scores for both 
positive and negative affect. Although overall treatment scores on negative affect were 
lower for the intervention group than for the control group, this difference was non-
significant. Adjusting for the number of treatment stages and pregnancy outcome, group 
differences remained non-significant. No differences were found for the overall treatment 
scores on positive affect. Analyses of covariance showed that the intervention and control 
groups did not differ significantly on positive or negative affect during the individual 
treatment stages either. On the day of the pregnancy test however, the controls scored 
higher on negative affect than the intervention group (P = 0.07, one-tailed). Although this 
difference was not significant, the effect size (Cohen’s d = 0.58) can still be considered 
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as medium [105]. Due to the small sample size of the study, no subgroup analyses were 
carried out.
Anxiety and depression after the first IVF treatment cycle
No differences between the intervention (i; n = 18) and control (c; n = 15) groups were 
found on the depression subscale (Mi = 3.1, SDi = 2.6; Mc = 4.3, SDc = 2.6), on the 
anxiety subscale (Mi = 4.5, SDi = 2.6; Mc = 5.3, SDc = 2.6), or on the total scale of the 
HADS (Mi = 7.6, SDi = 4.5; Mc = 9.6, SDc = 4.5). Effect sizes were 0.46, 0.29 and 0.43, 
respectively.
Figure 1. CONSORT statement flow diagram
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Did not receive IVF (n=7)
Needed extended counselling  (n=1)
Lost to follow-up (n=11)
Analysed (n=22)
Allocated to intervention (n=43)
Did not receive IVF (n=4)
Needed extended counselling (n=1)
Lost to follow-up (n=13)
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Figure 2.1 CONSORT statement flow diagram
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Table 2.2 Demographic characteristics of intervention and control groups
Demographic variable Intervention
(n = 21)
Control
(n = 19)
Pa
Age of females (years)
   Mean (SD) 33.4 (4.7) 33.3 (5.2) 0.95
Highest level of education (%)
   Primary education
   Vocational education
   Secondary education
   University etc.
 5.3
52.6
10.5
31.6
 0.0
33.3
28.6
38.1
0.30
Duration of relationship (years)
   Mean (SD)  9.6 (5.3)  8.5 (5.4) 0.52
Duration of infertility (years)
   Mean (SD)  4.0 (1.7)  4.3 (3.6) 0.74
Cause of infertility (%)
   Female only
   Male only
   Female and male
   Unknown cause
36.8
36.8
 5.3
21.1
14.3
42.9
 9.5
33.3
0.49
One or more previous children (%) 21.1  9.5 0.40
a Two-tailed.
Table 2.3 Positive and negative affect assessed by the Daily Record Keeping Chart for each treatment stage
Negative affect Positive affect
Intervention Control Intervention Control
n M (95% CI) n M (95% CI) dª n M (95% CI) n M (95% CI) dª
Baseline 21
 
 5.1 (± 1.4) 20
 
 6.9 (± 2.0)
 
 0.41 21 7.9 (± 1.2) 20
 
7.2 (± 1.3) –0.24
Stimulation 21  7.7 (± 2.2) 20  7.4 (± 2.3) –0.05 21 6.9 (± 0.8) 20 7.5 (± 0.8)  0.30
Oocyte retrieval 20 12.0 (± 3.5) 19 12.1 (± 3.6)  0.01 20 7.0 (± 1.5) 19 6.7 (± 1.5) –0.08
Fertilization 20 11.8 (± 3.9) 18 10.9 (± 4.1) –0.11 20 5.9 (± 1.3) 18 6.5 (± 1.4)  0.21
Embryo transfer 17 10.4 (± 4.0) 15 10.1 (± 4.3) –0.04 17 7.9 (± 1.6) 15 8.0 (± 1.7)  0.03
Waiting days 17 11.1 (± 3.2) 15  9.3 (± 3.4) –0.26 17 7.1 (± 1.1) 15 7.3 (± 1.1)  0.06
Pregnancy test 16 13.7 (± 5.7) 14 20.5 (± 6.1)  0.58 16 5.5 (± 1.2) 14 5.7 (± 1.3)  0.08
Overall 22 10.1 (± 2.8) 22 12.0 (± 2.8)  0.33 22 6.6 (± 1.0) 22 6.8 (± 1.0)  0.10
a Cohen’s d as a measure of effect size: 0.2 = small; 0.5 = medium; 0.8 = large.
Effectiveness of a psychosocial counselling intervention for first-time IVF couples 31
Discussion
The objective of the present study was to evaluate the possible effect of a psychosocial 
counselling intervention for couples undergoing their first cycle of IVF treatment. This 
intervention consisted of three sessions with a social worker during the most demanding 
stages of the IVF cycle. In contrast to previous studies, the effect of counselling on the 
procedural distress women experienced during IVF was assessed before they were aware 
of the pregnancy outcome. Furthermore, this was the first intervention study in which 
a validated infertility-specific distress questionnaire was administered, namely the Daily 
Record Keeping Chart. This questionnaire was expected to be more sensitive to distress 
related to infertility compared to the general stress questionnaires used in other studies.
Consistent with previous studies, no effect of counselling was found when stress after 
the first IVF cycle was measured with a general stress questionnaire (HADS). Moreover, 
an effect for counselling was neither found with the use of the DRK. On the day of the 
pregnancy test however, there was a trend towards less negative affect for women in 
the intervention group when compared to women who had not received counselling. 
Women who had received additional care seemed to be better prepared for a negative 
treatment outcome. Indeed, one of the goals of our counselling intervention is to reduce 
unrealistic expectations couples might have concerning IVF treatment outcome. Even 
though the difference was marginally significant, we consider it promising, since the day 
of the pregnancy test was the most stressful stage of treatment for both the intervention 
and the control groups.
The relatively low response rate of this study suggests that there is little perceived need 
for psychosocial support among couples during a first IVF cycle. This is in keeping with 
the results of a study by Boivin et al. [106] in which the majority of 143 infertile patients 
did not consider themselves to be distressed enough to need counselling. The less dis-
tressed patients in this study reported that they received sufficient support from informal 
sources like their spouse, family and friends. The patients who were so distressed that 
they wanted to consult a counsellor did not do so for practical reasons, such as the 
perceived difficulty of scheduling sessions. Likewise, most couples who declined to par-
ticipate in our study stated that they did not have the time for three additional visits to the 
hospital. Although our response rate (32%) is comparable to the response rate in a study 
by McNaughton-Cassill et al. [107], Connolly et al. [60] were able to obtain a response rate 
of approximately 98%. In their study counselling sessions were combined with medical 
appointments. However, we intended to offer support at the most stressful treatment 
stages, the days before and after the pregnancy test. During these days couples do not 
have medical appointments. Considering our relatively low response rate, it is possible 
that the couples who really would have benefited from our counselling intervention did 
not participate in this study. In the future, effort should be made to integrate our counsel-
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ling intervention into the IVF treatment to meet the needs of IVF couples. The women 
who did not want to participate in this study did not differ in age from the women who 
did agree to participate. It would be very interesting to examine further the character-
istics of non-respondents in a future study. Targeting counselling interventions towards 
couples who have already undergone IVF treatment may be of greater benefit. The study 
of Laffont et al. [59] suggests that these couples show more interest in counselling.
Aside from the low response rate, this study also suffered from a high attrition rate. 
Many women did not return their diary. Additionally, many women stopped monitoring 
their distress after the day of the pregnancy test. Although women who dropped out of 
the study did not show more feelings of anxiety or depression before the start of the IVF 
treatment than women who did not drop out, this subgroup of women may have experi-
enced higher levels of distress during IVF treatment. In future studies, administering the 
DRK for a shorter time period than in this study may prevent drop-out.
Since the low response and high attrition rate have also affected the statistical power of 
our study, the results of this study should be interpreted with caution. These results do 
not favour routine psychosocial counselling for all first-time IVF patients, a finding that is 
in line with the results of two previous randomized controlled studies [60, 61]. In a recent 
review [56], it is suggested that group interventions that focus on education and skills 
training (e.g., relaxation training) would be more effective than counselling interventions 
like the one applied in this study. However, most women in this study seemed to be able 
to cope with the procedural distress of their first IVF treatment without additional coun-
selling. Since couples accepted for IVF treatment have to be in a stable relationship, it is 
likely that most are able to support each other during treatment or have other sources of 
support available to them, like family or friends. Also, the women in our study may have 
benefited from a supportive medical staff. Finally, it is not unlikely that the monitoring 
of distress itself may have had a positive effect on women’s distress. It was not possible 
to carry out subgroup analyses due to the modest sample size of this study. One could 
hypothesize that benefits of counselling would be greater for those people who started 
the intervention with higher levels of distress. In our opinion, future research should 
therefore be directed at identifying couples that are particularly vulnerable to distress dur-
ing their first IVF treatment cycle. Psychosocial counselling could be offered to couples 
who are most likely to benefit from additional support.
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Abstract
BACKGROUND: We discuss methodological considerations related to a study in IVF, 
which compares the effectiveness, health economics and patient discomfort of two treat-
ment strategies that differ in both ovarian stimulation and embryo transfer policies.
METHODS: This was a randomized controlled clinical trial in two large Dutch IVF cen-
tres. The tested treatment strategies are: mild ovarian stimulation [including gonadotro-
phin-releasing hormone (GnRH) antagonist co-treatment] together with the transfer of 
one embryo, versus conventional stimulation (with GnRH agonist long protocol co-treat-
ment) and the transfer of two embryos. Outcome measures are: (i) pregnancies resulting 
in term live birth; (ii) total costs per term live birth; and (iii) patient stress/discomfort per 
started IVF treatment, over a 12 month period. Power considerations for this study were 
an overall cumulative live birth rate of 45% for the conventional treatment strategy, with 
non-inferiority of the mild treatment strategy defined as a live birth rate no more than 
12.5% lower compared with the conventional study arm. For a power of 80% and alpha 
of 0.05, 400 subjects are required.
RESULTS: As planned, from February 2002 until February 2004, 410 patients were en-
rolled.
CONCLUSIONS: This effectiveness study applies an integrated medical, health economics 
and psychological approach with term live birth over a given period of time after start-
ing IVF as the end-point. Complete and timely patient enrolment vindicates many of the 
design decisions.
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Introduction 
The public health challenge for IVF today is to increase availability and acceptability and 
reduce adverse effects without compromising effectiveness. This study will address the 
methodological issues in designing a trial to test a less complex protocol against a com-
mon version of the standard current protocol.
IVF has been the treatment of choice in severe tubal infertility. For most other indica-
tions, IVF is applied as a last resort therapy after the failure of other treatment modalities. 
The high costs of the treatment, the burden of the ovarian stimulation for the patient 
and the complications [108], most notably the high chance of a multiple pregnancy and 
the associated costs, have prohibited the widespread use of IVF as a first line treatment 
option [64, 109]. However, the recent introduction of gonadotrophin-releasing hormone 
(GnRH) antagonists has opened up novel possibilities for milder stimulation protocols, 
which are better tolerated by the patient and less costly than the conventional stimulation 
regimens [110, 111]. Moreover, there is a growing awareness that the high rate of multiple 
pregnancies may be greatly reduced by a restricted, single embryo transfer (ET) policy 
[63, 65, 66, 112-114]. In theory, these developments hold promise for the future by reduc-
ing complications for both mother and child.
Single compared with dual ET has reduced success rates per fresh ET cycle, which 
can only be overcome by establishing a high-quality frozen-thawed embryo programme 
[66]. The pregnancy rates per cycle following GnRH antagonist co-treatment have been 
shown to be slightly, but significantly, inferior to those of the classical GnRH agonist long 
protocol [111]. Nevertheless, the mild stimulation approach might have advantages when 
evaluated over an entire (multiple cycle) treatment strategy, since the amount of time 
needed to complete a single IVF cycle is less and the costs of stimulation are reduced 
[110, 111]. More cycles could be performed on average in the same period of time for the 
same amount of money. Due to the better tolerability for patients, drop-out rates between 
cycles may be reduced, so that the number of patients reaching pregnancy within a given 
period of time could very well be higher compared with the conventional ovarian stimu-
lation approach, with similar costs per pregnancy [115]. Hence, a mild ovarian stimulation 
protocol with GnRH antagonist co-treatment could offer a means to compensate for 
reduced pregnancy chances when single ET is considered. Applying such an approach, 
pregnancy rates will be reduced when evaluated per cycle [63, 116], but not for a given 
treatment period, which is more relevant to the patient. The importance of defining 
success of infertility therapies as live birth per treatment started instead of per cycle has 
been stressed recently [117]. The time has come seriously to reconsider the definition of 
successful IVF [112], and design future studies accordingly. 
We designed a randomized controlled trial to investigate whether IVF using mild ovar-
ian stimulation combined with single ET is not inferior in clinical effectiveness, more 
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patient friendly and more efficient in cost-effectiveness compared with conventional 
treatment. In this report, the design of the study is presented and discussed in detail. 
Methodological considerations 
The study is designed as a two-arm randomized controlled non-inferiority effectiveness 
trial. The treatment strategies are mild ovarian stimulation with GnRH antagonist co-treat-
ment along with the transfer of a single embryo versus ‘conventional’ ovarian stimulation 
combined with pituitary downregulation through the administration of a GnRH agonist 
long protocol, and transfer of two embryos. In brief, patients with a regular indication for 
IVF (with or without the addition of ICSI), female age < 38 years, normal menstrual cycle 
(interval between periods 25–35 days) and without severe obesity or underweight (body 
mass index 18–28 kg/m2) were eligible for the study. Two academic medical centres 
(Rotterdam and Utrecht) participated in the study. Patient data are collected on standard 
patient-record forms. Patients will be followed-up for a maximum of 12 months treatment 
plus resulting pregnancy, until 6 weeks post-term. Analysis will be performed accord-
ing to the intention-to-treat principle. The primary outcome measures are: (i) pregnancy 
within 1 year after randomization leading to term live birth; (ii) total costs per term live 
birth; and (iii) patient discomfort/distress during IVF treatment. In the following, we will 
describe the background of the study and justify the choices that were made in the design 
of the study.
Treatment protocols 
The two treatment protocols were executed in a standardized fashion, as depicted in 
Figure 3.1. In the conventional, GnRH agonist long protocol, two ET arm, standard ovar-
ian stimulation is performed. After ~2 weeks GnRH agonist subcutaneously (s.c.) daily, 
starting during the mid-luteal phase of the pretreatment cycle (leuproline, 0.2mg/day; 
or triptoreline, 0.1mg/ day, depending on the clinic), ovarian stimulation is started with 
a starting dose varying between patients from 112.5 to 150 IU/day recombinant FSH 
(recFSH) s.c. The recFSH dose can be adjusted in subsequent cycles if needed. HCG 10 
000 IU s.c. is administered for the induction of final oocyte maturation, when the largest 
follicle reaches at least 18 mm in diameter and at least one additional follicle >15 mm 
is observed [110]. Oocyte retrieval and fertilization are performed according to standard 
procedures, as described previously [118, 119]. A maximum of two (best quality) em-
bryos is transferred [120]. Luteal phase supplementation by progesterone, 600mg/day, 
intravaginally is started at the evening of oocyte pick-up and continued until 12 days 
thereafter. In case good quality excess embryos are available, they are cryopreserved and 
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transferred in the subsequent unstimulated cycle, according to standard procedures [121]. 
The maximum number of IVF cycles is three. 
In the mild, GnRH antagonist co-treatment, single ET arm, mild ovarian stimulation is 
performed by a fixed starting dose of 150 IU recFSH s.c. per day, initiated on cycle day 
5. GnRH antagonist (ganirelix, 0.25mg/day; or cetrorelix, depending on the clinic) is 
administered s.c. if at least one follicle ≥14 mm is observed [110]. The starting day or dose 
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as a management trial (Sackett and Gent, 1979) and should be
distinguished from an efficacy or explanatory trial, whic
answers the question: can a treatment work under ideal circum-
stances? (World Health Organization, 1971; Haynes, 1999). In
an effectiveness trial, inclusion criteria and clinical protocols
should resemble everyday reality. We used broad inclusion cri-
teria and different pharmac utical products, according to the
daily routine in the two participating centres. The multi-centre
design in itself leads to results that are more relevant to daily
practice and less idealized than a highly controlled single
centre trial.
Two versus four arms. By combining the choice between two
ovarian stimulation strategies with the choice between single
and dual ET, four different combinations are possible, at least
in theory. The current study compares only two arms: mild
ovarian stimulation and GnRH antagonist co-treatment com-
bined with single ET versus conventional stimulation and
GnRH agonist co-treatment combined with dual ET. The rea-
son for this choice is both pragmatic (the statistical power of a
four-arm trial would be much less, given the number of partici-
pants that could feasibly be recruited) as well as conceptual
[the current comparison is between the conventional ‘gold
standard’ treatment strategy in Northern Europe at the time of
design of the study (Griesinger et al., 2005) and a new, poten-
tially more patient- and child-friendly integrated approach].
The possibility to perform more cycles in the same period of
time (because of better patient tolerance) renders mild stimula-
tion a suitable combination with single ET. More cycles mean
additional pregnancy chances, which can compensate for the
reduction in live birth rate per cycle due to the use of GnRH
antagonist co-treatment along with the transfer of a single
Figure 1. Schematic overview of the study design.
a) Conventional stimulation, 2 ET and the mild stimulation, 1ET arms
2 embryo’s 2 embryo’s 2 embryo’s
1 embryo 1 embryo 1 embryo 1 embryo
Mild stimulation
Conventional stimulation
200 patients
200 patients
b) Conventional and mild stimulation protocol per cycle 
GnRH-agonist
Rec-FSH 150 IU
CD 21 B P
Conventional Stimulation 
+ 2 ET
GnRH-antagonist
Rec-FSH 150 IU
CD 21 B P
Mild Stimulation 
+ 1 ET
CD 5 Follicle >= 14 mm
hCG
hCG
CD 21: day 21 of the preceding cycle 
B: day of bleeding 
CD 5: day 5 of the cycle 
P: day of follicle puncture for oocyte retrieval 
Figure 3.1 Schematic overview of the study design
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can be adjusted in subsequent cycles. Similar criteria apply for HCG, for oocyte retrieval 
and fertilization procedures as in the conventional group. Only the best quality embryo 
is transferred. Standard luteal phase support, and criteria to cryopreserve embryos will be 
applied as in the conventional arm. The maximum number of mild IVF cycles is four.
Background ovarian stimulation 
In conventional long-protocol ovarian stimulation, the pituitary-ovarian axis is suppressed 
through the administration of a GnRH agonist. Subsequently, ‘high dose’ gonadotrophins 
are needed over a long period of time to let the FSH levels rise above the threshold for 
ovarian stimulation, and the FSH ‘window’ is widened for an extended recruitment of 
follicles. A heterogeneous cohort of follicles is recruited in this way. 
In mild ovarian stimulation, natural recruitment of follicles is achieved by the inter-cycle 
FSH rise [122] and exogenous FSH is administered only during the mid-follicular phase, 
allowing more than one follicle to gain dominance [110]. This mode of stimulation in-
terferes less with natural follicle selection and results in a lower number of aneuploid 
embryos, as shown recently [123].
Trial design 
Effectiveness versus efficacy
The current trial is an effectiveness trial, aimed at answering the question: will the treat-
ment strategy under consideration achieve the desired benefits in everyday routine prac-
tice? This type of trial is also referred to as a management trial [124] and should be distin-
guished from an efficacy or explanatory trial, which answers the question: can a treatment 
work under ideal circumstances [125, 126]? In an effectiveness trial, inclusion criteria and 
clinical protocols should resemble everyday reality. We used broad inclusion criteria and 
different pharmaceutical products, according to the daily routine in the two participat-
ing centres. The multi-centre design in itself leads to results that are more relevant to 
daily practice and less idealized than a highly controlled single centre trial.
Two versus four arms
By combining the choice between two ovarian stimulation strategies with the choice 
between single and dual ET, four different combinations are possible, at least in theory. 
The current study compares only two arms: mild ovarian stimulation and GnRH antago-
nist co-treatment combined with single ET versus conventional stimulation and GnRH 
agonist co-treatment combined with dual ET. The reason for this choice is both pragmatic 
(the statistical power of a four-arm trial would be much less, given the number of par-
ticipants that could feasibly be recruited) as well as conceptual [the current comparison 
is between the conventional ‘gold standard’ treatment strategy in Northern Europe at the 
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time of design of the study [127] and a new, potentially more patient- and child-friendly 
integrated approach]. The possibility to perform more cycles in the same period of time 
(because of better patient tolerance) renders mild stimulation a suitable combination with 
single ET. More cycles mean additional pregnancy chances, which can compensate for 
the reduction in live birth rate per cycle due to the use of GnRH antagonist co-treatment 
along with the transfer of a single embryo. The acceptance of the proposed treatment 
strategies is illustrated by the timely accrual of patients into the study as depicted in 
Figure 3.2. 
A maximum of three fresh IVF cycles was chosen in the conventional arm, for practical 
reasons: it is the number of cycles traditionally covered by insurance in The Nether-
lands. In the new treatment strategy, one extra cycle was allowed to let patients realize 
the potential of more cycles in the same amount of time. The cumulative number of 
cycles completed by the first 200 patients included is depicted in Figure 3.3. 
The other two alternatives have a priori disadvantages: mild stimulation with dual ET 
might give more pregnancies over time, but does not reduce the twin pregnancy rate. 
Conventional stimulation with single ET does not diminish the physical and psychologi-
cal burden of the conventional stimulation regime. Lower pregnancy rates have been 
observed [63, 116] following the transfer of fresh embryos only, and similar rates when 
cryo transfer is also considered [66]. A cryo policy is also applied in the current study.
Non-inferiority versus equivalence: one-sided versus two-sided testing
The study is a non-inferiority trial. A non-inferiority trial is appropriate when a new 
intervention has fewer adverse effects and/or lower costs, and one might accept a little 
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embryo. The acceptance of the proposed treatment strategies is
illustrated by the timely accrual of patients into the study as
depicted in Figure 2.
A maximum of three fresh IVF cycles was chosen in the
conventional arm, for practical reason : it is the number of
cycles traditionally covered by insurance in The Netherlands.
In the new treatment strategy, one extra cycle was allowed to
let patients realize the potential of more cycles in the same
amount of time. The cumulative number of cycles completed
by the first 200 patients inclu ed is depicted in Figure 3.
The other two alternatives have a priori disadvantages: mild
stimulation with dual ET might give more pregnancies over
time, but does not reduce the twin pregnancy rate. Conventional
stimulation with single ET does not diminish the physical and
psychological burden of the conventional stimulation regime.
Lower pregnancy rates have been observed (De Sutter et al.,
2003b; Gerris et al., 2004) following the transfer of fresh
embryos only, and similar rates when cryo transfer is also con-
sidered (Thurin et al., 2004). A cryo policy is also applied in
the current study.
Non-inferiority versus equivalence: one-sided versus two-sided
testing. The study is a non-inferiority trial. A non-inferiority
trial is appropriate when a new intervention has fewer adverse
effects and/or lower costs, and one might accept a little less
than the benefit of the standard intervention to gain this advant-
age in adverse effects or costs. It is well established that the
overall costs of pregnancy as well as the complications are
greatly reduced by single ET, due to the elimination of twin
pregnancies (Wolner-Hanssen and Rydhstroem, 1998; Collins,
2002; De Sutter et al., 2003a; Koivurova et al., 2004; Lukassen
et al., 2004). If we are able to demonstrate that the mild stimu-
lation/single ET strategy is not worse in clinical outcome com-
pared with the conventional strategy, the reduction in multiple
pregnancies with their associated higher complications and
costs will become decisive in favour of the new strategy. Even
if the new strategy were found to be less effective, the reduc-
tion in costs may still make it the more efficient option. There-
fore, the focus in the statistical comparison will be to establish
that the mild stimulation, single ET strategy is not inferior,
within a predefined margin, to the long protocol, dual ET strat-
egy, i.e. a one-sided hypothesis.
We calculated the required sample size for the study on a
non-inferiority criterion derived from cost-effectiveness con-
siderations. We used the total costs of one IVF treatment cycle
of 1500 Euro from Goverde et al. (2000), and data regarding
costs of pregnancy, separately for singletons and for twins
from Wolner-Hanssen and Rydhstroem (1998), 5300 and
46 000 Euro, respectively, including costs of delivery, neonatal
care and disability. Furthermore, we chose 45% as the total live
birth rate in the conventional IVF arm (with a maximum of
three cycles), of whom 30% are twins, based on annual reports
of Utrecht and Rotterdam IVF data, which are compatible with
other published Dutch data (Stolwijk et al., 2000; Kremer
et al., 2002). The expected costs per live birth would then be
26 000 Euro. We assumed that the mild stimulation, one ET
strategy (with a maximum of four cycles) could have a lower
cumulative live birth rate but also lower costs, due to the
absence of twin pregnancies. We tested a range of differences
(from –5 to –15%) in live birth rate between the new and the
conventional strategy and calculated at each specified differ-
ence the costs per extra live birth of the conventional strategy
compared with the experimental strategy. This cost-effectiveness
ratio varied from 90 000 Euro (at a difference of –5%) to
25 000 Euro (at a –15% difference). At a difference of –12.5%,
costs were 35 000 Euro. At this latter figure, we (rather arbi-
trarily, and only for the calculation of sample size) considered
the conventional strategy no longer acceptable. Therefore, we
Figure 2. Accrual rate of the trial: cumulative number of patients
included in the study against calendar time.
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Figure 3. Cumulative number of started IVF cycles per patient
against time since randomization, separately for the agonist two ET
and antagonist one ET group. Couples who became pregnant are cen-
sored: the curve represents the theoretical number of cycles in case no
one would become pregnant.
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Figure 3.2 Accrual rate of the trial: cumulative number of patients included in the study against calendar time
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less than the benefit of the standard intervention to gain this advantage in adverse effects 
or costs. It is well established that the overall costs of pregnancy as well as the complica-
tions are greatly reduced by single ET, due to the elimination of twin pregnancies [109, 
128-131]. If we are able to demonstrate that the mild stimulation/single ET strategy is 
not worse in clinical outcome compared with the conventional strategy, the reduction in 
multiple pregnancies with their associated higher complications and costs will become 
decisive in favour of the new strategy. Even if the new strategy were found to be less 
effective, the reduction in costs may still make it the more efficient option. Therefore, the 
focus in the statistical comparison will be to establish that the mild stimulation, single 
ET strategy is not inferior, within a predefined margin, to the long protocol, dual ET 
strategy, i.e. an one-sided hypothesis. 
We calculated the required sample size for the study on a non-inferiority criterion 
derived from cost-effectiveness considerations. We used the total costs of one IVF treat-
ment cycle of 1500 Euro from Goverde et al. [132], and data regarding costs of pregnancy, 
separately for singletons and for twins from Wolner-Hanssen and Rydhstroem [131], 5300 
and 46 000 Euro, respectively, including costs of delivery, neonatal care and disability. 
Furthermore, we chose 45% as the total live birth rate in the conventional IVF arm (with 
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embryo. The acceptance of the proposed treatment strategies is
illustrated by the timely accrual of patients into the study as
depicted in Figure 2.
A maximum of three fresh IVF cycles was chosen in the
conventional arm, for practical reasons: it is the number of
cycles traditionally covered by insurance in The Netherlands.
In the new treatment strategy, one extra cycle was allowed to
let patients realize the potential of more cycles in the same
amount of time. The cumulative number of cycles completed
by the first 200 patients included is depicted in Figure 3.
The other two alternatives have a priori disadvantages: mild
stimulation with dual ET might give more pregnancies over
time, but does not reduce the twin pregnancy rate. Conventional
stimulation with single ET does not diminish the physical and
psychological burden of the conventional stimulation regime.
Lower pregnancy rates have been observed (De Sutter et al.,
2003b; Gerris et al., 2004) following the transfer of fresh
embryos only, and similar rates when cryo transfer is also con-
sidered (Thurin et al., 2004). A cryo policy is also applied in
the current study.
Non-inferiority versus equivalence: one-sided versus two-sided
testing. The study is a non-inferiority trial. A non-inferiority
trial is appropriate when a new intervention has fewer adverse
effects and/or lower costs, and one might accept a little less
than the benefit of the standard intervention to gain this advant-
age in adverse effects or costs. It is well established that the
overall costs of pregnancy as well as the complications are
greatly reduced by single ET, due to the elimination of twin
pregnancies (Wolner-Hanssen and Rydhstroem, 1998; Collins,
2002; De Sutter et al., 2003a; Koivurova et al., 2004; Lukassen
et al., 2004). If we are able to demonstrate that the mild stimu-
lation/single ET strategy is not worse in clinical outcome com-
pared with the conventional strategy, the reduction in multiple
pregnancies with their associated higher complications and
costs will become decisive in favour of the new strategy. Even
if the new strategy were found to be less effective, the reduc-
tion in costs may still make it the more efficient option. There-
fore, the focus in the statistical comparison will be to establish
that the mild stimulation, single ET strategy is not inferior,
within a predefined margin, to the long protocol, dual ET strat-
egy, i.e. a one-sided hypothesis.
We calculated the required sample size for the study on a
non-inferiority criterion derived from cost-effectiveness con-
siderations. We used the total costs of one IVF treatment cycle
of 1500 Euro from Goverde et al. (2000), and data regarding
costs of pregnancy, separately for singletons and for twins
from Wolner-Hanssen and Rydhstroem (1998), 5300 and
46 000 Euro, respectively, including costs of delivery, neonatal
care and disability. Furthermore, we chose 45% as the total live
birth rate in the conventional IVF arm (with a maximum of
three cycles), of whom 30% are twins, based on annual reports
of Utrecht and Rotterdam IVF data, which are compatible with
other published Dutch data (Stolwijk et al., 2000; Kremer
et al., 2002). The expected costs per live birth would then be
26 000 Euro. We assumed that the mild stimulation, one ET
strategy (with a maximum of four cycles) could have a lower
cumulative live birth rate but also lower costs, due to the
absence of twin pregnancies. We tested a range of differences
(from –5 to –15%) in live birth rate between the new and the
conventional strategy and calculated at each specified differ-
ence the costs per extra live birth of the conventional strategy
compared with the experimental strategy. This cost-effectiveness
ratio varied from 90 000 Euro (at a difference of –5%) to
25 000 Euro (at a –15% difference). At a difference of –12.5%,
costs were 35 000 Euro. At this latter figure, we (rather arbi-
trarily, and only for the calculation of sample size) considered
the conventional strategy no longer acceptable. Therefore, we
Figure 2. Accrual rate of the trial: cumulative number of patients
included in the study against calendar time.
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Figure 3. Cumulative number of started IVF cycles per patient
against time since randomization, separately for the agonist two ET
and antagonist one ET group. Couples who became pregnant are cen-
sored: the curve represents the theoretical number of cycles in case no
one would become pregnant.
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Figure 3.3 Cumulative number of started IVF cycles per patient against time since randomization, separately for the agonist two ET and 
antagonist one ET group. Couples who became pregnant are censored: the curve represents the theoretical number of cycles in case no one 
would become pregnant.
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a maximum of three cycles), of whom 30% are twins, based on annual reports of Utrecht 
and Rotterdam IVF data, which are compatible with other published Dutch data [2, 133]. 
The expected costs per live birth would then be 26 000 Euro. We assumed that the mild 
stimulation, one ET strategy (with a maximum of four cycles) could have a lower cumu-
lative live birth rate but also lower costs, due to the absence of twin pregnancies. We 
tested a range of differences (from –5 to –15%) in live birth rate between the new and 
the conventional strategy and calculated at each specified difference the costs per extra 
live birth of the conventional strategy compared with the experimental strategy. This 
cost-effectiveness ratio varied from 90 000 Euro (at a difference of –5%) to 25 000 Euro 
(at a –15% difference). At a difference of –12.5%, costs were 35 000 Euro. At this latter 
figure, we (rather arbitrarily, and only for the calculation of sample size) considered the 
conventional strategy no longer acceptable. Therefore, we used a difference in live birth 
rate between the experimental and the conventional strategy of –12.5% as the critical 
threshold for non-inferiority. 
The number of patients should be at least 200 per arm (400 in total) to assure with 
80% power that the lower boundary of the 95% one-sided confidence interval around the 
difference in live birth rate between the experimental and the conventional group will not 
fall below –12.5%, in case there is no difference in reality. The use of a one-sided alpha 
is allowed in this case since we have a non-inferiority trial [134]. Normally, one-sided 
confidence intervals are treated with disdain because they prohibit testing a treatment 
effect in the direction opposite to that anticipated. Here, the opposite direction would be 
that the new strategy is really inferior. However, it would be of no concern that the new 
strategy were so inferior that the difference was statistically significant: as long as the 
difference remains—with 95% confidence—within the predefined noninferiority margin, 
it is not clinically relevant.
Randomization
Block randomization, stratified by clinic, was applied to achieve balance between the two 
groups within each centre. Randomization was performed by sealed envelopes available 
at a central location in both centres. Envelopes were opened by the treating physician 
at the IVF intake. As appropriate for an effectiveness trial, the analysis will be according 
to the intention-to-treat principle, meaning that all patients will be analysed in the group 
into which they were randomized, whether they received the allocated treatment or 
not. This also applies to patients who cross over to the other treatment group. Again, this 
is in line with the spirit of an effectiveness trial, since in everyday practice patients may 
also display a preference for a treatment modality other than the one they started with.
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Numerator: cumulative live birth as end-point
We defined as primary outcome a pregnancy leading to a term live birth. Term live birth is 
defined as live birth after a normal gestational length of 37–42 weeks. The debate is ongo-
ing as to whether twins should be regarded as a success [112] or as a complete medical 
failure. From the clinical perspective, a term twin birth without complications is definitely 
a success. However, the increased rates of complicated deliveries, preterm births and 
low birth weight (all giving rise to increased chances for perinatal morbidity or mortality) 
associated with twin pregnancies have led to the opinion that medical intervention in 
infertility should preferably aim at establishing a singleton pregnancy [112]. Our choice 
of term live birth as primary outcome was made to give a fair advantage to healthy twin 
births, instead of counting all twins as a failure. In this way, the increased chance of 
complications of twins will be expressed in the higher rate of preterm deliveries and 
discounted proportionally in the outcome.
Denominator: per treatment period versus per cycle
For an effectiveness trial, the natural focus is not on the (technical) results per cycle, but 
rather on the overall result that a patient may expect over a given treatment period [117]. 
Therefore, we have chosen an analysis per treatment period, which will allow the treat-
ment strategy that is best tolerated by the patients and requires the least amount of time 
per cycle, to realize more treatment cycles—thus more ‘chance exposure’—than the other 
treatment strategy. We will use the Kaplan–Meier method, in which the usual censoring 
will be applied to couples who are still under treatment, but who do not yet have the 
maximum follow-up at the time of analysis. In contrast, drop-outs who do not wish to 
receive any more treatment will be assumed to have a zero chance of the outcome, i.e. 
a pessimistic assumption [135]. In this way, we establish a statistical penalty for drop-out 
due to intolerability of the treatment. The time period of analysis will start from the mo-
ment of randomization, to avoid post-randomization selective drop-out. 
Health economics considerations
The economic evaluation of the study uses the societal perspective, which is central to 
health economics as it explicitly considers the question of how to get the most benefit 
from the scarce resources available to a society [136]. It implies that not only medical 
costs, i.e. costs made within the health care sector, should be included, but also non-
medical costs, when relevant. For both medical and non-medical costs, we consider direct 
costs, defined as directly related to the health care problem (infertility) and treatment 
(IVF) under consideration, as well as indirect costs, which are made after the treatment 
period. 
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The costs of the two IVF strategies at hand can be broken down into two stages: (i) 
the costs of IVF treatment itself, starting with the first IVF cycle and ending with the 
outcome of the last IVF cycle (being pregnant, no pregnancy or drop-out); and (ii) the 
costs of antenatal, peripartal and post-partum care in women who have become pregnant 
after IVF treatment. Since the applied ET policy during treatment will affect costs during 
pregnancy, the cost analysis should include all costs from the start of the first IVF cycle 
up to and including the costs of post-partum care. Post-partum costs will be counted until 
6 weeks post-term, since the term period (40 weeks gestation) is the only time horizon 
that is uniformly applicable to all patients. Costs are measured as the product of health 
care resource use (‘volumes’) and cost per unit estimates (‘prices’). 
The costs of IVF treatment are broken down into direct medical costs in the hospital 
and outside the hospital, as well as non-medical direct costs. Direct medical costs in the 
hospital consist of scheduled and unscheduled out-patient visits, number of IVF cycles, 
personnel time per cycle, use of GnRH analogues and recFSH, costs of ultrasound and 
hormonal monitoring, the ET procedure and costs associated with complications. Out-
side hospital costs consist of GP visits, while indirect non-medical costs include travel 
and time costs and absence from work/sick leave due to treatment or complications. 
Cost volumes in the treatment stage are recorded with case record forms (CRFs), hospital-
based management and budgetary information systems, patient questionnaires and the 
literature. Prices of hospital-based care are estimated as ‘true’ economic costs (including 
fixed costs and overheads), as variable costs and in terms of reimbursement fees. Out of 
hospital care is priced with reference values for The Netherlands [137]. To describe the 
variability in costs between the two centres, resource use and critical cost parameters are 
documented for each participating centre separately. 
The costs of pregnancy and obstetric care can be broken down into direct medical 
costs in the hospital (secondary obstetric care) and direct medical costs outside the hospi-
tal (e.g. primary obstetric care, GP care, etc.). The pregnant patients will receive question-
naires covering 3 month periods of their pregnancy, regarding the out of hospital costs. 
The last questionnaire covers the period around the calculated term date, until 6 weeks 
thereafter. This means that the neonatal costs are covered for a 6 week period post-term. 
For preterm births, the postnatal period that we consider will therefore be extended, 
resulting in higher costs, as is customary in studies on neonatal care [138]. 
The incidence of disabilities is markedly increased in multiple pregnancies, and the 
associated long-term costs might be included in a cost analysis [139]. In our study, we 
will add the costs related to long-term health consequences in a scenario analysis, i.e. 
we will repeat the calculations, with projected costs of lifelong disability added to the 
cost analysis. 
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Psychological considerations 
For a number of decades, outcome measures of medical interventions have not been 
restricted to rates on survival, mortality, morbidity and—in reproductive medicine—
pregnancies, but have involved other life aspects as well. Many of these are subsumed 
under the denominator of ‘quality of life’. Quality of life measures encompass: (i) global 
measures of patient satisfaction; (ii) multi-dimensional measures of health status (which 
often include social, psychological and physical dimensions); (iii) disease-specific mea-
sures that chart problems associated with a specific illness; and finally (iv) domain-
specific measures that focus on a specific psychological outcome, such as anxiety or 
depression. Case reports have shown that IVF treatment is sometimes accompanied by 
intense moments of stress and emotional instability. Aside from being caused by physical 
stimuli, this emotional instability can also be attributed to the fact that patients swing 
between hope for a successful pregnancy and fear of failure. When choosing psychologi-
cal outcomes to be included in an IVF effect study, it therefore seems essential to register 
negative emotions and moods, rather than assessing psychopathology. 
Most psychological effect studies that have been carried out in a medical setting in-
volved patients with a chronic disease. Often, retrospective questionnaires that cover a 
relatively long period of time are applied in these studies, since short-term psychological 
changes are less relevant in the context of chronic illness. In the case of episodic diseases 
or treatments (e.g. migraine and its medication), diary measures are used to monitor the 
day-to-day mood fluctuations that may accompany the different stages of the disease 
and the treatment. While the use of diary measures may reduce recollection bias [140], 
compliance with retrospective questionnaires may be better, as keeping a diary might be 
a burden to patients. In small studies, interviews are sometimes conducted to explore pa-
tients’ reactions more thoroughly. Given the complexity of IVF treatment, a combination 
of retrospective questionnaires and diary measures would be optimal for recording both 
its long-term and short-term psychological effects. 
Many previous studies examining the psychological consequences of IVF treatment 
have used depression and anxiety as their main outcome variables. These outcomes 
are usually measured at a few specific moments during IVF treatment (often before or 
after a treatment cycle) with retrospective questionnaires, such as the Spielberger’s State 
and Trait Anxiety Inventory (STAI) and Beck’s Depression Inventory (BDI). Other out-
comes that are frequently measured with retrospective questionnaires in psychological 
IVF studies are marital adjustment and self-esteem. Aside from these general adjustment 
measures, some studies have used infertility-specific stress measures. The Fertility Prob-
lem Inventory (FPI), for example, measures five domains of stress that are specific to 
infertility: social concern; sexual concern; relationship concern; need for parenthood; 
and rejection of child-free lifestyle. Infertility-specific stress measures are believed to 
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be more sensitive to patient responses to infertility and its treatment than general stress 
measures. The use of standardized diaries to measure psychological variables is not wide-
spread in the IVF field, with the exception of the Daily Record Keeping Chart [93]. This 
questionnaire has been developed to assess daily emotional, physical and social reactions 
to infertility treatment. 
In the present study, a combination of retrospective and diary measures is used to 
ascertain both the long-term and the short-term effects of IVF treatment. During the first 
IVF treatment cycle, both negative and positive affect are assessed daily with the use of 
the Daily Record Keeping Chart, which has shown good criterion-related and convergent 
validity and good internal consistency [101]. Additionally, subjects are asked to fill in 
three retrospective questionnaires at several time points during the first treatment cycle: 
after randomization (baseline), on the first day of ovarian stimulation (to assess the effects 
of pituitary downregulation) and after embryo transfer. This last moment is considered 
by many patients to be the most stressful stage of IVF treatment [60]. The retrospective 
questionnaires are also used to measure possible psychological effects during subsequent 
IVF cycles. To gain insight into possible side effects related to IVF treatment, self-reported 
physical discomfort is measured with the somatic subscale of the Hopkins Symptom 
Checklist [141]. The Dutch version of the Hopkins Symptom Checklist has shown ad-
equate to good test–re-test reliability, internal consistency and validity [142]. Addition-
ally, subjective sleep quality is measured with the Subjective Sleep Quality Scale, a Dutch 
questionnaire [143], which consists of 10 items on various aspects of sleep. This scale 
has shown good reliability and homogeneity. Finally, stress is assessed with the Hospital 
Anxiety and Depression Scale (HADS), which has been developed as a screening tool to 
detect anxiety and depression in medical patients [102]. The Dutch version of the HADS 
has shown good test–re-test reliability, homogeneity and internal consistency in previous 
studies [103].
Discussion
In the current report, we describe the design of a study attempting to answer the ques-
tion of whether the use of a mild ovarian stimulation protocol (using GnRH antagonist 
co-treatment) combined with single ET is not inferior to a conventional stimulation pro-
tocol (using GnRH agonist co-treatment) with dual ET, while resulting in reduced patient 
discomfort and lower overall costs per pregnancy. 
Success of IVF treatment has for long been focused towards technical aspects of the 
treatment: the number of follicles harvested, the fertilization rate or the implantation rate. 
The only outcome of interest to the patient, and therefore the one that should be of inter-
est to the doctor, is whether the procedure will lead to the desired result, a healthy baby 
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[117, 144, 145]. All other outcome measures are no more than surrogates for this end-
point. Treatments should be evaluated against this outcome measure. A point of ongoing 
discussion is how to define ‘healthy’. Certainly, preterm and higher order multiple births 
are outcomes that should be avoided if possible, but increased perinatal morbidity is also 
reported following twin pregnancies [112]. Should a distinction between twins versus 
higher order multiples be made or should only a singleton, term delivery be regarded as 
a success? The current study uses a term live birth as primary clinical outcome measure, 
which implies that adverse effects of multiple pregnancies will be reflected in a higher 
rate of preterm births. 
In the field of infertility treatment, the chances of success come in discrete, biologi-
cally defined, portions of time, i.e. the menstrual cycle of the woman. Because of the 
ease of analysis and the simplicity of the cycle concept, the focus in the literature on 
treatment results has been almost entirely on results per cycle, particularly in IVF. An 
improvement seems to be the reporting of cumulative pregnancy rates per patient over 
multiple cycles [117]. However, as in other medical fields, the interest of the patient will 
be how long it will take until the desired outcome is reached. Obviously, the duration of 
treatment is also related to costs. Cumulative rates over a number of cycles are not very 
informative if it remains unknown how long it will take to finish the treatment. Thus, 
the concept of assessing success rates per given time interval should be considered. In 
our study, we hypothesized that the mild stimulation method may lead to a shorter dura-
tion of a single treatment cycle and therefore the possibility to perform more cycles in the 
same amount of time compared with the conventional method. 
However, success rates—regardless of how this is defined— still should not be the 
only outcome used when comparing treatment options. The costs associated with the 
treatments, the patient discomfort, side effects and complications (mainly ovarian hyper-
stimulation syndrome and multiple pregnancies as mentioned earlier) should also be part 
of the equation. In the current study, we measure all these aspects in order to give an in-
tegrated evaluation of the two tested treatment strategies. In the case where one treatment 
strategy is comparable with the other as far as success is concerned, but with a reduced 
complication rate, and better in the psychological and cost dimensions, it is clearly pref-
erable. In other cases, the costs and patient stress and discomfort will be related to the 
success rate in a cost-effectiveness analysis. The preferability will then depend on how 
high the extra costs and psychological burden of the most successful treatment strategy 
are per extra pregnancy. The design of this study allows all these aspects to be assessed 
and for a complete evaluation of two treatment strategies to be obtained.
4
Chapter 4
The psychological impact of mild ovarian 
stimulation combined with single embryo 
transfer compared with conventional IVF
C de Klerk, EMEW Heijnen, NS Macklon, HJ Duivenvoorden, 
BCJM Fauser, J Passchier and JAM Hunfeld
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Abstract
BACKGROUND: The objective of this study was to assess the psychological implications 
of mild ovarian stimulation combined with single embryo transfer (SET) during a first In 
Vitro Fertilization (IVF) cycle.
METHODS: We conducted a randomized controlled two-centre trial. Three hundred and 
ninety-one couples were randomized to undergo either mild ovarian stimulation with 
GnRH antagonist co-treatment and SET (n = 199) or conventional GnRH agonist long 
protocol ovarian stimulation with double embryo transfer (DET) (n = 192). Women com-
pleted the Hospital Anxiety and Depression Scale, the Hopkins Symptom Checklist and 
the Subjective Sleep Quality Scale at baseline, on the first day of ovarian stimulation and 
following embryo transfer. Affect was assessed daily with the Daily Record Keeping Chart 
(DRK) from the first day of ovarian stimulation until the day treatment outcome became 
known.
RESULTS: The conventional IVF group experienced elevated levels of physical and de-
pressive symptoms during pituitary downregulation. At oocyte retrieval, this group ex-
perienced more positive affect and less negative affect than the mild IVF group. In the 
conventional IVF group, cycle cancellation was associated with less positive and more 
negative affect.
CONCLUSIONS: During the first IVF treatment cycle, mild ovarian stimulation and SET 
does not lead to more psychological complaints than conventional IVF.
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Introduction
Ovarian stimulation for In Vitro Fertilisation (IVF) with the use of gonadotrophin-releasing 
hormone (GnRH) agonist co-treatment is not without health risks. Between 0.1 and 0.5 
percent of women receiving ovarian stimulation will develop ovarian hyperstimulation 
syndrome (OHSS) [6]. Furthermore, IVF combined with multiple embryo transfer is asso-
ciated with a high incidence of multiple pregnancy [112]. In 2001, ~26% of IVF deliveries 
in Europe were multiples [146]. As compared to IVF singleton pregnancies, IVF twin 
pregnancies are associated with a higher incidence of pre-eclampsia, lower birth weight 
and gestational age and higher frequency of sick leave and hospitalization [147].
Apart from health risks, standard IVF treatment can be an emotional burden to patients. 
According to a study by Olivius et al. [96], psychological distress is the main reason 
why many patients drop out of IVF treatment before they have received all reimbursed 
treatment cycles. The authors reported a cumulative drop-out rate of 54% after two free 
cycles. Many couples have to face treatment failure, which seems to be related to an 
increased prevalence of subclinical anxiety and depression in women [41]. Furthermore, 
IVF treatment itself with its daily injections, scans and invasive procedures, such as 
oocyte retrieval, might be a cause of psychological distress in patients. There is some 
evidence that ovarian suppression with the use of GnRH agonists can cause symptoms of 
depression, anxiety [5] and headache [4] in patients. Multiple pregnancy may also be as-
sociated with emotional distress in parents. In a recent study, mothers with IVF multiples 
seemed to experience more parenting stress than mothers with either naturally conceived 
or IVF singletons [53].
In recent years, the clinical availability of GnRH antagonists has facilitated the develop-
ment of milder ovarian stimulation protocols for IVF [62]. Milder stimulation is likely to 
be associated with fewer side effects and a lower risk of OHSS than standard ovarian 
stimulation [64]. Moreover, in a recent randomized study, pregnancy rates per started 
IVF cycle after mild ovarian stimulation with GnRH antagonist co-treatment were similar 
to a standard long GnRH agonist protocol [110]. Single embryo transfer (SET) offers the 
most efficient means of reducing the incidence of multiple pregnancy. Although a slightly 
reduced pregnancy rate per cycle may occur, similar overall pregnancy rates have been 
reported when the transfer of cryopreserved embryos is included [66]. However, little is 
known regarding the psychological disadvantages or benefits of the use of mild stimula-
tion protocols and SET. To date, there has been one study addressing patients’ satisfac-
tion with minimal stimulation protocols [68]. In this study, patients receiving minimal 
stimulation (unstimulated cycle or clomiphene citrate) reported fewer side effects and 
stress related to hormone treatment and cycle cancellation compared to conventional 
stimulation. Among the minimal stimulation group, however, non-pregnant patients were 
less likely to prefer the same treatment protocol for future ovarian stimulation than preg-
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nant patients. This suggests that patients who fail to conceive with minimal stimulation 
IVF start to question the effectiveness of low stimulation protocols. Likewise, most IVF 
couples seem to be more concerned about the possible higher risk of treatment failure 
associated with SET than about potential maternal, foetal and neonatal complications 
related to multiple embryo transfer [69]. Many infertile couples actually consider multiple 
birth to be a favourable treatment outcome [71]. Also, IVF patients are concerned about 
possible psychological and physical effects of increased length of treatment associated 
with SET [148]. Since the duration of GnRH antagonist co-treatment is shorter compared 
with treatment with GnRH agonists, the use of mild ovarian stimulation protocols might 
facilitate the acceptability of SET [149].
In this randomized controlled trial, potential psychological implications of mild ovarian 
stimulation in combination with SET were assessed. Self-reported physical and psycho-
logical complaints of women undergoing mild ovarian stimulation using GnRH antago-
nist co-treatment combined with SET were compared to those of women undergoing 
conventional IVF treatment (GnRH agonist long protocol with double embryo transfer 
(DET)). We aimed to ascertain whether the combination of mild ovarian stimulation and 
SET reduces physical and psychological complaints related to medical procedures or 
whether this mild approach leads to more psychological complaints related to doubts 
about the effectiveness of treatment. In this chapter, the results of the first treatment cycle 
are presented.
Materials and methods
Subjects
Between February 2002 and February 2004, women admitted to an IVF programme at the 
Erasmus MC (Rotterdam, The Netherlands) and the University Medical Centre (Utrecht, 
The Netherlands) were invited to participate in this study. To exclude women for whom 
either mild stimulation or SET would not be suitable, the study was limited to women 
aged < 38, with a regular menstrual cycle (25–35 days) and a body mass index between 
18 and 28 kg/m2 [77]. Only couples with no previous unsuccessful IVF treatment were 
included. Since women had to be able to read and write Dutch to complete the question-
naires, only women who spoke Dutch were selected. Three hundred and eighty-eight 
women agreed to participate in the study.
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Intervention
Conventional stimulation with DET
In the conventional, GnRH agonist long protocol, DET group, standard ovarian stimula-
tion was performed. After daily administering GnRH agonist subcutaneously (s.c.) (leu-
proline, 0.2 mg/day; or triptoreline, 0.1 mg/day) for ~2 weeks from the mid-luteal phase 
of the pretreatment cycle onwards, ovarian stimulation was started with a starting dose 
between 112.5 and 150 IU/day recombinant follicle-stimulating hormone (recFSH) s.c. 
Human chorionic gonadotrophin (hCG) 10 000 IU s.c. was administered to induce final 
oocyte maturation, when the largest follicle had reached at least 18 mm in diameter 
and at least one additional follicle > 15 mm had been observed. Oocyte retrieval and 
fertilization in vitro was performed according to standard procedures as described previ-
ously [118, 119]. A maximum of two (best quality) embryos was transferred [120]. Luteal 
phase supplementation with progesterone, 600 mg/day, intravaginally was started on the 
evening of the oocyte retrieval and continued for 12 days.
Mild stimulation with SET
In the mild, GnRH antagonist co-treatment, SET group, mild ovarian stimulation was 
performed with a fixed starting dose of 150 IU recFSH s.c. per day, initiated on the fifth 
cycle day. GnRH antagonist (ganirelix, 0.25 mg/day; or cetrorelix, 0.25 mg/day) was 
administered s.c. when at least one follicle ≥ 14 mm was observed [110]. Similar criteria 
applied for hCG, oocyte retrieval, fertilization and luteal phase support procedures as in 
the conventional IVF group. Only the best quality embryo was transferred [120].
Measures
Demographics
Information on women’s demographics and infertility history was gathered from medical 
records and patient questionnaires.
Daily Record Keeping Chart (DRK)
Infertility-specific distress was measured with the DRK [93, 101]. The DRK consists of 
21 items that represent emotional reactions common to women undergoing infertility 
treatment. Each item is rated on a 4-point-Likert scale (‘none’ to ‘severe’). Scores on 
four subscales (range 0–12) can be obtained: depression/anger, uncertainty, anxiety and 
positive affect. The depression/anger, uncertainty and anxiety subscales can be combined 
into one negative affect scale (range 0–36). The DRK has shown good criterion-related 
validity and good convergent validity with other conceptually related scales, such as 
the Spielberger State Anxiety Inventory. The DRK has shown good internal consistency: 
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Cronbach coefficient alphas varied from 0.76 to 0.88 for the individual subscales, while 
the coefficient alpha for the negative affect scale was 0.87 [101]. The original items of the 
DRK were translated into Dutch in a previous study [150].
Hospital Anxiety and Depression Scale (HADS)
The HADS [102] was developed as a screening tool to detect anxiety and depression in 
medical patients. This questionnaire does not include physical symptoms of anxiety and 
depression, such as insomnia and weight loss, to avoid bias as a result of coexisting 
medical conditions. Each of the two subscales (range 0–21) of the HADS consists of seven 
items, which are scored on a 4-point-Likert scale from 0 to 3. Subjects were asked how 
they had felt during the last week. The Dutch version of the HADS [103] has shown good 
test-retest reliability, homogeneity and internal consistency. Cronbach alphas for the total 
scale and both subscales ranged from 0.71 to 0.90.
Hopkins Symptom Checklist (HSCL)
To gain insight into possible physical side effects related to IVF treatment, self-reported 
physical complaints were measured with the somatic subscale of the HSCL [141]. Indi-
viduals were asked to score how they had felt during the past week on eight items, which 
were rated on a 4-point-Likert scale from 0 (‘not at all’) to 3 (‘extreme’). The Dutch ver-
sion of the HSCL has shown adequate to good test-retest reliability, internal consistency 
and validity [142]. Cronbach alphas from 0.68 to 0.78 were found for this subscale, while 
test-retest correlation coefficients ranged from 0.71 to 0.86.
Subjective Sleep Quality Scale (SSQS)
Subjective sleep quality was assessed with the SSQS, a Dutch questionnaire [143] that 
consists of 10 dichotomous (‘yes’ and ‘no’) items on various aspects of sleep (e.g. ‘I easily 
fall asleep’, ‘I often wake up several times during the night’). Subjects were asked to rate 
their sleeping problems during the past week. The SSQS has shown high reliability and 
homogeneity: Cronbach alphas varied between 0.84 and 0.87, while the item homogene-
ity coefficients (Loevingers H) ranged from 0.48 and 0.50.
Study design
This psychological study is part of a randomized controlled trial, which encompasses the 
medical, economical and psychological evaluation of mild ovarian stimulation combined 
with SET.
Four hundred and one couples were randomized according to a computer-generated 
random-numbers table into either the mild IVF arm (n = 205) or the conventional IVF arm 
(n = 196) by one of the researchers. Block-randomization, stratified by clinic, was applied 
to achieve balance between the two groups within each hospital. For this psychological 
The psychological impact of mild stimulation combined with single embryo transfer 53
study, women who spoke Dutch were selected (n = 388). Women completed the HADS, 
the HSCL and the SSQS after they had received their stimulation schedule (baseline), on 
the first day of ovarian stimulation and again some days (range: 0–15) following embryo 
transfer. In addition, women’s affect was measured daily with the DRK during 1 week 
at baseline and again from the first day of ovarian stimulation until the day treatment 
outcome became known.
Procedure
This study was reviewed and approved by the Ethical Review Boards of both participat-
ing clinics. Couples were verbally informed about the study during information evenings 
for couples about to start their first IVF cycle. During these meetings, all couples received 
written information with regard to the study. In Rotterdam, patients who met the eligi-
bility criteria were invited to participate in the study by their fertility physician during 
the IVF planning consultation. In Utrecht, couples received an invitation by one of the 
medical researchers either on the day of their first medical appointment or during the in-
formation evening. After the objectives of the study were discussed, both partners signed 
an informed consent form. Randomization was carried out using sealed envelopes. Enve-
lopes were opened by the fertility physician or one of the researchers. Women received a 
booklet containing the psychological questionnaires. At the time of this study, three IVF 
treatment cycles were covered by health insurances in The Netherlands. Couples in the 
mild IVF group received an additional reimbursed treatment cycle to compensate for the 
possible lower birth rate associated with mild ovarian stimulation combined with SET.
Statistical analyses
Demographic data were analysed using Student’s t-test for continuous variables and χ2-
test for categorical variables. Analyses of covariance (ANCOVAs) were performed for the 
HADS scores, the HSCL scores and the SSQS scores, while controlling for the baseline 
scores. For the analysis of the DRK scores, a distinction was made between seven in-
dividual IVF treatment stages: baseline, ovarian stimulation, oocyte retrieval, fertiliza-
tion, embryo transfer, waiting period and pregnancy test. Stage scores for both positive 
and negative affect were calculated by averaging daily scores on the DRK within each 
treatment stage. ANCOVAs were conducted for group comparisons of both positive and 
negative affect during each individual treatment stage, adjusting for baseline affect scores. 
Analyses for the day of the pregnancy test were also statistically controlled for pregnancy 
outcome.
To determine changes in affect over treatment for all subjects, including women whose 
first IVF cycle got cancelled, random effects regression analysis was conducted. Random 
effects regression allows for missing observations, assessments at different end-points, 
time-independent co-variables and time-dependent co-variables. Individual time trend 
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curves are based on the available data from a specific individual and data from all other 
subjects: intercepts represent estimated baseline functioning, while slopes characterize 
change in functioning over time. Since affect is strongly related to treatment outcome, 
the first treatment cycle was divided into periods: the period before treatment outcome 
was known (from baseline until the waiting days) and the day that treatment outcome 
became known.
In the random effects regression analyses for stage scores from baseline until the wait-
ing period, both dependent variables (negative affect and positive affect) were modelled 
on the basis of a random intercept term, a random effect representing time (stage) in 
treatment, and fixed effects representing treatment (mild IVF versus conventional IVF) 
and cancellation (yes or no). In a second series of random effects regression analyses, 
both dependent variables were modelled on the basis of a random intercept term, a 
random effect representing time (before versus after treatment outcome) in treatment, 
and fixed effects representing treatment (mild IVF versus conventional IVF), pregnancy 
(no versus yes), and cancellation (no or yes). Interaction terms were entered into the 
models if it made sense both clinically and statistically. All models were adjusted for the 
time-independent co-variable hospital (Rotterdam versus Utrecht) and were fitted using 
restricted maximum likelihood measures. The covariance matrix was specified as unstruc-
tured (general covariance). All analyses were performed using the Statistical Package for 
the Social Sciences (SPSS version 10.1), while random effects regression models were 
implemented with the PROC MIXED procedure of SAS System (version 8.2). Significance 
testing on all outcome measures was done at 0.05 level of significance (two-tailed). Effect 
sizes were measured using Cohen’s d [105]. The standard deviation (SD) of the conven-
tional IVF group was used as the denominator of Cohen’s d.
Results
Demographics
Of the 388 couples that were recruited, 29 couples did not receive their allocated interven-
tion (See Figure 4.1). Table 4.1 shows the demographic characteristics for the remaining 
women in both the mild and the conventional IVF group. No significant differences were 
found for any of the demographic variables between groups. Twenty-six women failed 
to return their psychological questionnaires. Drop-outs did not differ from participants 
on most demographics, with the exception of the number of previous children. Of the 
drop-outs, 25.5% (12 out of 47) had one or more children of their own at the time they 
started treatment, while 13.3% (37 out of 278) of the participants were parents.
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Psychological and physical complaints related to pituitary downregulation
Table 4.2 shows the adjusted means and 95% confidence intervals (CIs) of the scores on 
the HADS, the HSCL and the SSQS for both the mild and the conventional IVF group 
at three points during the first IVF treatment cycle. To assess the possible physical and 
psychological complaints related to downregulation, group comparisons (ANCOVA) were 
made for all scores on the first day of ovarian stimulation. Women in the conventional IVF 
group reported more depressive symptoms (P < 0.01, two-tailed) and more physical dis-
comfort (P < 0.01, two-tailed) in the week before the first day of ovarian stimulation (last 
week of downregulation) than women in the mild IVF group (no downregulation). In that 
week, women undergoing pituitary downregulation reported more frequent headache, 
lower back pain and muscle pain than women in the control group. Effect sizes of these 
differences were small (Cohen’s d = 0.43) and medium (Cohen’s d = 0.57), respectively. 
Exploratory analyses showed that 5.2% (8 out of 154) of women in the conventional IVF 
group scored above the cut-off score for probable depressive disorder against 2.4% (4 out 
of 170) of women in the control group.
Psychological and physical complaints during each individual IVF stage
In Table 4.3, the adjusted means and 95% CI of the DRK scores are shown for both groups 
for each individual treatment stage. ANCOVAs showed that the mild and the conventional 
IVF groups did not differ significantly on positive or negative affect for most individual 
treatment stages, with the exception of the day of oocyte retrieval. On this day, women 
in the mild IVF group scored higher on negative affect (P = 0.03, two-tailed) and lower 
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25.5% (12 out of 47) had one or more children of their own at
the time they started treatment, while 13.3% (37 out of 278) of
the participants were parents.
Psychological and physical complaints related to pituitary 
downregulation
Table II shows the adjusted means and 95% confidence intervals
(CIs) of the scores on the HADS, the HSCL and the SSQS for
both the mild and the co vention  IVF group at three points
during the first IVF treatment cycle. To assess the possible
physical and psychological complaints related to downregula-
tion, group comp risons (ANCOVA) were made for all scores
on the first day of ovarian stimulation. Women in the conven-
tional IVF group reported more depressive symptoms (P<
0.01, two-tailed) and more physical discomfort (P<0.01, two-
tailed) in the week before the first day of ovarian stimulation
(last week of downregulation) than women in the mild IVF
group (no downregulation). In that week, women undergoing
pituitary downregulation reported more frequent headache,
lower back pain and muscle pain than women in the control
group. Effect sizes of these differences were small (Cohen’s d=
0.43) and medium (Cohen’s d= 0.57), respectively. Explora-
tory a alyses showed that 5.2% (eight out of 154) of women in
the conventional IVF group scored above the cut-off score for
probable depressive disorder against 2.4% (four out of 170) of
women in the control group.
Psychological and physical complaints during each 
individual IVF stage
In Table III, the adjusted means and 95% CIs of the DRK
scores are shown for both groups for each individual treatment
stage. ANCOVA showed that the mild and the conventional
IVF groups did not differ significantly on positive or negative
affect for most individual treatme t stages, with the exception
of the day of oocyte retrieval. On this day, women in the mild
IVF group scored higher on negative affect (P=0.03, two-tailed)
and lower on positive affect (P=0.01, two-tailed) than women
in the conventional IVF group. However, the effect sizes of
these differences were small (Cohen’s d=–0.28 and Cohen’s
d= 0.32, respectively). No group differences were found on
HADS, HSCL and SSQS sc res during the waiting days.
Positive and negative affect over time (first IVF cycle)
The results of the random effects regression analyses evaluat-
ing changes in positive and negative affect fro  baseline until
the waiting period are presented in Table IV. For positive
affect, a significant effect for treatment by cancellation was
found (P< 0.01). Women in the conventional IVF group whose
first treatment cycle was cancelled experienced less positive
Figure 1. CONSORT statement flow diagram. ET  embryo transfer; TVE=transvaginal endoscopy.
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6*: spontaneous pregnancy 
1*: relationship problems 
2*: stop IVF 
1*: forced to stop IVF 
Reason 
4*: spontaneous pregnancy 
7*: switched ET-strategy 
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4*: stop IVF 
1*: stop research protocol 
1*: uterus bicornis on TVE 
Allocation 
Analysis 
Lost to follow-up 
n=13 
Discontinued strategy 
n=19 
Analysed 
n=174 
Analysed 
n=159 
Lost to follow-up 
n=13 
Follow Up 
Table I. Demographic characteristics of mild and conventional IVF groups
Demographic variable Mild IVF 
(n=187)
Conventional IVF 
(n=172)
Age (years) mean (SD) 33.0 (2.9) 32.7 (3.3)
Duration of wish for a child 
(years) mean (SD)
3.6 (1.9) 3.6 (2.1)
Duration of infertility 
(years) mean (SD)
3.9 (2.0) 3.6 (2.0)
Cause of infertility (%)
Female 19.8 25.0
Male 49.2 52.3
Female and male 5.3 4.7
Unknown cause 25.7 18.0
One or more previous children (%) 17.6 14.6
Highest level of education (%) (n=173) (n=159)
Primary education 0.6 3.1
Secondary education 63.0 61.0
Higher education 36.4 35.8
Figure 4.1 CONSORT statement flow diagram. ET = embryo transfer; TVE = transvaginal echoscopy
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on positive affect (P = 0.01, two-tailed) than women in the conventional IVF group. How-
ever, the effect sizes of these differences were small (Cohen’s d = –0.28 and Cohen’s d = 
0.32, respectively). No group differences were found on HADS, HSCL and SSQS scores 
during the waiting days.
Positive and negative affect over time (first IVF cycle)
The results of the random effects regression analyses evaluating changes in positive and 
negative affect from baseline until the waiting period are presented in Table 4.4. For posi-
tive affect, a significant effect for treatment by cancellation was found (P < 0.01). Women 
in the conventional IVF group whose first treatment cycle got cancelled experienced less 
positive affect during treatment than women in the mild IVF group with a cancelled first 
cycle. Significant effects for time were found for both positive and negative affect. The 
day of oocyte retrieval was associated with more negative and less positive affect than 
other treatment stages.
In Table 4.5, the results are presented of the random effects regression analyses evalu-
ating changes in positive and negative affect from the period before treatment outcome 
to the day that treatment outcome became known. For positive affect, a significant effect 
for treatment by cancellation was found (P < 0.01). Women in the conventional IVF 
group with a cancelled first cycle experienced less positive affect on the day their treat-
ment was cancelled than women undergoing mild IVF. For negative affect, a significant 
effect for time by treatment was found (P < 0.01). Women undergoing conventional IVF 
Table 4.1 Demographic characteristics of mild and conventional IVF groups
Demographic variable Mild IVF
(n = 187)
Conventional IVF
(n = 172)
Age (years)
   Mean (SD) 33.0 (2.9) 32.7 (3.3)
Duration of wish for a child (years)
   Mean (SD)  3.6 (1.9)  3.6 (2.1)
Duration of infertility (years)
   Mean (SD)  3.9 (2.0)  3.6 (2.0)
Cause of infertility (%)
   Female
   Male
   Female and male
   Unknown cause
19.8
49.2
 5.3
25.7
25.0
52.3
 4.7
18.0
One or more previous children (%) 17.6 14.6
Highest level of education (%)
   Primary education
   Secondary education
   Higher education
(n = 173)
 0.6
63.0
36.4
(n = 159)
 3.1
61.0
35.8
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experienced more negative affect on the day treatment outcome became known than the 
mild IVF group. Significant effects were found for time and time by pregnancy for both 
positive and negative affect. Women experienced more negative and less positive affect 
on the day treatment outcome became known than during treatment, especially women 
who were not pregnant.
Table 4.4 Random effects regression models for positive and negative affect (DRK) from intake until the waiting days
Positive affect ba (95% CI) Negative affect ba (95% CI)
Intercept 5.7 (± 0.6)b 9.4 (± 1.2)b
Stage: baseline 1.7 (± 0.3)b -3.5 (± 0.7)b
Stage: stimulation 1.0 (± 0.3)b -1.9 (± 0.7)b
Stage: oocyte retrieval -0.1 (± 0.3) 2.6 (± 0.7)b
Stage: fertilization 0.2 (± 0.3) -0.6 (± 0.7)
Stage: embryo transfer 1.5 (± 0.3)b -0.2 (± 0.7)
Stage: waiting days 0.0 (± 0.0) 0.0 (± 0.0)
Treatment (0=SET, 1=DET) 0.6 (± 0.7) -0.8 (± 1.2)
Cancellation (0=no, 1=yes) 0.5 (± 1.1) 0.5 (± 1.7)
Hospital (0=Rotterdam, 1=Utrecht) 0.0 (± 0.6) -0.7 (± 1.2)
Time x treatment 
Treatment x cancellation -2.6 (± 1.8)b
a b = unstandardized regression coefficient.
b Significant effect (P < 0.05).
SET = single embryo transfer; DET = double embryo transfer.
Table 4.5 Random effects regression models for positive and negative affect (DRK) from before until after treatment outcome
Positive affect ba (95% CI) Negative affect ba (95% CI)
Intercept
 
6.6 (± 0.6)b
 
8.1 (± 1.3)b
Time (0=before outcome, 1=after outcome) -4.6 (± 0.4)b 10.9 (± 1.0)b
Treatment (0=SET, 1=DET) 0.6 (± 0.6) 0.1 (± 1.5)
Pregnancy (0=no, 1=yes) -0.6 (± 0.7) 2.0 (± 2.3)
Cancellation (0=no, 1=yes) 0.7 (± 1.0) 0.4 (± 1.8)
Hospital (0=Rotterdam, 1=Utrecht) 0.1 (± 0.6)  -0.5 (± 1.3)
Time x treatment  1.7 (± 1.4)b
Time x pregnancy 6.3 (± 0.6)b  -9.9 (± 1.6)b
Treatment x pregnancy  -2.6 (± 2.9)
Treatment x cancellation -3.0 (± 1.7)b
a  b = unstandardized regression coefficient.
b Significant effect (P < 0.05).
SET = single embryo transfer; DET = double embryo transfer.
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Discussion
The objective of this study was to investigate whether mild ovarian stimulation in com-
bination with SET represents a more patient-friendly alternative for conventional IVF 
treatment. In this study, pituitary downregulation with GnRH agonist was associated with 
elevated levels of physical discomfort. Women who were undergoing pituitary down-
regulation more frequently reported symptoms such as headache, abdominal pain and 
sore muscles, in the week before the start of ovarian stimulation compared to the control 
group. During subsequent treatment stages, however, no differences were found with 
regard to physical discomfort between the two study groups. This suggests that mild 
ovarian stimulation might not be milder in terms of experience for the patient. Since 
the average cycle duration is shorter for mild stimulation protocols, patients suffer from 
physical complaints for a shorter period of time.
In line with previous research [5], pituitary downregulation with GnRH agonist was 
associated with elevated levels of symptoms of depression in the current study. However, 
average depression scores did not reach the cut-off score defining clinical depression in 
either group. Furthermore, the percentage of women that showed probable depression 
disorder was just a little higher in the conventional IVF group than in the control group. 
During most corresponding treatment stages, women in the mild IVF group did not differ 
from the conventional IVF group in terms of self-reported psychological symptoms. At 
oocyte retrieval, however, the mild IVF group showed significantly more negative and 
less positive affect than women undergoing conventional IVF. It must be noted that the 
clinical relevance of this finding might be limited, since effect sizes of these differences 
were small. Nonetheless, there might be a change of attitude needed in the way fertility 
physicians view the mild IVF approach. Since some of the fertility physicians were a little 
sceptical about the mild stimulation protocol, it is possible that these physicians were 
more inclined to show negative reactions towards mild IVF patients at oocyte pick-up. 
Furthermore, patients receiving mild IVF might have compared their results with the 
results of patients who were treated with standard IVF treatment which might also have 
influenced how patients in the mild IVF group perceived their chance of success. In 
future, information provision about expected results throughout treatment might reduce 
concerns about effectiveness in patients.
Consistent with the findings of Højgaard et al. [68], the results of this study suggest 
that cycle cancellation is associated with a less positive and a more negative mood in 
women undergoing conventional IVF than in women who undergo mild IVF. When cycle 
cancellation occurs, women undergoing mild IVF have usually been through a few days 
of ovarian stimulation only. Women in the conventional IVF group, on the other hand, 
have already invested much more in their treatment at that time. Aside from a few days 
of ovarian stimulation, they have also been through 1–2 weeks of medication in order 
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to achieve pituitary downregulation. Another explanation for this finding could be the 
fact that women undergoing mild stimulation were offered a maximum of four instead of 
three reimbursed cycles in conventional IVF.
The attrition rate of the study was just 14.2% (55 out of 388). After randomization, 
seven couples in the conventional IVF group preferred SET to DET. None of the couples 
that were randomized into the mild IVF group changed their minds about having SET 
before treatment had started. Only 26 women failed to return their booklet with question-
naires. Not all women who did return their booklet provided scores on all time points, 
probably because of the complexity and the frequency of the measurements. This might 
have led to an underestimation of symptoms, since one could hypothesize that filling 
in questionnaires would have been a greater burden to women who were experiencing 
more symptoms.
Another limitation of this study is that no records were kept on non-respondents. It is 
therefore not entirely clear how representative the study group is for all patients that are 
eligible for mild ovarian stimulation combined with SET. Based on the average number 
of couples which undergo IVF treatment annually in the two participating hospitals and 
who would qualify for the study (n = 300), the estimated response rate is 64.7% (388 out 
of 600). This estimated number of patients who were willing to undergo SET is relatively 
high in comparison with other studies on patient attitudes towards SET. In a study by 
Pinborg et al. [151], for example, only 25% of 870 interviewed IVF mothers would agree 
to SET. However, 25% of these women would reconsider accepting SET, if offered more 
than the usual number of covered treatment cycles. In the present study women in the 
mild IVF group were offered four reimbursed treatment cycles instead of the usual three, 
which may have been an incentive to participate.
One could expect that psychological complaints in women undergoing mild IVF would 
only emerge after a negative treatment outcome. In the study by Højgaard et al. [68], 
patients undergoing minimal ovarian stimulation were less likely to prefer the same treat-
ment protocol for future ovarian stimulation after treatment failure. In the current study, 
women in the mild IVF group actually experienced less negative affect on the day of 
pregnancy test than women in the conventional IVF group, although this difference was 
only marginally significant. Future research is needed to study psychological consequenc-
es of mild IVF during later cycles. What if overall treatment fails? Maybe then women will 
start wondering whether or not they chose the best treatment protocol available.
In conclusion, these first results suggest that mild stimulation in combination with SET 
represents a patient-friendly alternative for conventional IVF. Mild stimulation protocols 
circumvent the need for pituitary downregulation, which is associated with symptoms of 
depression, headache, lower back pain and muscle pain. Possible concerns with regard 
to the effectiveness that may arise during treatment (especially around the day of oocyte 
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retrieval) might be reduced if objective information concerning treatment and expected 
results is provided during all stages of treatment.
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Abstract
BACKGROUND: Mild in-vitro fertilization (IVF) treatment might lessen both patients’ dis-
comfort and multiple births, with their associated risks. We aimed to test the hypothesis 
that mild IVF treatment can achieve the same chance of a pregnancy resulting in term 
live birth within 1 year compared with standard treatment, and can also reduce patients’ 
discomfort, multiple pregnancies, and costs.
METHODS: We did a randomized, non-inferiority effectiveness trial. 404 patients were 
randomly assigned to undergo either mild treatment (mild ovarian stimulation with go-
nadotropin-releasing hormone [GnRH] antagonist co-treatment combined with single em-
bryo transfer) or a standard treatment (stimulation with a GnRH agonist longprotocol and 
transfer of two embryos). Primary endpoints were proportion of cumulative pregnancies 
leading to term live birth within 1 year after randomization (with a non-inferiority thresh-
old of −12.5%), total costs per couple up to 6 weeks after expected date of delivery, and 
overall discomfort for patients. Analysis was by intention to treat. This trial is registered 
as an International Standard Randomized Clinical Trial, number ISRCTN35766970.
FINDINGS: The proportions of cumulative pregnancies that resulted in term live birth 
after 1 year were 43.4% with mild treatment and 44.7% with standard treatment (absolute 
number of patients = 86 for both groups). The lower limit of the one-sided 95% CI was 
−9.8%. The proportion of couples with multiple pregnancy outcomes was 0.5% with 
mild IVF treatment versus 13.1% (P < 0.0001) with standard treatment, and mean total 
costs were € 8333 and € 10 745, respectively (difference € 2412, 95% CI 703–4131). There 
were no significant differences between the groups in the anxiety, depression, physical 
discomfort, or sleep quality of the mother.
INTERPRETATION: Over 1 year of treatment, cumulative rates of term live births and 
patients’ discomfort are much the same for mild ovarian stimulation with single embryos 
transferred and for standard stimulation with two embryos transferred. However, a mild 
IVF treatment protocol can substantially reduce multiple pregnancy rates and overall 
costs.
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Introduction
In-vitro fertilisation (IVF) is a complex treatment for infertility that entails costly regimens 
for ovarian stimulation [7], serious discomfort to patients [64] and substantial risks of com-
plications [6, 112]. Ovarian stimulation protocols aim to generate many oocytes to com-
pensate for inefficiencies in laboratory procedures and to generate several embryos for 
transfer into the uterus. Conventional ovarian stimulation protocols include co-treatment 
with gonadotropin-releasing hormone (GnRH) agonists, to desensitise the pituitary gland 
[152]. By contrast, GnRH antagonists can be administered on only those days in the mid-
to-late follicular phase of the menstrual cycle during which there is a risk of a premature 
rise in luteinising hormone (LH). This method allows the endogenous intercycle rise in 
follicle-stimulating hormone (FSH) to be utilised rather than suppressed [122]. Mild stimu-
lation protocols, in which exogenous FSH is given only in the mid-to-late follicular phase, 
have been shown to be feasible for stimulation of growth of several dominant follicles for 
IVF [64, 110]. Although reduction in effectiveness per cycle is a potential drawback of co-
treatment with GnRH antagonists [111, 153], mild stimulation protocols could also lessen 
patients’ discomfort by diminishing symptoms associated with pituitary downregulation 
[64]. The resultant reduction in drop-outs could create additional pregnancy chances in 
subsequent IVF cycles [96].
Because (higher-order) multiple pregnancies are associated with increases in infant 
mortality and morbidity, they are seen as the most important complication of IVF treat-
ment [112]. The financial effect of multiple births on health-care resources has been 
shown to be greater than the cost of IVF treatment itself [109, 154]. Multiple pregnancies 
due to IVF treatment can be avoided by transfer of a single embryo [155]. The reported 
decrease in the chance of pregnancy per cycle after single embryo transfer could possibly 
be overcome by establishment of a high-quality cryopreservation programme for surplus 
embryos (which would provide additional pregnancy chances in subsequent cycles) [66], 
or by additional IVF cycles [156]. A growing number of northern European centres offer 
single embryo transfer as standard practice for young women [157]. However, widespread 
implementation of single embryo transfer is hindered by a perceived need to ensure the 
maximum chance of pregnancy per cycle [115].
Strategies with shorter ovarian stimulation protocols (such as GnRH antagonist co-treat-
ment) and transfer of a single embryo could allow more IVF cycles in the same period 
as conventional treatment, and produce a similar proportion of term live births, despite a 
minor reduction in the proportion of term live births per treatment cycle. Moreover, mild 
strategies could reduce patients’ discomfort and diminish costs associated with multiple 
pregnancies. We aimed to test this hypothesis—i.e., that a mild IVF protocol could produce 
a similar proportion of term live births to conventional treatment in the same period, and 
also reduce patients’ discomfort, multiple pregnancies, and total costs per couple [158].
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Methods
Participants and study design
We recruited patients with an indication for IVF or intracytoplasmic sperm injection on 
the basis of tubal, male, or unexplained infertility at two academic medical centres in 
Rotterdam and Utrecht between February, 2002, and March, 2004.18 Eligible patients had 
had no previous IVF treatment or had borne a healthy child after previous IVF treatment, 
were aged younger than 38 years, and had a menstrual cycle length of 25–35 days and a 
body-mass index of 18–28 kg/m² [158].
This study was designed as a parallel-group randomized, open-label, non-inferiority 
effectiveness trial [158]. The study protocol was approved by the local ethics review 
committee of the Erasmus Medical Centre, Rotterdam, and the University Medical Cen-
tre, Utrecht. Written informed consent was obtained from all patients before they were 
randomly assigned to mild or standard treatment groups. To compensate for a possible 
reduction in probability of pregnancy per IVF cycle, patients in the mild treatment group 
were offered reimbursement of one extra cycle in addition to the three cycles normally 
reimbursed in the Netherlands. We estimated that within 1 year of the start of treatment, 
most patients undergoing standard treatment could complete up to three cycles, whereas 
those undergoing the shorter mild treatment could complete up to four cycles [158].
Procedures and assessment
The randomization sequence was computer-generated; random blocks of size four and 
six were stratified by centre to maintain balance between the two treatment groups within 
each centre. The resultant sets of treatment assignments were put into numbered sealed 
envelopes and made available at each centre; envelopes were sequentially allocated to 
consecutive patients and opened by treating physicians at IVF planning consultations.
One treatment group was given mild ovarian stimulation, consisting of GnRH antagonist 
co-treatment, combined with single embryo transfer, and the other was given standard 
ovarian stimulation with the GnRH agonist longprotocol, combined with transfer of two 
embryos [158]. Supernumerary high-quality embryos were cryopreserved and thawed for 
transfer in a subsequent unstimulated cycle before the start of a new IVF treatment cycle. 
These frozen-thawed embryo-transfer cycles were treated as a part of the previous IVF 
cycle. In both groups either one or two cryopreserved embryos were transferred, accord-
ing to the patient’s preference. Intervals between IVF cycles were determined by logistic 
reasons and patients’ preference. Patients were treated by independent physicians.
The costs of the two IVF strategies for the financial year 2004 were divided into two 
stages: treatment itself, up to the outcome of the last IVF cycle, and antenatal, peripartum, 
and postpartum care until 6 weeks after the expected delivery date in women who con-
ceived within the treatment period [158]. Costs of miscarriages and ectopic pregnancies 
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were also taken into account. Data on resource use were collected for each individual 
from case-record forms and questionnaires. Real medical costs were calculated from a 
societal perspective, by use of the microcosting method [159].
The Hospital Anxiety and Depression Scale (range 0–21), the somatic subscale of Hop-
kins Symptom Checklist (range 0–24), and the Subjective Sleep Quality Scale (range 
10–0), were used to assess patients’ stress (anxiety and depression), physical discomfort, 
and sleep quality, respectively [158]. Women completed these questionnaires at baseline 
(just after randomization), directly after the first embryo transfer, and 1 week after the 
outcomes of subsequent cycles (such as cancellations or pregnancy tests) [158]. For as-
sessment of patients’ discomfort, the areas under the cumulative score within 12 months 
were compared between study groups by use of ANCOVA, after adjustment for baseline 
scores.
Primary outcome measures were pregnancy and term live birth within 1 year of ran-
domization; total costs per couple and child up to 6 weeks after expected delivery; and 
patients’ discomfort [158].
Statistical analysis
200 patients per group were needed to assure with 80% power that the lower limit of 
the 95% one-sided CI for the difference in the proportion of term live births was within a 
prespecified non-inferiority boundary of 12.5% [158]. The standard treatment strategy was 
assumed to have a 45% cumulative chance of success [158]. Data were analysed accord-
ing to the principle of intention to treat. All pregnancies within 1 year of randomization 
were analysed, whether achieved by IVF, cryopreservation, intrauterine insemination, or 
spontaneous conception. To ensure that the comparison of treatment strategies was not 
affected by patients who changed to a different stimulation protocol or embryo-transfer 
policy, another analysis was done without these patients. The Kaplan-Meier method 
was used to calculate the 1-year cumulative proportion of pregnancies leading to term 
live births; patients who withdrew from IVF treatment were not censored. Spontaneous 
pregnancies after patients withdrew from treatment were included in analysis. Patients 
who achieved a continuing pregnancy that did not lead to term live birth were censored 
when they became pregnant. Cumulative term singleton live births were calculated by 
the same method.
To show that 1 year was sufficient for most patients to finish treatment, we calculated 
the proportion of term live births after four IVF cycles with mild treatment and three 
cycles with standard treatment. Couples who did not start a subsequent cycle within 6 
months received a questionnaire to obtain all information about pregnancies that hap-
pened within 1 year after randomization. We analysed all cycles finished before 1 year 
after randomization—whether cancelled, pregnant, or non-pregnant.
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We calculated costs for each cycle and also total costs per patient, accumulated over 
1 year. Patients who withdrew before 1 year were assumed to have incurred no further 
costs related to treatment. Difference in mean total costs between the two treatments 
was calculated with a two-sample t test [158]. The difference in cumulative percentages 
was used to represent the difference in mean cost-effects (since pregnancy is a binary 
outcome). This trial is registered as an International Standard Randomized Clinical Trial, 
number ISRCTN74651862.
Role of the funding source
This study was funded by ZonMw (Netherlands), programme Doelmatigheidsonderzoek. 
This funding source had no role in study design, data collection, analysis, interpretation, 
or writing of the report. The first author had full access to all data and final responsibility 
for the decision to submit the paper for publication.
Results
404 patients were included in the study, and randomly assigned to either mild or standard 
treatment groups (Figure 5.1). The mild and standard groups did not differ from each 
other in terms of baseline clinical and demographic characteristics (Table 5.1). We did 
769 IVF cycles in 1 year (444 in the 205 patients treated with a mild IVF strategy and 
325 in the 199 patients treated with standard protocols). For mild treatment, the mean 
number of started cycles was 2.3 (SD 1.2); the mean for oocyte retrievals was 1.8 (1.1); 
and a mean of 1.5 (1.0) embryo transfers were done in 1 year. For standard treatment, 
these means were 1.7 (1.0), 1.6 (0.9), and 1.4 (0.9), respectively (P < 0.0001, 0.008, and 
Table 5.1 Baseline demographics and clinical characteristics of patients assigned to mild or standard treatment
Mild (n = 205) Standard (n = 199)
Age woman (years)  32.9 (3.1)  32.8 (3.2)
Body-mass index (kg/m²)  23.0 (2.6)  23.2 (2.5)
Duration of infertility (years)   3.6 (1.9)   3.6 (2.1)
Primary infertility  73.7%  72.9%
Child after previous IVF treatment   6.4%   5.6%
Cause of infertility
   Male 108 (53%) 113 (57%)
   Tubal  31 (15%)  36 (18%)
   Unexplained  55 (27%)  36 (18%)
   Other  11 (5%)  15 (8%)
Values are mean (SD) or number (%) of patients.
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0.5, respectively, by use of the t test). Table 5.2 shows cycle-specific characteristics of the 
IVF cycles finished within 1 year.
Of 96 continuing pregnancies (positive heartbeat on ultrasonography 10 weeks after 
embryo transfer) in the mild treatment group during the year-long study, 11 were spon-
taneous, 78 arose from fresh embryo transfer, six were from cryopreserved embryos, 
and one took place after so-called escape intrauterine insemination due to low ovarian 
response to stimulation. Of 102 continuing pregnancies in the standard treatment group, 
four were spontaneous, 93 happened after fresh embryo transfer, and five were from 
cryopreserved embryos. 86 term live births were produced in each of the two groups 
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livebirths after four IVF cycles with mild treatment and 
three cycles with standard treatment. Couples who did not 
start a subsequent cycle within 6 months received a 
questionnaire to obtain all information about pregnancies 
that happened within 1 year after randomisation. We 
analysed all cycles fi nished before 1 year after random-
isation—whether cancelled, pregnant, or non-pregnant. 
We calculated costs for each cycle and also total costs 
per patient, accumulated over 1 year. Patients who 
withdrew before 1 year were assumed to have incurred 
no further costs related to treatment. Diff erence in mean 
total costs between the two treatments was calculated 
with a two-sample t test.18 The diff erence in cumulative 
percentages was used to represent the diff erence in mean 
cost-eff ects (since pregnancy is a binary outcome). This 
trial is registered as an International Standard 
Randomised Clinical Trial, number ISRCTN74651862. 
Role of the funding source
This study was funded by ZonMw (Netherlands), 
programme Doelmatigheidsonderzoek. This funding 
source had no role in study design, data collection, 
analysis, interpretation, or writing of the report. The fi rst 
author had full access to all data and fi nal responsibility 
for the decision to submit the paper for publication.
Results
404 patients were included in the study, and randomly 
assigned to either mild or standard treatment groups 
(fi gure 1). The mild and standard groups did not diff er 
from each other in terms of baseline clinical and 
demographic characteristics (table 1). We did 769 IVF 
cycles in 1 year (444 in the 205 patients treated with a mild 
IVF strategy and 325 in the 199 patients treated with 
standard protocols). For mild treatment, the mean number 
of started cycles was 2·3 (SD 1·2); the mean for oocyte 
retrievals was 1·8 (1·1); and a mean of 1·5 (1·0) embryo 
transfers were done in 1 year. For standard treatment, 
these means were 1·7 (1·0), 1·6 (0·9), and 1·4 (0·9), 
respectively (p<0·0001, 0·008, and 0·5, respectively, by 
use of the t test). Table 2 shows cycle-specifi c characteristics 
of the IVF cycles fi nished within 1 year.
Of 96 continuing pregnancies (positive heartbeat on 
ultrasonography 10 weeks after embryo transfer) in the 
mild treatment group during the year-long study, 11 were 
spontaneous, 78 arose from fresh embryo transfer, six 
were from cryopreserved embryos, and one took place 
after so-called escape intrauterine insemination due to 
low ovarian response to stimulation. Of 102 continuing 
pregnancies in the standard treatment group, four were 
spontaneous, 93 happened after fresh embryo transfer, 
and fi ve were from cryopreserved embryos. 86 term 
livebirths were produced in each of the two groups after 
1 year of treatment.
Figure 2 compares the 1-year cumulative proportion of 
pregnancies that produced term livebirths—43·4% with 
mild IVF treatment and 44·7% with the standard protocol. 
Standard IVF treatment resulted in 1·3% more term 
livebirths than mild treatment; the lower limit of the one-
sided 95% CI was −9·8%. The proportion of multiple 
pregnancies per couple during 1 year of IVF treatment 
was 0·5% (95% CI 0–2·7) with the mild strategy and 
13·1% (8·7–18·6) with the standard strategy (p<0·0001, 
 404 patients randomised
 205 assigned mild IVF 
  treatment
 199 assigned standard IVF
  treatment
 444 IVF cycles in 1 year  325 IVF cycles in 1 year
 193 first cycles
 136 second cycles
 78 third cycles
 31 fourth cycles
 6 fifth cycles
 186 first cycles
 98 second cycles
 35 third cycles
 6 fourth cycles
 0 fifth cycles
 36 discontinued treatment
 4 before first cycle
 8 after first cycle
 12 after second cycle
 12 after third cycle
 3 other (1 after Crohn’s disease diagnosis,
             1 due to partner having 25% chance of  
             Huntington’s disease, 1 due to 0% 
             spermatozoon)
      1 problems in relationship
 4 treatment burden too high
 3 problems in relationship
 1 unknown
 3 treatment burden too high
 2 medical reasons
 2 unknown
 2 adoption
 2 problems in relationship
 1 other (diagnosis of mamma carcinoma)
 6 medical reasons
 3 treatment burden too high
 2 unknown
 1 adoption
 32 discontinued treatment
 6 before first cycle
 11 after first cycle
 15 after second cycle
 0 after third cycle
 3 other (1 due to 0% spermatozoon, 
             2 due to stress)
 2 problems in relationship
 1 treatment burden too high
 5 unknown
 4 treatment burden too high
 2 other (1 total fertilisation failure, 
            1 persistent endometriosis cyst) 
 6 unknown
 5 treatment burden too high
 3 medical reasons
 1 adoption
Mild (n=205) Standard (n=199)
Age of women (years) 32·9 (3·1) 32·8 (3·2)
Body-mass index (kg/m²) 23·0 (2·6) 23·2 (2·5)
Duration of infertility (years) 3·6 (1·9) 3·6 (2·1)
Primary infertility 73·7% 72·9%
Child after previous IVF treatment 6·4% 5·6%
Cause of infertility
Male 108 (53%) 113 (57%)
Tubal 31 (15%) 36 (18%)
Unexplained 55 (27%) 36 (18%)
Other 11 (5%) 15 (8%)
Values are mean (SD) or number (%) of patients.
Table �: Baseline demographics and clinical characteristics of patients 
assigned to mild or standard treatment
Figure �: Trial profi le
Reason for withdrawals do not include pregnancy or preference for another stimulation protocol or embryo 
transfer policy. 
Figure 5.1 Trial profile
Note: Reason for withdrawals do not include pregnancy or preference for another stimulation protocol or embryo transfer policy.
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after 1 year of treatment. Figure 5.2 compares the 1-year cumulative proportion of preg-
nancies that produced term live births—43.4% with mild IVF treatment and 44.7% with 
the standard protocol. Standard IVF treatment resulted in 1.3% more term live births than 
mild treatment; the lower limit of the onesided 95% CI was −9.8%. The proportion of mul-
tiple pregnancies per couple during 1 year of IVF treatment was 0.5% (95% CI 0–2.7) with 
the mild strategy and 13.1% (8.7–18.6) with the standard strategy (P < 0.0001, χ² test). 
Table 5.3 shows the characteristics of children born from pregnancies within 12 months 
after randomization. The proportion of miscarriages was 15.0% with mild treatment and 
17.1% with standard treatment.
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χ² test). Tabl  3 shows the characteristics of children born 
from pregnancies within 12 months after randomisation. 
The proportion of miscarriages was 15·0% with mild 
treatment and 17·1% with tandard treatment. Figure 2 
shows that th  cumulative proportion of pregnancies 
leading to singleton term livebirth after 1 year was 43·4% 
in the mild group and 35·7% in the standard group.
36 and 32 patients withdrew from mild and standard 
treatment, respectively, for reasons shown in fi gure 1. 
Although these patients withdrew at various stages 
during treatment, the study design allowed comparison 
of drop-out rates only for the fi rst two treatment cycles. 
The drop-out rate for mild treatment was 5·1% after the 
fi rst cycle and 11·2% after the second, compared with 
9·1% and 19·5%, respectively, for standard treatment. 
The drop-out rate per cycle was signifi cantly lower in the 
mild treatment group than in the standard group (odds 
ratio=0·53, 95% CI 0·28–0·98, p=0·04, corrected for 
cycle number). Patients who withdrew were signifi cantly 
younger than were those who fi nished treatment, with a 
mean age of 32·3 years (SD 3·4) and 33·3 years (3·2), 
respectively (p=0·047). However, those who withdrew did 
not have signifi cantly diff erent durations of infertility 
(p=0·4) or pregnancy histories (p=0·7). Cycle cancellation 
or the number of oocytes retrieved did not signifi cantly 
aff ect drop-out rates (p=0·4 and p=0·6, respectively, 
corrected for cycle number). 12 patients (6%) given mild 
treatment and 15 (8%) given standard treatment switched 
to another stimulation protocol or embryo-transfer 
strategy. When these patients were excluded from 
analysis, the 1-year cumulative proportion of pregnancies 
leading to term livebirth was 43·2% in the mild group 
and 44·6% in the standard group. 
The proportion of pregnancies leading to a term 
livebirth was 50·3% after completion of three standard 
cycles and 52·4% after completion of four mild cycles. 
The diff erence, of 2·1% in favour of the mild strategy, 
has a lower one-sided 95% confi dence bound of −6·6%. 
Table 4 shows the lower total costs associated with mild 
treatment (diff erence €2412, 95% CI 703–4131). Therefore, 
the incremental costs per additional pregnancy leading 
to term livebirth with standard treatment, compared with 
mild treatment, would be €185 000 (diff erence €2412, 
success rate 0·447–0·434), with a lower 95% CI of €22 000 
(determined by 5000 bootstrap samples). 
Figure 3 shows the distribution of unadjusted scores 
for four psychological variables during the fi rst year after 
randomisation for the mild and standard treatment 
groups. We found no diff erence in non-response to 
Mild treatment
(n=444)
Standard treatment
(n=325)
p
Duration of ovarian stimulation (days) 8·3 (2·2) 11·5 (3) <0·0001*
Duration of injections (days) 8·5 (2·7) 25·3 (6·8) <0·0001*
Total dose of follicle stimulating hormone (IU) 1307 (529) 1832 (758) <0·0001*
Cancellation of started cycle 80 (18·0%) 27 (8·3%) <0·0001†
Number of oocytes per  retrieval 6·9 (4·8) 8·5 (4·3) <0·0001*
‡Number of embryos per retrieval 2·8 (2·7) 3·8 (2·9) 0·0002*
Number of cryopreserved embryos per fresh embry transfer cycle 0·9 (1·8) 0·6 (1·4) 0·04*
Continuing pregnancy per started cycle (fresh embryos) 78 (17·6%) 93 (28·6%) <0·0001†
Continuing pregnancy per started cycle (cryopreserved embryos) 6 (1·4%) 4  (1·2%) 0·8†
Term livebirth per started cycle (fresh embryos) 70 (15·8%) 78 (24·0%) 0·003†
Term livebirth per started cycle (cryopreserved embryos) 49 (1·1%) 3 (0·9%) 0·8†
§Ovarian hyperstimulation syndrome 6 (1·4%) 12 (3·7%) 0·04†
Values are mean (SD) or number (%) of cycles. *t test for diff erence or †Pearson χ² test for diff erence. ‡Embryos suitable for embryo transfer. §Mild, moderate, and severe 
ovarian hyperstimulation syndrome.
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Figure �: Proportions of pregnancies leading to cumulative term livebirth 
within 12 months after starting IVF
Mild: mild ovarian stimulation with GnRH antagonist and single embryo transfer 
Standard: standard ovarian stimulation with GnRH antagonist and dual embryo 
transfer. The shaded area represents the singleton livebirth rate after 12 months. 
Figure 5.2 Proportions of pregnancies leading to cumulative term livebirth within 12 months after starting IVF
Note:
Mild: mild ovarian stimulation with GnRH antagonist and single embryo transfer. Standard: standard ovarian stimulation with GnRH antagonist 
and dual embryo transfer. The shaded area represents the singleton livebirth rate after 12 months.
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Figure 5.2 shows that the cumulative proportion of pregnancies leading to singleton 
term live birth after 1 year was 43.4% in the mild group and 35.7% in the standard 
group.
36 and 32 patients withdrew from mild and standard treatment, respectively, for rea-
sons shown in Figure 5.1. Although these patients withdrew at various stages during 
treatment, the study design allowed comparison of drop-out rates only for the first two 
treatment cycles. The drop-out rate for mild treatment was 5.1% after the first cycle and 
11.2% after the second, compared with 9.1% and 19.5%, respectively, for standard treat-
Table 5.2 Cycle-specific characteristics of IVF cycles finished within 1 year
Mild
(n = 444)
Standard
(n = 325)
P
Duration of ovarian stimulation (days)    8.3 (2.2)   11.5 (3) < 0.0001*
Duration of injections (days)    8.5 (2.7)   25.3 (6.8) < 0.0001*
Total dose of follicle stimulating hormone (IU) 1307 (529) 1832 (758) < 0.0001*
Cancellation of started cycle   80 (18%)   27 (8.3%) < 0.0001†
Number of oocytes per retrieval    6.9 (4.8)    8.5 (4.3) < 0.0001*
‡ Number of embryos per retrieval    2.8 (2.7)    3.8 (2.9)   0.0002*
Number of cryopreserved embryos per fresh embryo transfer cycle    0.9 (1.8)    0.6 (1.4)   0.04*
Continuing pregnancy per started cycle (fresh embryos)   78 (17.6%)   93 (28.6%) < 0.0001†
Continuing pregnancy per started cycle (cryopreserved embryos)    6 (1.4%)    4 (1.2%)   0.8†
Term livebirth per started cycle (fresh embryos)   70 (15.8%)   78 (24.0%)   0.003†
Term livebirth per started cycle (cryopreserved embryos)   49 (1.1%)    3 (0.9%)   0.8†
§ Ovarian hyperstimulation syndrome    6 (1.4%)   12 (3.7%)   0.04†
Values are mean (SD) or number (%) of cycles. *t-test for difference or †Pearson χ2 test for difference. ‡Embryos suitable for embryo transfer. § 
Mild, moderate and severe ovarian hyperstimulation syndrome.
Table 5.3 Pregnancy outcome following mild and standard IVF treatment
Mild strategy Standard strategy
Singleton Multiple* Singleton Multiple
Livebirths (total) 91 1 76 26
Liveborn children 91 3 76 51†
Term livebirth ( ≥ 27 weeks’ gestation) 86 0 69 17
Late preterm live birth
(≥ 32-37 weeks’ gestation)
 2 0  6  6
Early preterm live birth
(< 32 weeks’ gestation)
 3 1  1  3
Birth weight (kg)‡  3.34 (0.76) 1.34  3.35 (0.76)  2.34 (0.73)
*One set of triplets were born in the mild treatment group after intrauterine insemination in a cycle that was cancelled because of monofollicular 
growth. †One twin pregnancy resulted in one intrauterine death and one livebirth. ‡Birthweight is mean (SD). For multiple pregnancies the mean 
birthweight of the twins or triplets was used to calculate the overall mean birthweight per treatment group. The difference in distribution of 
term, late preterm, and early preterm livebirths between the standard and mild treatment group is significant (P = 0.04, χ2 test with continuity 
correction).
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ment. The drop-out rate per cycle was significantly lower in the mild treatment group 
than in the standard group (odds ratio = 0.53, 95% CI 0.28–0.98, P = 0.04, corrected for 
cycle number). Patients who withdrew were significantly younger than were those who 
finished treatment, with a mean age of 32.3 years (SD 3.4) and 33.3 years (3.2), respec-
tively (P = 0.047). However, those who withdrew did not have significantly different 
durations of infertility (P = 0.4) or pregnancy histories (P = 0.7). Cycle cancellation or the 
number of oocytes retrieved did not significantly affect drop-out rates (P = 0.4 and P = 
0.6, respectively, corrected for cycle number). 12 patients (6%) given mild treatment and 
15 (8%) given standard treatment switched to another stimulation protocol or embryo-
transfer strategy. When these patients were excluded from analysis, the 1-year cumulative 
proportion of pregnancies leading to term live birth was 43.2% in the mild group and 
44.6% in the standard group.
The proportion of pregnancies leading to a term live birth was 50.3% after completion 
of three standard cycles and 52.4% after completion of four mild cycles. The difference, 
of 2.1% in favour of the mild strategy, has a lower one-sided 95% confidence bound of 
−6.6%.
Table 5.4 shows the lower total costs associated with mild treatment (difference € 2412, 
95% CI 703–4131). Therefore, the incremental costs per additional pregnancy leading 
to term live birth with standard treatment, compared with mild treatment, would be 
€ 185 000 (difference € 2412, success rate 0.447–0.434), with a lower 95% CI of € 22 000 
(determined by 5000 bootstrap samples).
Figure 5.3 shows the distribution of unadjusted scores for four psychological variables 
during the first year after randomization for the mild and standard treatment groups. We 
found no difference in non-response to questionnaires between the two groups (47% 
for both, P = 0.8). Responders did not differ from the nonresponders in age (P = 0.7), 
duration of infertility (P = 0.9), or pregnancy history (P = 0.07). However, non-response 
Table 5.4 Total costs (€) of IVF treatment over 12 months including costs of pregnancies up to 6 weeks after delivery (per couple)
Mild (n = 205) Standard (n = 199) P*
IVF Treatment
   Technical Procedures 1083 (734)    991 (584) 0.16
   Medication 1626 (1088)   1737 (1069) 0.3
   Monitoring  750 (561)    576 (693) 0.006
   Indirect costs 1948 (2280)   1740 (1845) 0.3
Pregnancy and neonatal period
   Medical costs 2547 (4553)   4899 (10 746) 0.01
   Indirect costs  379 (1177)    802 (2270) 0.03
Total costs 8333 (5418) 10 745 (11 225) 0.006
Data are mean (SD). *Independent groups t-test (assuming unequal variances). Analysis includes costs of pregnancies up to 6 weeks after delivery. 
Mean costs for pregnancy are across the whole group, including those who did not achieve pregnancy.
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was associated with cycles in which no oocytes were retrieved or no embryo could 
be transferred (P = 0.0002, P < 0.0001, respectively). Non-response was not related to 
achievement of pregnancy (P = 0.24). In a multivariate analysis, only achievement of an 
embryo transfer remained statistically significant. Treatment strategy was not a significant 
factor in this analysis (P = 0.6). There were no significant differences between the two 
groups between the area under the curve for scores on the hospital anxiety and depres-
sion scale for anxiety (P = 0.9) or depression (P = 0.8), the Hopkins symptom checklist 
for physical discomfort (P = 0.5), and the subjective sleep quality scale (P = 0.3).
Discussion
Our study showed that, in women younger than 38 years, the 1-year cumulative propor-
tion of pregnancies leading to term live births was much the same with a mild strategy 
for IVF, consisting of GnRH antagonist co-treatment with single embryo transfer, as with 
the standard IVF strategy. Moreover, overall discomfort to patients was similar, despite 
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an increase in the average number of IVF cycles for the group assigned mild treatment. 
The proportion of multiple pregnancies per couple was greatly reduced with the mild 
strategy, as were the overall costs per term live birth.
Previous studies that focused on outcomes in single cycles [66, 113, 156] have shown 
that single embryo transfer in women younger than 36 years is highly effective for re-
duction of multiple pregnancies, but at the expense of the probability of pregnancy per 
cycle. Although we also noted a reduced chance of term live births per cycle for the mild 
strategy, the cumulative 1-year proportion of pregnancies that produced term live births 
was about 45% for either strategy. Therefore, the reduced chances of birth per cycle 
with mild IVF treatment should be considered in the context of its shorter and less costly 
cycles of ovarian stimulation, less risk of ovarian hyperstimulation syndrome, reduced 
rates of discontinuation of treatment, and increased numbers of IVF cycles in a set time. 
The difference between the 1-year analysis and the per-treatment-group analysis was 
small, illustrating that 1 year was long enough for most couples to complete the treatment 
strategy (three standard cycles or four mild cycles).
For calculation of the chance of a term live birth per 12 months per couple, we counted 
every live birth as equivalent to one child—i.e., we did not count term-born twins as 
two live births. Term-born twins could be perceived as a positive outcome—e.g., for 
parents who wanted more than one child the need for subsequent IVF treatments might 
be reduced. However, in addition to the distinct increase in perinatal morbidity, mortality, 
and long-term health consequences associated with twin pregnancies, parents of multiple 
pregnancies have shown to be at greater risk of depression and anxiety [160]. Consider-
ation of the benefits of single embryo transfer should also take account of the live births 
which might arise from the subsequent transfer of cryopreserved surplus embryos [66]. 
By contrast, others argue that only a singleton term live birth is a successful outcome of 
IVF [145].
We used the Kaplan-Meier method to calculate the 1-year cumulative proportion of term 
live births; this differs from standard method of censoring, which assumes that patients 
who drop out have a similar chance of pregnancy to patients who continue treatment 
[133]. Because we were able to use all information about pregnancies that happened 
within 1 year, we could do an intention-to-treat analysis of the true cumulative proportion 
of patients who achieved term live births, without making assumptions about pregnancy 
chance for those who withdrew (no censoring). The proportion of term live births we 
calculated is lower than those usually reported, since censoring masks the numbers of 
patients who discontinue treatment (e.g., because of discomfort). Censoring is therefore 
not appropriate for studies with endpoints linked to treatment-related stress.
Although the mild treatment group had more IVF cycles within 1 year, overall dis-
comfort to patients in the two groups during that year was similar. We used assessments 
of discomfort at the end of each IVF cycle to calculate the cumulative discomfort score 
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over time. Although stress levels might have varied during and between treatment cycles, 
patients’ discomfort associated with the mild strategy seemed to be stable over time, 
whereas the discomfort associated with standard treatment intensified during subsequent 
treatment cycles. The questionnaire response rate, of just 50%, was within normally re-
ported ranges for this type of psychological assessment [161], and did not differ between 
the two treatment groups (data not shown). Women who had no oocyte retrieval or no 
embryo transfer were significantly less likely to respond than were other patients, which 
could have led these features to be underestimated in both treatment groups. How-
ever, this difference is unlikely to have biased the results in favour of either treatment 
strategy.
The potential health economic benefits of single embryo transfer have been investigat-
ed in only a few studies [128, 131]. One randomized trial suggested that a single embryo 
transfer strategy was associated with lower total costs per cycle than cycles in which two 
embryos were transferred, because of the associated reduction in multiple pregnancies 
[154]. Despite the higher average number of cycles that are possible in 1 year with the 
mild strategy (and consequently the higher monitoring and indirect costs) the overall 
costs per term live birth within that time were lower than those of the standard treatment 
strategy. Savings were mainly attributable to the reduction in multiple pregnancies. We 
assessed costs for a postnatal period of only 6 weeks after the expected date of delivery, 
which resulted in a conservative estimate of the additional costs, since prematurity is also 
associated with long-term health consequences [162].
Challenges to contemporary notions of success in assisted reproduction, which em-
phasise single cycle outcomes, could facilitate further development of IVF [117]. The 
Cochrane Menstrual Disorder and Subfertility group has proposed that success should be 
defined per IVF treatment period rather than per cycle [163]. The definition of success 
could be further refined to incorporate chances for term live birth (or healthy child) per 
IVF treatment period (which could include several cycles) in relation to cost, patients’ 
discomfort, and risks of complications.
Our findings emphasise the medical, health, economic, and psychological benefits of 
mild IVF strategies in women younger than 38 years. However, if this mild IVF treatment 
strategy is to be widely implemented, IVF outcomes should be redefined in broader 
terms that encompass the interests of the couple, the child, and even the providers of 
health care. In other medical specialties, such as oncology, normal practice is to present 
success of a treatment strategy as survival per time period [164]. The chance that IVF can 
produce a healthy baby (or babies) needs to be weighed against the discomfort and risks 
of complications and costs associated with the treatment. Adoption of the endpoint of 
term delivery per time period (which might consist of several IVF cycles) would encour-
age patient-friendly stimulation protocols and single embryo transfer. In conclusion, our 
findings should encourage more widespread use of mild ovarian stimulation and single 
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embryo transfer in clinical practice. However, adoption of our mild IVF treatment strategy 
would need to be supported by counselling of both patients and health-care providers to 
redefine IVF success and explain the risks associated with multiple pregnancies [165] and 
by institution of reimbursement systems that encourage, rather than penalise, the practice 
of single embryo transfer [166].
6
Chapter 6
The psychological impact of IVF failure 
after two or more cycles of IVF with a mild 
versus standard treatment strategy
C de Klerk, NS Macklon, EMEW Heijnen, MJC Eijkemans, BCJM Fauser, 
J Passchier and JAM Hunfeld
Human Reproduction 2007; 22: 2554-8
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Abstract
BACKGROUND: Failure of IVF treatment after a number of cycles can be devastating for 
couples. Although mild IVF strategies reduce the psychological burden of treatment, fail-
ure may cause feelings of regret that a more aggressive approach, including the transfer 
of 2 embryos, was not employed. In this study, the impact of treatment failure after two 
or more cycles on stress was studied, following treatment with a mild versus a standard 
treatment strategy.
METHODS: Randomized controlled two-centre trial (ISRCTN35766970). Women were ran-
domized to undergo mild ovarian stimulation (including GnRH antagonist co-treatment) 
and single embryo transfer (n = 197) or standard GnRH agonist long-protocol ovarian 
stimulation with double embryo transfer (n = 194). Participants completed the Hospital 
Anxiety and Depression Scale prior to commencing treatment and 1 week after the out-
come of their final treatment cycle was known. Data from women who underwent two 
or more IVF cycles were subject to analysis (n = 253).
RESULTS: Women who experienced treatment failure after standard IVF treatment pre-
sented more symptoms of depression 1 week after treatment termination compared with 
women who had undergone mild IVF: adjusted mean (± 95% confidence interval) = 10.2 
(± 2.3) versus 5.4 (± 1.8), respectively, P = 0.01.
CONCLUSIONS: Failure of IVF treatment after a mild treatment strategy may result in 
fewer short-term symptoms of depression as compared to failure after a standard treat-
ment strategy. These findings may further encourage the application of mild IVF treat-
ment strategies in clinical practice.
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Introduction
The implementation of IVF treatment strategies which combine shorter and milder ovar-
ian stimulation protocols and single embryo transfer (SET) can reduce short-term side 
effects related to ovarian stimulation [161] and prevent multiple pregnancies [167]. A pos-
sible drawback of milder strategies is the higher cycle cancellation rate and the necessity 
of a greater number of treatment cycles to achieve pregnancy [64]. Women who undergo 
this type of IVF treatment may therefore have to face the uncertainty and disappointment 
related to a failed IVF cycle more frequently. This could in turn result in an increase in 
treatment related stress. However, we have recently shown that the combination of SET 
with mild ovarian stimulation in IVF results in similar overall patient discomfort over 1 
year of treatment compared with standard stimulation with the transfer of two embryos 
[167]. Furthermore, Højgaard et al. [68] suggest that treatment burden increases over cy-
cles more in women treated by a standard long protocol compared with women receiving 
mild stimulation. However, it remains unclear whether the psychological consequences 
of treatment failure after multiple cycles of mild IVF are more or less severe than failure 
of standard IVF regimens.
In general, IVF treatment failure seems to be associated with a deterioration of emo-
tional well being [31]. In a study by Verhaak et al. [41], over 20% of the women who did 
not achieve pregnancy showed subclinical depression and/or anxiety up to 6 months 
after treatment termination. It may be postulated that women who receive milder ap-
proaches in IVF are more prone to regret the choice for a new and mild treatment 
compared with women receiving the standard IVF protocol when facing overall treatment 
failure and confronting the reality of childlessness. On the other hand, reduced stress and 
discomfort during milder IVF treatment may have a positive impact on the psychological 
status afterwards, even when pregnancy was not achieved.
In the present study, self-reported symptoms of depression and anxiety 1 week after 
treatment termination in women receiving mild ovarian stimulation using GnRH antago-
nist co-treatment combined with SET were compared with women receiving standard IVF 
treatment (GnRH agonist long protocol with the transfer of two embryos). The principal 
focus of the study was the impact of unsuccessful IVF treatment on women’s psychologi-
cal well being following the mild versus standard strategy.
Materials and methods
Subjects
Couples with an indication for IVF or IVF/ ICSI were recruited at the Erasmus MC Uni-
versity Medical Centre, Rotterdam (The Netherlands) and the University Medical Centre, 
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Utrecht (The Netherlands), between February 2002 and February 2004. Only couples with 
no previous unsuccessful IVF treatment were included. The study was limited to women 
aged < 38, with a regular menstrual cycle (25–35 days) and a body mass index of 18–28 
kg/m2. These study criteria were chosen to exclude women for whom either mild stimula-
tion or SET would not normally be considered suitable. Only women who had sufficient 
knowledge of the Dutch language to fill out the questionnaires were invited to take part 
in the psychological study.
Intervention
Standard stimulation with the transfer of two embryos
In the standard treatment arm, a GnRH agonist (leuproline 0.2 mg/day; or triptoreline 
0.1 mg/day) was started in the midluteal phase of the preceding cycle. After ~2 weeks 
of GnRH agonist administration subcutaneously (s.c.), ovarian stimulation was started 
with recombinant follicle-stimulating hormone (recFSH) s.c. at a daily dose of 150 IU/
day. When the leading follicle had reached at least 18 mm in diameter and at least one 
additional follicle measured > 15 mm, human chorionic gonadotrophin (hCG) 10 000 IU 
s.c. was administered to induce final oocyte maturation. Oocyte retrieval and fertilization 
in vitro was performed according to standard procedures as described previously [118]. A 
maximum of two embryos were transferred. Good quality embryos were cryopreserved 
and thawed for transfer in a subsequent unstimulated cycle. Luteal phase supplementa-
tion with progesterone, 600 mg/day, intravaginally was started on the evening of the 
oocyte retrieval and continued for 12 days.
Mild stimulation with SET
In the mild strategy group, ovarian stimulation was performed with a fixed starting dose 
of 150 IU recFSH s.c. per day, initiated on the fifth cycle day. GnRH antagonist s.c. 
(ganirelix, 0.25 mg/day; or cetrorelix, 0.25 mg/day) was commenced when at least one 
follicle ≥ 14 mm was observed [110]. Similar criteria applied for hCG, oocyte retrieval, 
fertilization and luteal phase support procedures as in the standard IVF group. Only 
the best quality embryo was transferred. Good quality embryos were cryopreserved for 
transfer in subsequent cycles.
Measures
Demographic data (e.g. age) and information on the couple’s infertility history (e.g. 
duration of infertility) were obtained from medical records and patient questionnaires. 
The Hospital Anxiety and Depression Scale (HADS) was used to measure anxiety and 
depression experienced by subjects in the week prior to screening [102]. Both subscales 
(range 0–21) of the HADS consist of seven items, which are scored on a 4-point-Likert 
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scale from 0 to 3. Higher scores indicate the presence of more symptoms. Cut-off scores 
for possible and probable depressive and anxiety disorder are 7/8 and 10/11, respectively. 
The Dutch version of the HADS has demonstrated good test-retest reliability, homogene-
ity and internal consistency [103].
Study design
This psychological study was part of a two-arm randomized controlled, non-inferiority, 
effectiveness trial, which encompasses the medical, economical and psychological evalu-
ation of mild ovarian stimulation combined with SET. Sample size was determined by a 
power calculation of the number required to demonstrate non-inferiority of the mild strat-
egy in achieving a live birth within 12 months of commencing treatment [158]. Couples 
were randomized into either the mild treatment group (GnRH antagonist co-treatment 
combined with SET) (n = 205) or the standard treatment group (standard ovarian stimula-
tion including a GnRH agonist long-protocol combined with the transfer of two embryos) 
(n = 199). Block-randomization, stratified by clinic, was applied to achieve balance be-
tween the two groups within each hospital. The study design has recently been described 
in detail [158] and the clinical outcomes of this randomized controlled trial (RCT) have 
recently been published elsewhere [167]. Only women who had sufficient knowledge of 
the Dutch language to fill out the questionnaires were invited to take part in the psy-
chological study (n = 391). Psychological outcomes during the first cycle have recently 
been published [161]. The analyses in the present article were limited to the subgroup of 
patients that received two or more IVF cycles (n = 253). Women were asked to complete 
the HADS prior to commencing IVF treatment and one week after treatment outcome of 
every IVF cycle, with the exception of the first cycle.
Procedure
The study was approved by the Ethical Review Boards of the two participating clinics. 
Patients who met the eligibility criteria were either recruited by their treating physician 
during the IVF planning consultation (Rotterdam) or by one of the medical researchers 
before their IVF planning consultation (Utrecht). Randomization was carried out using 
sealed envelopes. Envelopes were opened by the physician/researcher after written con-
sent was obtained from both partners. Women received a booklet containing the baseline 
questionnaire. Subsequent questionnaires were sent by mail. Couples in the mild IVF 
group were offered an extra fourth reimbursed treatment cycle to compensate for the 
possible reduction in birth rate.
Statistical analyses
Demographical data were analysed using Student’s t-test for continuous variables and 
χ2-test for categorical variables. Psychological assessments from the final stimulated IVF 
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treatment cycle were used for analysis. Multivariate analysis of covariance was performed 
on depression and anxiety scores with treatment strategy as independent variable and 
pregnancy status as effect modifier, while controlling for baseline depression and anxiety 
scores. Pregnancy status was defined as being either not pregnant and no remaining 
cryopreserved embryos, not pregnant but with remaining cryopreserved embryos or preg-
nant. χ2 analysis was used to compare the percentage of women who had HADS scores 
above the cut-off between the mild and standard IVF group. All analyses were performed 
using the Statistical Package for the Social Sciences (SPSS version 10.1). Significance test-
ing on all outcome measures was done at 0.05 level of significance (two-tailed).
Results
Of the 391 women that were recruited, 32 women did not receive their allocated interven-
tion. Of the remaining group, 253 women received multiple IVF cycles (Figure 6.1). No 
significant differences between the mild and standard IVF groups were found for age, 
duration of infertility, type of infertility (primary or secondary), cause of infertility and 
baseline psychological scores (Table 6.1). Women in the mild strategy arm received more 
IVF cycles than the standard strategy group (mean = 3.45; range = 2–6 versus mean = 
2.88; range = 2–5). One hundred and thirty-seven women failed to provide endpoint psy-
chological measurements. These were considered as study drop-outs. They differed from 
participants in pregnancy status only, and no differences between drop-outs and partici-
pants were observed for baseline stress variables (Table 6.2). Twelve further women were 
dropped from the analysis, since they had missing data for either baseline psychological 
variables or pregnancy status.
The adjusted means and 95% confidence intervals of the HADS scores are depicted 
in Table 6.3. Multivariate analysis of covariance showed no main effects of treatment 
strategy. Overall, women in the mild IVF strategy arm did not differ from women in the 
standard strategy arm on psychological variables. However, a modification effect of treat-
ment strategy by pregnancy status was found for depression (P = 0.002). In the group 
of women who did not get pregnant and had no cryopreserved embryos, those who 
underwent standard IVF showed more depressive symptoms than those who underwent 
mild IVF (P = 0.007). The modification effect of treatment strategy by pregnancy status for 
anxiety was not significant, but a trend was found (P = 0.07). Again, in women who did 
not get pregnant without cryopreserved embryos, the standard IVF group demonstrated 
more symptoms of anxiety than the mild IVF group (P = 0.04).
Additionally, significant main effects of pregnancy status were found for depression (P 
< 0.001) and anxiety (P = 0.01). Pregnant women showed fewer symptoms of depression 
and anxiety than non-pregnant women. Also, the main effects of both baseline depres-
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as being either not pregnant and no remaining cryopreserved embryos,
not pregnant but with remaining cryopreserved embryos or pregnant.
x2 analysis was used to compare the percentage of women who had
HADS scores above the cut-off between the mild and standard IVF
group. All analyses were performed using the Statistical Package for
the Social Sciences (SPSS version 10.1).
Significance testing on all outcome measures was done at 0.05 level
of significance (two-tailed).
Results
Of the 391 women who were recruited, 32 women did not
receive their allocated intervention. Of the remaining group,
253 women received multiple IVF cycles (Fig. 1). No signifi-
cant differences between the mild and standard IVF groups
were found for age, duration of infertility, type of infertility
(primary or secondary), cause of infertility and baseline
psychological scores (Table 1). Women in the mild strategy
arm received more IVF cycles than the standard strategy
group (mean ¼ 3.45; range ¼ 2–6 versus mean ¼ 2.88;
range ¼ 2–5). One hundred and thirty-seven women failed to
provide endpoint psychological measurements. These were
considered as study dropouts. They differed from participants
in pregnancy status only, and no differences between dropouts
and participants were observed for baseline stress variables
(Table 2). Twelve further women were dropped from the analy-
sis, since they had missing data for either baseline psychologi-
cal variables or pregnancy status.
The adjusted means and 95% confidence intervals of the
HADS scores are depicted in Table 3. Multivariate analysis
of covariance showed no main effects of treatment strategy.
Overall, women in the mild IVF strategy arm did not differ
from women in the standard strategy arm on psychological
variables. However, a modification effect of treatment strategy
by pregnancy status was found for depression (P ¼ 0.002). In
the group of women who did not get pregnant and had no cryo-
preserved embryos, those who underwent standard IVF showed
more depressive symptoms than those who underwent mild
IVF ( P ¼ 0.007). The modification effect of treatment strategy
by pregnancy status for anxiety was not significant, but a trend
was found (P ¼ 0.07). Again, in women who did not get preg-
nant without cryopreserved embryos, the standard IVF group
demonstrated more symptoms of anxiety than the mild IVF
group (P ¼ 0.04).
Additionally, significant main effects of pregnancy status
were found for depression (P, 0.001) and anxiety (P ¼
0.01). Pregnant women showed fewer symptoms of depression
and anxiety than non-pregnant women. Also, the main effects
of both baseline depression (P, 0.001) and baseline anxiety
(P , 0.001) were significant, as well as the interaction term
baseline anxiety by treatment strategy (P ¼ 0.02). Higher base-
line depression scores were associated with higher endpoint
depression scores, and higher baseline anxiety scores were
associated with higher endpoint anxiety scores, especially in
women undergoing standard IVF. When the number of IVF
Figure 1: CONSORT statement flow diagram
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Figure 6.1 CONSORT statement flow diagram
Table 6.1 Baseline characteristics of treatment strategy groups
Variable Mild strategy
(n = 148)
Standard strategy
(n = 105)
Age (years), mean (SD)  33.0 (3.0) 32.8 (3.3)
Duration of infertility (years), mean (SD)   3.7 (1.9)  3.6 (2.2)
Type of infertility
   Primary
   Secondary
108
 40
75
30
Cause of infertility
   Female
   Male
   Both
 26
 80
 42
22
60
23
Baseline HADS-Depression (SD) (n)   2.6 (2.6) (134)  2.5 (2.5) (93)
Baseline HADS-Anxiety (SD) (n)   5.0 (3.7) (134)  4.7 (3.2) (93)
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Table 6.2 Baseline characteristics of participants versus drop-outs
Variable Participants
(n = 116)
Drop-outs
(n = 137)
Age (years), mean (SD) 33.0 (3.4) 32.9 (2.9)
Duration of infertility (years), mean (SD)  3.6 (2.0)  3.6 (2.1)
Type of infertility
   Primary
   Secondary
85
31
98
39
Cause of infertility
   Female
   Male
   Both
17
68
31
31
72
34
Treatment strategy
   Standard
   Mild
49
67
56
81
Pregnancy status after final treatment cycle
   Not pregnant
   Pregnant
47
69
73a
64
Baseline HADS-Depression (SD) (n)  2.7 (2.8) (108)  2.5 (2.3) (119)
Baseline HADS-Anxiety (SD) (n)  4.8 (3.7) (108)  4.9 (3.5) (119)
a P  = 0.05, two-tailed.
Table 6.3 Adjusted means and 95% confidence intervals for depression and anxiety (HADS) during the last stimulated IVF cycle for women with 
multiple IVF cyclesa
Depression
Mean (95% CI)
Anxiety
Mean (95% CI) n
Not pregnant, no cryopreserved embryos
   Mild strategy
   Standard strategy 
 5.4 (±1.8)
10.2 (±2.3)
 6.0 (±1.8)
10.2 (±2.4)
17
10
Not pregnant, with cryopreserved embryos
   Mild strategy
   Standard strategy 
 8.3 (±3.6)
 4.4 (±2.6)
 8.0 (±3.7) 
 7.2 (±2.7)
 4
 8
Pregnant
   Mild strategy
   Standard strategy 
 3.4 (±1.1)
 3.4 (±1.5)
 5.4 (±1.1)
 5.8 (±1.5)
42
23
a Multivariate analysis of covariance.
Table 6.4 Percentages of women with clinically relevant depression (HADS-D) and anxiety (HADS-A) scores after multiple IVF cycles
Treatment strategy
Milda Standard
Possible depression disorder, HADS-D > 7 19.4 (13/67)b 38.8 (19/49)b
Probable depression disorder, HADS-D > 10 11.9 (8/67)  8.2 (4/49)
Possible anxiety disorder, HADS-A > 7 31.3 (21/67) 40.8 (20/49)
Probable anxiety disorder, HADS-A > 10 14.9 (10/67) 26.5 (13/49)
a χ2-analysis.
b P < 0.05, two-tailed.
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sion (P < 0.001) and baseline anxiety (P < 0.001) were significant, as well as the interac-
tion term baseline anxiety by treatment strategy (P = 0.02). Higher baseline depression 
scores were associated with higher endpoint depression scores, whereas higher baseline 
anxiety scores were associated with higher endpoint anxiety scores, especially in women 
undergoing standard IVF. When the number of IVF cycles was taken into account as a 
confounder in the analysis, no association was found with psychological scores (HADS-
D: P = 0.31; HADS-A: P =0.21). Therefore, this factor was omitted from the final model.
Percentages of women who showed clinically relevant depression and anxiety scores 
one week after the outcome of their final IVF cycle are depicted in Table 6.4. Chi2-analy-
ses showed that 38.8% (19/49) of the women in the standard IVF group who underwent 
multiple IVF cycles scored above the cut-off score for possible depressive disorder against 
19.4% (13/67) of the women in the mild IVF group (P = 0.04). No significant differences 
were found for probable depressive disorder and anxiety between mild and standard IVF 
arms.
Discussion
The main finding of this study is that a mild IVF treatment strategy is associated with 
fewer symptoms of depression after overall treatment failure than standard IVF treat-
ment. One week after they had finished their last treatment cycle, non-pregnant women 
without remaining cryopreserved embryos who had been repeatedly treated by a mild 
protocol reported significantly fewer symptoms of depression than non-pregnant women 
without remaining cryopreserved embryos who had received the standard IVF strategy. 
Furthermore, women who underwent multiple cycles of standard IVF showed more often 
clinically relevant symptoms of depression after treatment failure as compared to women 
who underwent multiple cycles of mild IVF.
Previous analyses of this RCT showed that a mild IVF treatment strategy results in 
similar patient discomfort during a first cycle as standard treatment [161]. However, the 
results presented in this article suggest that treatment burden becomes more severe with 
every cycle in women treated by a standard long protocol as compared to women who 
received mild IVF treatment. These findings are consistent with a previous study [68]. A 
possible explanation could be that prolonged ovarian suppression with the use of GnRH 
agonists caused more symptoms of depression in women who received standard IVF. 
Women who receive GnRH agonist medication experience a loss of endogenous ovarian 
gonadotrophin stimulation, which results in a decrease in both estrogens and androgens 
[168]. Results of a study by Warnock et al. [168, 169] suggest that depressive symptoms in-
crease in women on GnRH agonist therapy for endometriosis and are temporally related 
to the time women were taking the GnRH agonists. Case reports show that symptoms 
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related to GnRH therapy usually remit 4–6 weeks after the last injection [170]. No signifi-
cant differences in depression and anxiety between groups were found in women who 
achieved pregnancy.
The results of this study also suggest that women who were treated by a mild IVF 
strategy did not regret their decision to take part in this study, even after overall treatment 
failure. The fact that only a small percentage of couples in the mild stimulation group 
indicated any wish to change to the standard treatment protocol after one or more failed 
cycles [167] supports this interpretation. Although psychological scores were in the nor-
mal range for the mild strategy group, this does not imply that doubts about this strategy 
were non-existent. Even though mild ovarian stimulation with SET can result in similar 
cumulative term live birth rates in one year of treatment compared to standard stimulation 
with the transfer of two embryos [167], patients might still prefer the lower frequency of 
treatment cycles associated with standard IVF protocols. It was shown previously that the 
possible lower pregnancy chance per transfer is the most important motive for patients 
to decide to transfer two embryos instead of one [171]. Therefore, counselling should not 
only entail the medical aspects of IVF treatment, but also the psychological consequences 
that can differ between different treatment strategies as the present study has shown. 
Furthermore, counselling should be a continuing process, since treatment implications 
seem to vary during different treatment stages.
Besides the strengths of this study (e.g. RCT, large sample, validated questionnaire), it 
also suffers from limitations. No questionnaire was completed after the first cycle, since 
this was considered to be an excessive burden to the patient who had to keep a daily 
diary throughout the first cycle [161]. Therefore, it is unknown how women who received 
only one cycle felt after treatment termination. Another limitation of the current study 
is the short length of the follow-up period (e.g. one week). To determine the long-term 
psychological consequences of mild IVF, a longer follow-up period is needed. An ongo-
ing negative psychological impact of unsuccessful infertility treatment has been reported 
up to six months after treatment termination [41].
No records were kept on non-respondents and therefore the general applicability of 
the study results is unclear. On the basis of the average number of couples which yearly 
undergo IVF treatment in the two participating hospitals and who would qualify for the 
study (n = 300), the estimated response rate was ~65% (391/600) [161]. Furthermore, 
this study suffered from a high drop-out rate (~54% (137/253)). This might have intro-
duced a reporting bias, since one could hypothesize that women who experienced more 
symptoms were less likely to fill in questionnaires. However, no differences in baseline 
anxiety and depression scores were found between study drop-outs and women who 
did complete the study. High attrition rates are not uncommon in this research area: in 
a similar longitudinal study by Verhaak et al. [41] the attrition rate was ~45%. Tracking 
couples throughout their IVF treatment provides a practical challenge.
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In conclusion, the results of this study provide the first evidence that the use of a mild 
IVF treatment strategy which combines GnRH antagonist ovarian stimulation and SET is 
associated with less patient stress immediately following overall treatment failure than 
standard IVF treatment. The acceptability of mild IVF protocols by patients and clinicians 
might be facilitated by these results. Couples facing IVF need to be thoroughly counselled 
about the medical, psychological and economical implications of their choice of treat-
ment strategy in order to maximize patient autonomy.
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Chapter 7
Low negative affect prior to treatment is 
associated with a decreased chance of live 
birth from a first IVF cycle
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Abstract
BACKGROUND: Psychological variables, such as anxiety and depression, may have a 
negative impact on IVF outcomes, but the evidence remains inconclusive. Previous stud-
ies have usually measured a single psychological parameter with clinical pregnancy as 
the outcome. The objective of the current study was to determine whether pretreatment 
or procedural psychological variables in women undergoing a first IVF cycle affect the 
chance of achieving a live birth from that cycle.
METHODS: Between February 2002 and February 2004, 391 women with an indication 
for IVF were recruited at two University Medical Centres in the Netherlands. Pretreatment 
anxiety and depression were measured with the Hospital Anxiety and Depression Scale. 
The Daily Record Keeping Chart was used to measure negative and positive affect before 
treatment and daily during ovarian stimulation. Multiple stepwise forward logistic regres-
sion analysis was performed with term live birth as the dependent variable.
RESULTS: Regression analysis showed that women who expressed less negative affect 
at baseline were less likely to achieve live birth (P = 0.03). After one IVF cycle, women 
who received a standard IVF strategy were more likely to reach live birth delivery than 
women who received a mild IVF strategy (P = 0.002). A male/female indication for IVF 
was associated with a higher chance of achieving term live birth than a female only in-
dication (P = 0.03). Age, duration of infertility or type of infertility were not independent 
predictors of live birth.
CONCLUSIONS: The relationship between psychological parameters and IVF success 
rates is more complex than commonly believed. The expression of negative emotions 
before starting IVF might not be always detrimental for outcomes.
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Introduction
IVF is a demanding and stressful treatment for patients, requiring daily hormone injec-
tions, ultrasound scans, semen analysis and invasive procedures, such as oocyte retrieval 
[91]. Furthermore, IVF is usually the final treatment option for infertile couples, and 
failure will probably mean they will remain childless. It is therefore not surprising that 
both women and men demonstrate elevated levels of anxiety during IVF treatment, espe-
cially at oocyte retrieval and pregnancy testing [93, 161]. In women who do not achieve 
pregnancy via IVF, an increased prevalence of subclinical anxiety and depression has 
been reported [41].
Although IVF treatment is known to increase stress [43], the evidence for an association 
between stress and IVF outcome is inconclusive [17, 172, 173]. Several studies have shown 
psychological stress to have a negative impact on IVF treatment outcomes. Smeenk and 
colleagues [83] e.g. found that pre-existing psychological variables, especially state anxi-
ety, are independently related to the probability of becoming pregnant after IVF/ICSI. In 
contrast, a recent large multi-centre study showed no associations between stress levels 
and IVF outcomes [87]. In the latter study, depression and anxiety were measured prior 
to the first cycle of IVF, and again one day before oocyte retrieval.
The conflicting results in this research area may reflect limitations in study sample 
size and design, since most previous studies were either retrospective or cross-sectional. 
Moreover, psychological measurements have usually been limited to a single stress pa-
rameter. Since the majority of studies reported clinical pregnancy as the endpoint, data 
relating to spontaneous abortion and premature delivery are scarce. To date, only one 
study has reported live birth delivery as an endpoint [84]. In this study, live birth rate 
was negatively influenced by baseline stress, but not by procedural stress. If the impact 
of stress on IVF outcomes is to be properly addressed, more large prospective studies 
that apply multiple stress measures and report live birth as the endpoint are required. 
The objective of the present two-centre study was therefore, to prospectively examine 
anxiety, depression and affect in women before and during a first IVF or IVF/ICSI cycle 
and to study their relationship with live birth delivery rates.
Materials and methods
Subjects
Between February 2002 and February 2004, couples about to start their first cycle of IVF 
or IVF/ ICSI treatment at the Erasmus MC University Medical Centre, Rotterdam, and the 
University Medical Centre, Utrecht, were recruited to the study. The study was approved 
by the Ethical Review Boards of the two participating clinics. Only couples with no previ-
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ous unsuccessful IVF treatment were included. Inclusion criteria limited participation to 
women aged < 38 yrs, with a regular menstrual cycle (25–35 days) and a body mass index 
of 18–28 kg/m2. These study criteria were chosen to exclude women for whom either mild 
stimulation or single embryo transfer (SET) was considered a priori to be inappropriate 
[110]. Couples received either mild ovarian stimulation (including GnRH antagonist co-
treatment) and SET or conventional GnRH agonist long-protocol ovarian stimulation with 
the transfer of two embryos [158, 167]. Patients who met the eligibility criteria were either 
recruited by their treating physician during the IVF planning consultation (Rotterdam) or 
by one of the medical researchers before their IVF planning consultation (Utrecht). After 
written consent was obtained from both partners, women received a booklet containing 
all psychological questionnaires.
Measures
The Hospital Anxiety and Depression Scale (HADS) is a general stress measure that was 
developed as a screening tool to measure anxiety and depression experienced by medical 
patients in the past week [102]. Both subscales (range 0–21) of the HADS consist of seven 
items, which are scored on a 4-point-Likert scale from 0–3. Higher scores imply the pres-
ence of more symptoms. Cut-off scores for possible and probable depressive and anxiety 
disorder are 7/8 and 10/11, respectively. The Dutch version of the HADS has shown good 
test-retest reliability, homogeneity and internal consistency [103].
The 21 items of the Daily Record Keeping Chart (DRK) represent emotional reac-
tions common to women receiving infertility treatment [93, 101]. Each item is rated on 
a 4-point-Likert scale (‘none’ to ‘severe’). Scores on four subscales can be obtained: 
depression/anger; uncertainty; anxiety; and positive affect (range 0–12). The depression/
anger, uncertainty and anxiety subscales can be combined into a single scale measuring 
negative affect (range 0–36). The DRK has demonstrated good criterion-related validity, 
good convergent validity and good internal consistency. Cronbach coefficient alphas 
varied from 0.76 to 0.88 for the individual subscales [101]. The DRK is available in Dutch 
translation [150].
Additional data on the subjects’ demographics and infertility history were obtained 
from medical records.
Study design
This psychological study was part of a two-arm randomized controlled, non-inferiority, 
effectiveness trial, which encompassed the medical, economical and psychological evalu-
ation of mild ovarian stimulation combined with SET compared with standard IVF treat-
ment. Clinical outcomes of this randomized controlled trial have recently been published 
elsewhere [167]. Only women who had sufficient knowledge of the Dutch language to 
fill out the questionnaires were invited to take part in the psychological study (n = 391). 
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Pretreatment stress was measured with the HADS on the day of IVF planning consultation 
carried out within 6 weeks of commencing treatment. Women also completed the DRK 
daily for 1 week, starting on the day of the planning consultation. Procedural stress was 
measured daily with the DRK from the first day of ovarian stimulation until the day before 
oocyte retrieval. The endpoint chosen for this study was term (≥ 37 weeks gestation) live 
birth resulting from the first cycle of IVF.
Statistical analyses
Demographics and data on infertility history were analysed using Student’s t-test for con-
tinuous variables and χ2-test for categorical variables. Daily DRK scores were computed 
into two average scores: one for baseline and one for ovarian stimulation. Group differ-
ences in psychological variables between women who achieved live birth and women 
who did not were analysed using Student’s t-test. Multiple stepwise forward logistic 
regression analysis was performed with term live birth as the dependent variable. Inde-
pendent variables included all psychological variables, age, duration of infertility, cause 
of infertility, type of infertility and IVF strategy. All analyses were performed using the 
Statistical Package for the Social Sciences (SPSS version 10.1). Significance testing on all 
outcome measures was done at 0.05 level of significance (two-tailed).
Results
Of the 391 women that were recruited, 32 (8%) women dropped out of the study before 
commencing a first IVF cycle. Ten women had a spontaneous pregnancy, ten women did 
not start IVF treatment, and twelve women discontinued participation in the study [167]. 
Seventy women (19%) failed to fill out one or more baseline psychological questionnaires 
and were therefore excluded from analysis. The excluded women differed significantly 
from analysed women only in terms of cause of infertility (Table 7.1). Of the remaining 
289 women, seventy-three participants (25%) achieved a live term delivery after the first 
IVF cycle. Table 7.2 shows the sample characteristics with respect to psychological vari-
ables of women who achieved and failed to achieve live birth. Univariate testing showed 
that the mean score for baseline negative affect was significantly lower in the latter group 
(P = 0.02). With regard to changes in affect between baseline and ovarian stimulation, no 
significant differences were found between these groups. Pearson correlation coefficients 
between psychological variables are shown in Table 7.3.
The findings of the stepwise logistic regression analysis are given in Table 7.4. Live 
birth was predicted positively by baseline negative affect as measured with the DRK (P 
= 0.03). Baseline anxiety, depression and positive affect as well as affect (both positive 
and negative) during ovarian stimulation were omitted from the model due to a lack of 
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Table 7.1 Baseline demographical and medical characteristics of participants 
Variable Analysed women
(n = 289)
Non-analysed women
(n = 70)
Age (years), mean (SD)  32.8 (3.1) 32.8 (2.9)
Duration of infertility (years), mean (SD)   3.6 (1.9)  3.6 (2.3)
Type of infertility
   Primary
   Secondary
222 (76.8%)
 67 (23.2%)
46 (65.7%)
24 (34.3%)
Cause of infertility
   Female
   Male
   Female/male
 46 (15.9%)
161 (55.7%)
 82 (28.4%)
22 (31.4%)a
33 (47.1%)
15 (21.4%)
IVF strategy
   Standard
   Mild
137 (47.4%)
152 (52.6%)
35 (50%)
35 (50%)
IVF outcome 
   No term live birth
   Term live birth
216 (75.7%)
 73 (25.3%)
52 (74.3%)
18 (25.7%)
a P < 0.05, two-tailed.
Table 7.2 Psychological characteristics of participants
Variable mean (SD) Women who achieved live birth
(n = 73)
Women who failed to achieve live 
birth (n = 216)
Baseline anxiety 5.1 (3.9) 5.0 (3.4)
Baseline depression 2.5 (2.8) 2.6 (2.6)
Baseline positive affect 7.5 (2.6) 7.8 (3.2)
Baseline negative affect 6.4 (4.7) 5.0 (4.5)a
Positive affect during ovarian stimulation 6.9 (2.9) 7.2 (3.2)
Negative affect during ovarian stimulation 7.2 (6.1) 6.7 (5.4)
a P < 0.05, two-tailed.
Table 7.3 Pearson correlations between psychological variables
1 2 3 4 5 6
1. Baseline anxiety -  .60a -.39a .53a -.31a .41a
2. Baseline depression - -.43a .45a -.37a .33a
3. Baseline positive affect - -.46a .79a -.27a
4. Baseline negative affect - -.31a .55a
5. Treatment positive affect - -.47a
6. Treatment negative affect -
a P < 0.01, two-tailed.
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correlation with live birth. Of the medical variables, IVF strategy (mild or standard) and 
cause of infertility were shown to have a significant effect on the probability of live birth 
delivery. After one IVF cycle, women who had received a standard IVF strategy were 
more likely to reach live birth delivery than women who underwent a mild IVF strategy 
(P = 0.002). Furthermore, a male/female indication for IVF was associated with a higher 
chance of achieving term live birth than a female only indication for IVF (P = 0.03). In 
this study neither age, duration of infertility or type of infertility were found to be inde-
pendent predictors of live birth.
Discussion
This study examined the relationship between pretreatment and procedural psychologi-
cal variables with term live birth in women undergoing a first IVF or IVF/ICSI cycle. No 
evidence was found for an association between psychological variables and IVF outcome 
when using a general depression and anxiety measure. However, a small but signifi-
cant effect of DRK-scores on live birth rates was observed. Perhaps surprisingly, women 
who showed few feelings of anger, depression, uncertainty and/or anxiety (e.g. negative 
affect) before treatment were less likely to achieve term live birth than women who 
expressed a moderate level of negative affect. Neither positive affect nor negative affect 
during ovarian stimulation did influence the possibility of live birth.
Infertility-specific questionnaires such as the DRK are likely to be more sensitive to the 
diverse reactions women might experience during the various stages of IVF treatment 
than general stress measures such as the HADS. The fact that the DRK is a prospective 
diary-based measure, whereas the HADS is a retrospective measure, may further benefit 
the sensitivity of the DRK. This might be a reason why the results from this study are 
incongruent with earlier studies [83] in which general stress measures were mostly used. 
Table 7.4 Logistic regression model with variables predicting term live birtha
Variable OR P-value 95% CI
Baseline negative affect
   Continuous 1.07 0.03 [1.01, 1.1]
IVF strategy
   Standardb
   Mild
1.0
0.38 0.002 [0.21, 0.69]
Cause of infertility
   Female factorb
   Male factor
   Male/female factor
1.0
1.74
3.53
0.27
0.03
[0.66, 4.58]
[1.27, 9.79]
a Optimism corrected value by bootstrapping = 0.62 [182].
b Reference category.
OR: odds ratio; CI: confidence interval.
Ch
ap
te
r 7
96
The results of a recent study by Cooper et al. [174], in which an infertility-specific ques-
tionnaire (e.g. Fertility Problem Inventory) was used, were in line with the results of the 
present study. The authors reported that couples who did not get pregnant during their 
first IVF cycle expressed less infertility-related stress before treatment than conceiving 
couples. However, no conclusions can be made about the effect of strong infertility-
related stress and IVF outcomes based on the results of either study, as mean scores on 
the infertility-related stress questionnaires were all in the low to moderate range. There-
fore, it remains possible that the expression of high infertility-related stress is harmful. 
However, the expression of moderate infertility-related stress seems more beneficial than 
extreme low levels of negative affect.
It may be hypothesized that the association between extreme low levels of negative 
affect and negative IVF outcomes could be explained by the fact that women receiving 
IVF frequently use defence mechanisms such as repression and denial to cope with the 
emotional strain associated with treatment. Previous studies have shown that patients un-
derreport feelings of stress during IVF treatment, afraid that they might be dropped from 
the IVF programme or that they might be “jinxed” [93, 175]. Positive thinking seems to be 
the most frequently used coping strategy during IVF treatment [176]. In the present study, 
low scores for negative affect might indicate the use of repression and positive thinking 
strategies. It is possible that the use of these strategies elicit physiological responses that 
adversely affect IVF outcomes. Psychological defence strategies, such as repression, have 
been found to be associated with autonomic reactivity that may be a risk factor for medi-
cal illness [177]. Future studies are needed to explore the possible association between 
repressive coping strategies and IVF outcomes.
In contrast to previous studies [178, 179] no associations between age, duration of infer-
tility, and live birth rates were found in the current study, possibly due to the study’s strict 
inclusion criteria. However, a lower chance of achieving term live birth was observed 
when a female only indication for IVF was present than when a male/female indication 
(including unexplained infertility) existed. These findings are congruent with the results 
of a study by Omland et al. [180] in which unexplained infertility was associated with 
higher live birth rates compared with minimal endometriosis-associated or tubal factor 
infertility. As shown before [167], women who had received a standard IVF strategy were 
more likely to reach live birth delivery after a single treatment cycle than women who 
underwent a mild IVF strategy.
Despite the large sample size, the use of multiple stress measures and the use of live 
birth as the endpoint, there are some limitations to this study. Only women who were 
eligible for mild ovarian stimulation combined with the transfer of a single embryo were 
included. Therefore, it might not be possible to generalize the results of this study to 
IVF patients with a less favourable prognosis. Furthermore, no records were kept on 
non-respondents. Based on the average number of couples who undergo IVF treatment 
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annually in the two participating hospitals and who would qualify for the study (n = 300), 
the estimated response rate was calculated to be ~65% (391 out of 600). In addition, 19% 
of the participants could not be analysed due to missing psychological data. In these 
women, a female factor was more often the cause of infertility. Finally, this study did not 
measure stress in male patients. The results of the few studies that have addressed stress 
scores in the male partner also suggest a complex association between infertility-related 
stress and IVF outcomes [80, 174, 181].
In general, stress is perceived to be detrimental to fertility and outcomes of infertility 
treatments. Many clinicians as well as researchers implicitly subscribe to the psychogenic 
model of infertility which can easily result in ‘victim blaming’ [16]. As a result, couples 
opting for IVF may downplay their negative emotions, as they often feel dependent on 
their physicians for their continued treatment participation. The results of this study show 
that the relationship between psychological variables and IVF success rates is more com-
plex than commonly believed. Patients should not be discouraged to express negative 
emotions related to infertility and its treatment.
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Introduction
IVF treatment requires the woman to undergo several invasive procedures, which are 
repeated in subsequent treatment cycles. In addition to the physical burden, the threat 
of treatment failure confronts the couple with the possibility that they have to give up 
hope to have a child of their own. In line with the psychological consequences of infertil-
ity model [16], women seem to experience moderate levels of negative emotions (e.g. 
distress) before, during and after IVF treatment [30-32, 36, 37, 39-41, 183]. According to 
another psychological model on infertility and infertility treatment, e.g. the cyclical model 
of stress, patient distress might have a negative influence on IVF pregnancy chance [16, 
18]. However, the scientific evidence to support this model is contradictory [31, 80-87].
It has been widely argued that people undergoing IVF should receive infertility coun-
selling by a psychosocial counsellor to help them cope with negative emotions related to 
treatment and infertility [97]. Hence, the first aim of this study was to evaluate the effect 
of a psychosocial counselling intervention during IVF treatment on distress in first-time 
IVF patients in a randomized controlled trial. The results of the few earlier randomized 
controlled studies on psychosocial counselling interventions did not find a decrease in 
distress due to counselling. However, effects of counselling might have gone unnoticed 
due to a limited number of measurements of distress in these studies. In contrast to these 
earlier studies, distress was measured continuously throughout IVF treatment in the study 
described in this thesis.
The aim of counselling is to minimize negative emotions related to a stressor (e.g. IVF 
treatment). An alternative way to decrease distress related to IVF treatment might be to 
change the stressor. New ‘mild’ IVF strategies which combine mild ovarian stimulation 
with single embryo transfer may represent a more patient-friendly approach than standard 
IVF treatment. Mild ovarian stimulation protocols with gonadotropin-releasing hormone 
(GnRH) antagonists are likely to be associated with less physical discomfort and psycho-
logical distress than standard ovarian stimulation with GnRH agonists [62]. However, the 
use of mild IVF strategies, which include single embryo transfer, might also be stressful 
to patients, as patients seem to prefer double embryo transfer to single embryo transfer 
because of the increased chance of achieving a pregnancy in a given cycle [171]. The 
combination of GnRH antagonist co-treatment and single embryo transfer was expected 
to enable patients to have more treatment cycles with additional pregnancy chances in 
the same time period as standard IVF, due to a shorter cycle duration and possible fewer 
side effects associated with mild stimulation. This thesis presents the first longitudinal, 
randomized controlled trial to study not only the clinical and economical consequences, 
but also the psychological impact of the use of such mild IVF strategies for IVF patients.
The third aim of this thesis was to explore the relation between distress and IVF live 
birth delivery rates. The popular belief that distress adversely affects IVF outcome may 
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cause feelings of shame and guilt in IVF patients who do not conceive. A better under-
standing of the association between distress and IVF outcome might further benefit the 
emotional adjustment of IVF patients. Whereas most studies in this area report pregnancy 
rate as the endpoint, the large prospective study presented in this thesis studied the 
relationship between distress and term live birth.
Can psychosocial counselling alleviate distress related to IVF treatment?
Counselling interventions in infertility treatment focus on expression of emotions and 
discussion of thoughts related to infertility and its treatment. These interventions are 
usually characterized by the non-directiveness of the counsellor, the couple format of the 
sessions and a short duration [56]. In the study described in Chapter 2, counselling was 
provided by a social worker who is part of the multi-disciplinary IVF team in Rotterdam. 
In our clinic, psychosocial counselling is optional for all IVF patients during all stages of 
IVF treatment. The social worker provides counselling in line with the principles of the 
Experiential Psychosocial Therapy [99]. The central focus of Experiential Psychosocial 
Therapy is the way individuals relate to others. Even though women have to undergo 
most of the invasive procedures related to IVF treatment, infertility is a shared problem of 
both male and female partners. The shared experience of infertility might bring partners 
closer together, as they are forced to talk about emotional and existential aspects of life 
[184]. However, men and women often cope differently with childlessness and the stress 
related to infertility treatment, which may put pressure on the partner relationship. Fur-
thermore, difficulties in partner communication lead to higher distress after unsuccessful 
fertility treatment in both women and men [185]. Therefore, the counselling intervention 
studied in this thesis, was targeted at both partners. During the counselling sessions 
couples were invited to express their feelings and discuss their thoughts on topics related 
to infertility and IVF treatment, such as coping strategies and the availability of social 
support, patient-physician communication, decision-making related to IVF treatment, an-
ticipation on possible treatment outcomes and alternatives to IVF (e.g. adoption).
Consistent with previous studies [60, 61], our counselling intervention hardly influ-
enced the amount of distress women experienced during their first cycle of IVF treat-
ment. Furthermore, counselling did not seem to influence distress experienced by male 
partners either [104]. At pregnancy testing however, women who had received additional 
psychosocial counselling expressed less negative affect than women who had received 
routine care and no additional psychosocial counselling. Although this difference was 
marginally significant, this result might still indicate that our psychosocial counselling 
intervention succeeded in reducing unrealistic expectations women might have about IVF 
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success rates. As male partners did not keep a distress diary during treatment, no group 
comparisons could be made.
The data presented in this thesis indicate that most couples do not think they need 
additional psychosocial counselling during their first IVF treatment cycle. Furthermore, 
men were less likely than women to be interested in additional counselling by a social 
worker. It is possible that more couples would have participated in our study if the timing 
of the counselling sessions had been different. We chose to offer counselling during the 
IVF stages which couples usually perceive to be the most distressing, e.g. before the start 
of the first treatment cycle, during the waiting period and then again after completion of 
the first cycle. During these stages patients usually do not have medical appointments. 
Since couples were already required to make several hospital visits during IVF treatment, 
work or other obligations might have prevented them to take additional time off for the 
counselling sessions. Furthermore, the semi-structured interviews that were performed 
after completion of the first IVF cycle suggest that women might want to focus on the 
medical aspects rather than on the possibly negative psychological consequences of 
treatment during a first cycle. However, some participants who had not received ad-
ditional counselling, in hindsight reported the need for contact with the IVF staff during 
the waiting period or after a failed IVF cycle. Psychosocial counselling might more easily 
be accepted by veteran IVF patients, as they are more aware of the psychological impact 
of IVF treatment [59]. First-time IVF patients might more readily accept interventions 
that integrate both medical and psychosocial aspects of infertility treatment. Moreover, 
educational interventions which focus on information provision and skills training seem 
to lead to more positive changes in infertile people than counselling interventions [56]. 
In contrast to counselling interventions, educational interventions are often carried out 
in a group format with a higher number of structured sessions. Each of these unique 
characteristics could explain why educational interventions might be more beneficial to 
infertile people’s well being than psychosocial counselling [56]. However, the current 
evidence only moderately supports the effectiveness of such psychosocial interventions 
in reducing patient distress [56]. Hence, alternative ways to decrease distress related to 
IVF treatment should also be considered.
Does a mild strategy in IVF result in less treatment-related distress?
The psychological consequences of one cycle of mild IVF
Mild treatment strategies in IVF avoid pituitary downregulation with GnRH agonists, 
which was found to be associated with headache, abdominal pain, painful muscles, 
and symptoms of depression (Chapter 4). During most stages of the first IVF cycle, mild 
ovarian stimulation did not lead to a different level of physical complaints or psychologi-
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cal distress than conventional stimulation. However, as the average cycle duration was 
shorter for mild stimulation protocols, women suffered from physical and psychological 
discomfort for a shorter period of time during one cycle. The shorter and less burden-
some period of treatment associated with mild stimulation may also explain why cycle 
cancellation during the first IVF cycle was associated with a more positive and less nega-
tive mood in mild IVF than in standard IVF.
During one stage of the first IVF treatment cycle the mild IVF approach resulted in 
higher distress levels than the standard strategy, e.g. the day of oocyte retrieval. Mild 
ovarian stimulation usually leads to the growth and retrieval of fewer oocytes than long-
protocol stimulation, which may have influenced the perceived chance of treatment suc-
cess in some women. Comparisons of the number of oocytes harvested with women 
using standard ovarian simulation may have resulted in doubts about the effectiveness of 
mild stimulation. During the semi-structured interviews that were also performed as part 
of this study, women occasionally raised concerns about the effectiveness of the mild 
treatment protocol. These doubts usually concerned the lower success rate per transfer 
associated with single embryo transfer, rather than the perceived effectiveness of mild 
ovarian stimulation. However, during the IVF stages subsequent to the day of oocyte 
transfer, distress levels associated with the mild IVF strategy were comparable with the 
standard IVF strategy. Even though worries about the effectiveness of mild IVF strate-
gies might still have been present, these did apparently not lead to increased distress in 
women during the final stages of their first IVF cycle.
The psychological consequences of prolonged mild IVF treatment
In chapter 5 it was shown, that overall patient discomfort during the first year of treat-
ment was similar among the two strategies, even though the average number of treatment 
cycles per couple was higher in mild IVF. However, the level of distress and self-reported 
physical complaints associated with the mild strategy were stable over time, whereas the 
level of patient discomfort related to standard IVF increased during subsequent treatment 
cycles [68]. Furthermore, treatment failure was associated with less distress in mild IVF 
than in standard IVF treatment (chapter 6). As it seems reasonable to assume that the 
losses related to treatment failure (fertility, self-esteem, social status etc.) are the same for 
both strategies, the latter finding suggests that the distress women experience due to IVF 
treatment failure not only results from the threat of infertility, but also from IVF treatment 
itself. According to the cognitive dissonance theory [186], people will value their goal 
more if it is harder to reach. In line with this theory, one could hypothesize that these 
people are more likely to experience higher distress when this goal cannot be reached 
than people who invested less in the achievement of the same goal. The fact that women 
who underwent the standard IVF strategy were more distressed at treatment failure, 
might suggest that overall, standard IVF was related to more treatment-related discomfort 
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and distress than mild IVF. Interestingly, distress levels were comparable in conceiving 
women using either strategy, which might suggest that the achievement of pregnancy 
neutralizes differences in treatment-related distress.
Does patient distress result in lower live birth rates?
According to the cyclical model of infertility and stress, the chance of conceiving through 
IVF is negatively influenced by high levels of psychological distress [16, 18]. Surprisingly, 
we found that women who reported a low level of pretreatment distress were less likely 
to achieve term live birth than women who expressed a moderate level of distress (Chap-
ter 7). Still, as the majority of participating women did not meet the criteria for either 
clinical depression or anxiety, the results of this thesis do not rule out that high patient 
distress leads to worse IVF outcomes than moderate distress. In contrast to pretreatment 
distress, distress related to ovarian stimulation was not associated with live birth delivery 
chance.
This study is not the first to find a positive association between distress and IVF out-
comes, but results of these studies are not often cited by other researchers in this field. 
Merari and colleagues [181] found that couples who showed strong negative emotional 
reactions to IVF treatment 10-15 day prior to its initiation had a higher chance of con-
ceiving. Likewise, Cooper and colleagues [174] reported that couples who got pregnant 
during their first IVF cycle expressed more infertility-related stress before treatment than 
non-conceiving couples. In another study, women with either extremely high or low 
scores for anxiety prior to the start of treatment were more likely to get pregnant [82]. A 
study of the influence of dietary sodium restriction on anxiety in women undergoing IVF 
showed a higher increase in both state and trait anxiety during treatment in conceiving 
women as compared to women who did not conceive, which was not influenced by 
dietary sodium restriction [187]. Finally, Demyttenaere and colleagues [188] found an 
association between increased depressive symptoms prior to the start of treatment and 
higher pregnancy rates 12 months later in participants with a male indication for IVF.
Apparently, the relationship between patient distress and IVF success rates is not as 
straightforward as commonly believed by researchers, clinicians and patients. This rela-
tionship might be curvilinear, rather than linear. The results obtained from an exploratory 
analysis of our data also hinted at such an association. Both extremely high and extremely 
low levels of distress seemed to be associated with adverse IVF outcomes. The expres-
sion of extreme low levels of distress may reflect a tendency to repress awareness of 
negative emotions caused by IVF treatment. People who use repressive coping strategies 
tend to selectively avoid attending to threat-related stimuli and also tend to interpret 
threat-related information in a non-threatening way, including their own physiological 
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activity, behaviour and cognitions, as well as external stimuli [189]. People who use 
this coping style describe themselves as non-emotional and rational [190]. Indeed, IVF 
patients have been shown to use defensive coping styles, possibly related to the fear 
that the expression of distress may lead to discontinued treatment participation or to 
treatment failure [93, 175]. Whereas repressors usually exhibit low levels of self-reported 
distress, they often have high levels of physiological distress, especially in the presence of 
social evaluation [191]. For example, repressors have been shown to exhibit similar high 
cortisol levels [192] as highly anxious people. Future studies are needed to explore the 
possible association between distress, repressive coping strategies and IVF outcomes.
Study limitations and directions for future research
The studies described in this thesis have several strengths (e.g. randomized controlled tri-
als, validated questionnaires) and several limitations. As with many psychological studies 
in the IVF field, both randomized controlled trials described in this thesis suffered from 
a high drop-out rate. This might have introduced a reporting bias, as women who ex-
perienced high distress might have been less inclined to fill in questionnaires. However, 
study drop-outs did not report higher levels of distress at the initiation of IVF treatment 
than women who completed the study. Still, the statistical power of the study described 
in Chapter 6 might be limited, as this study also suffered from a low response rate. It is 
possible that women who were the most vulnerable to experience distress during IVF 
treatment were not included in this study. Therefore, the results of this study should be 
interpreted with caution. Another limitation of both trials presented in this thesis, is the 
short length of the follow-up period (e.g. one week after treatment failure). A longer 
follow-up period is needed to determine the long-term psychological consequences of 
mild IVF as well as the effects of psychosocial counselling on distress. Women experi-
ence distress related to unsuccessful infertility treatment up to six months after treatment 
termination [41].
In this thesis, both general measures as well as an infertility-specific questionnaire were 
used to measure distress. Whereas most other studies on psychological aspects of IVF 
treatment only use retrospective questionnaires, the studies described in this thesis also 
used diary measures to assess distress. Nevertheless, even the infertility-specific diary 
measure used in these studies might not have been sensitive enough to determine spe-
cific psychological consequences of IVF treatment or infertility counselling. Furthermore, 
self-report distress questionnaires tap into one aspect of human emotions, e.g. the subjec-
tive experience. However, emotions are believed to be made up of multiple components, 
including cognitions, physiological responses and behavioural reactions [193]. Responses 
in these different domains may not always be in concordance. Some people may report 
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low distress levels in stressful conditions, even though they show signs of heightened 
physiological distress (e.g. heightened heart rate). Although such response dissociation 
may reflect social-desirability bias, it may also indicate the use of emotion-focused coping 
strategies which are aimed at emotion-regulation, such as repression. Future studies that 
aim to test the cyclical model of infertility and stress should therefore not only incorporate 
distress measures, but also measures of coping strategies. Ideally, both self-report mea-
sures and biological markers of distress should be included in such studies. Considering 
the results of the present thesis, it would be highly interesting to investigate associations 
between distress, repressive coping strategies and IVF outcomes, using proxy measures, 
observational measures and physical measures apart from self-report questionnaires.
Clinical implications
Despite study limitations, the results of this thesis do not support the provision of routine 
counselling by a psychosocial counsellor for all first-time IVF patients. We believe psy-
chosocial interventions should only be offered to those people who are the most vulner-
able to distress and therefore are most likely to benefit from additional care. However, 
studies of possible predictors of distress related to IVF treatment are scarce [43]. Although 
there are some studies that link psychological factors, such as personality [194], relation-
ship characteristics [185], and coping [185] with increased distress in IVF patients, further 
study of these associations is warranted. Such studies may promote early identification 
and referral of women who are at risk for psychological problems during treatment.
The data presented in this thesis provide the first evidence that overall, the use of a 
mild IVF treatment strategy leads to less patient distress than standard IVF treatment. Do 
these findings imply that the use of mild IVF strategies should be made into the new 
standard? Some authors have argued that the physician who performs the IVF treatment 
should determine the maximum number of embryos transferred. According to these au-
thors, physicians have a professional responsibility for the welfare of the future child, 
because of his or her causal and intentional contribution to IVF treatment and its out-
come, including problems related to multiple embryo transfer [195]. Other authors claim 
that practice standards which are aimed at minimizing multiple pregnancies compromise 
patient autonomy. They argue that infertile couples have the right to make educated 
treatment decisions [196]. However, women who attend infertility clinics usually do not 
possess the knowledge about the specific risks associated with multiple pregnancies to 
be truly able to make educated decisions. When informed of the actual risks related to 
multiple gestations, women seem to be less wishful of a twin pregnancy [197]. Still, the 
majority of women undergoing IVF/ICSI would not prefer single embryo transfer if this 
procedure led to even the smallest reduction in pregnancy rates [198]. However, most 
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women who prefer single embryo transfer in the absence of a difference in pregnancy 
rates, would be willing to undergo an additional treatment cycle, if needed [198]. The 
results of this thesis show that the combination of single embryo transfer and mild ovar-
ian stimulation can result in similar cumulative term live birth rates over one year of IVF 
treatment compared to standard stimulation with two embryo transfer, while significantly 
reducing multiple pregnancy rates. This information, as well as the scientific evidence for 
the psychological advantages of the use of mild IVF strategies presented in this thesis, 
might change preferences in favour of mild IVF in patients.
Clearly, fertility physicians need to be aware of the importance of counselling patients 
regarding the implications and decision-making related to IVF treatment. Counselling 
should not only entail information about term live birth rates and medical risks associated 
with different IVF treatment strategies for both mother and child. Physicians should also 
educate patients about the psychological (and social) aspects of infertility and its treat-
ment to enable them to make educated treatment-related decisions. As the findings of this 
thesis show, the psychological consequences of different treatment strategies differ dur-
ing different treatment stages. Therefore, personalised counselling by physicians should 
be a continuing process throughout all IVF stages, including treatment termination. In-
creased knowledge of the psychological aspects of infertility in physicians might also 
lead to an earlier detection of psychosocial problems in IVF patients. Moreover, adopting 
the psychological consequences model of infertility rather than the cyclical model of stress 
will prevent patients from feeling shame or guilt about (possible) future treatment failure. 
Patients who feel free to express negative emotions about their infertility and infertility 
treatment to their physician might be open to a referral to a social worker or psychologist, 
when needed.
R
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Chapter 1
IVF treatment requires the woman to undergo several invasive procedures, which are 
repeated in subsequent treatment cycles. In addition to the physical burden, the threat of 
treatment failure confronts the couple with the possibility that they may have to give up 
hope to have a child of their own. In line with the psychological consequences of infertility 
model, women seem to experience moderate levels of negative emotions (e.g. distress) 
before, during and after IVF treatment. According to another psychological model on 
infertility and infertility treatment, e.g. the cyclical model of stress, patient distress might 
have a negative influence on IVF pregnancy chance. However, the scientific evidence to 
support this model is contradictory.
It has been widely argued that people undergoing IVF should receive infertility coun-
selling by a psychosocial counsellor to help them cope with negative emotions related 
to treatment and infertility. Hence, the first aim of this study was to evaluate the effect 
of a psychosocial counselling intervention during IVF treatment on distress in first-time 
IVF patients in a randomized controlled trial. The results of the few earlier randomized 
controlled studies on psychosocial counselling interventions did not find a decrease in 
distress due to counselling. However, effects of counselling might have gone unnoticed 
due to limited number of measurements of distress in these studies. In contrast to these 
earlier studies, distress was measured continuously throughout IVF treatment in the study 
described in this thesis.
The aim of counselling is to minimize negative emotions related to a stressor (e.g. IVF 
treatment). An alternative way to decrease distress related to IVF treatment might be to 
change the stressor. New ‘mild’ IVF strategies which combine mild ovarian stimulation 
with single embryo transfer may represent a more patient-friendly approach than standard 
IVF treatment. Mild ovarian stimulation protocols with gonadotropin-releasing hormone 
(GnRH) antagonists are likely to be associated with less physical discomfort and psy-
chological distress than standard ovarian stimulation with GnRH agonists. However, the 
use of mild IVF strategies, which include single embryo transfer, might also be stressful 
to patients, as patients seem to prefer double embryo transfer to single embryo transfer 
because of the increased chance of achieving a pregnancy in a given cycle. The combina-
tion of GnRH antagonist co-treatment and single embryo transfer was expected to enable 
patients to have more treatment cycles with additional pregnancy chances in the same 
time period as standard IVF, due to a shorter cycle duration. This thesis presents the first 
randomized controlled trial to study not only the clinical and economical consequences, 
but also the psychological impact of the use of such mild IVF strategies for IVF patients.
The third aim of this thesis was to explore the relation between distress and IVF live 
birth delivery rates. The popular belief that distress adversely affects IVF outcome may 
cause feelings of shame and guilt in IVF patients who do not conceive. A better under-
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standing of the association between distress and IVF outcome might further benefit the 
emotional adjustment of IVF patients. Whereas most studies in this area report pregnancy 
rate as the endpoint, this thesis studies the relationship between distress and term live 
birth.
Chapter 2
The objective of the study described in this chapter was to evaluate a psychosocial coun-
selling intervention for first-time IVF couples. In this chapter the impact of this interven-
tion on women’s distress is presented. Two hundred and sixty-five couples admitted to 
an IVF treatment programme at the Erasmus MC were asked to participate in this study. 
Eighty-four couples agreed and were randomized according to a computer-generated 
random-numbers table into either a routine-care control group or an intervention group. 
The intervention consisted of three sessions with a social worker trained in experiential 
psychosocial therapy: one before, one during and one after the first IVF cycle. Distress 
was measured daily during treatment by the Daily Record Keeping Chart. Depression and 
anxiety were measured before and after treatment by the Hospital Anxiety and Depres-
sion Scale. We did not find significant group differences on any of these psychological 
variables. The results of this study do not support the implementation of our counselling 
intervention for all first-time IVF couples. Furthermore, the low response rate suggests 
that there is little perceived need for psychosocial counselling among couples during a 
first IVF treatment cycle.
Chapter 3
In this chapter, the methodological considerations related to a study comparing the ef-
fectiveness, health economics and patient discomfort of two IVF treatment strategies are 
discussed. A randomized controlled clinical trial was performed in two large Dutch IVF 
centres. The tested treatment strategies were: mild ovarian stimulation [including gonad-
otrophin-releasing hormone (GnRH) antagonist co-treatment] together with the transfer 
of one embryo, versus conventional stimulation (with GnRH agonist long protocol co-
treatment) and the transfer of two embryos. Outcome measures were: (i) pregnancies 
resulting in term live birth; (ii) total costs per term live birth; and (iii) patient stress/
discomfort per started IVF treatment, over a 12 month period. Power considerations for 
this study were an overall cumulative live birth rate of 45% for the conventional treatment 
strategy, with non-inferiority of the mild treatment strategy defined as a live birth rate 
no more than 12.5% lower than the conventional study arm. For a power of 80% and 
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alpha of 0.05, 400 subjects were required. As planned, from February 2002 until February 
2004, 410 patients were enrolled. This effectiveness study applied an integrated medical, 
health economics and psychological approach with term live birth over a given period 
of time after starting IVF as the end-point. Complete and timely patient enrolment has 
vindicated many of the design decisions.
Chapter 4
The objective of the study in Chapter 4 was to assess the psychological implications of 
mild ovarian stimulation combined with single embryo transfer (SET) during a first In 
Vitro Fertilization (IVF) cycle. We conducted a randomized controlled two-centre trial. 
Three hundred and ninety-one couples were randomized to undergo either mild ovarian 
stimulation with GnRH antagonist co-treatment and SET (n = 199) or conventional GnRH 
agonist long protocol ovarian stimulation with double embryo transfer (DET) (n = 192). 
Women completed the Hospital Anxiety and Depression Scale, the Hopkins Symptom 
Checklist and the Subjective Sleep Quality Scale at baseline, on the first day of ovar-
ian stimulation and following embryo transfer. Affect was assessed daily with the Daily 
Record Keeping Chart (DRK) from the first day of ovarian stimulation until the day 
treatment outcome became known. The conventional IVF group experienced elevated 
levels of physical and depressive symptoms during pituitary downregulation. At oocyte 
retrieval, this group experienced more positive affect and less negative affect than the 
mild IVF group. In the conventional IVF group, cycle cancellation was associated with 
less positive and more negative affect. In conclusion, mild ovarian stimulation and SET 
does not lead to more psychological complaints than conventional IVF during the first 
IVF treatment cycle.
Chapter 5
In this chapter, we aimed to test the hypothesis that mild IVF treatment can achieve the 
same chance of a pregnancy resulting in term live birth within 1 year as standard treat-
ment, and can also reduce patients’ discomfort, multiple pregnancies, and costs. We did 
a randomized, non-inferiority effectiveness trial. 404 patients were randomly assigned 
to undergo either mild treatment (mild ovarian stimulation with gonadotropin-releasing 
hormone [GnRH] antagonist co-treatment combined with single embryo transfer) or a 
standard treatment (stimulation with a GnRH agonist longprotocol and transfer of two 
embryos). Primary endpoints were proportion of cumulative pregnancies leading to term 
live birth within 1 year after randomization (with a non-inferiority threshold of −12.5%), 
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total costs per couple up to 6 weeks after expected date of delivery, and overall discom-
fort for patients. Analysis was by intention to treat. The proportions of cumulative preg-
nancies that resulted in term live birth after 1 year were 43.4% with mild treatment and 
44.7% with standard treatment (absolute number of patients = 86 for both groups). The 
lower limit of the one-sided 95% CI was −9.8%. The proportion of couples with multiple 
pregnancy outcomes was 0.5% with mild IVF treatment versus 13.1% (P < 0.0001) with 
standard treatment, and mean total costs were € 8333 and € 10 745, respectively (differ-
ence € 2412, 95% CI 703–4131). There were no significant differences between the groups 
in the anxiety, depression, physical discomfort, or sleep quality of the mother. Over 1 
year of treatment, cumulative rates of term live births and patients’ discomfort are much 
the same for mild ovarian stimulation with single embryos transferred and for standard 
stimulation with two embryos transferred. However, a mild IVF treatment protocol can 
substantially reduce multiple pregnancy rates and overall costs.
Chapter 6
In this study, the impact of treatment failure after two or more cycles on stress was 
studied, following treatment with a mild versus a standard treatment strategy. Women 
were randomized to undergo mild ovarian stimulation (including GnRH antagonist co-
treatment) and single embryo transfer (n = 197) or standard GnRH agonist long-protocol 
ovarian stimulation with double embryo transfer (n = 194). Participants completed the 
Hospital Anxiety and Depression Scale prior to commencing treatment and 1 week after 
the outcome of their final treatment cycle was known. Data from women who underwent 
two or more IVF cycles were subject to analysis (n = 253). Women who experienced treat-
ment failure after standard IVF treatment presented more symptoms of depression 1 week 
after treatment termination than women who had undergone mild IVF: adjusted mean (± 
95% confidence interval) = 10.2 (± 2.3) versus 5.4 (± 1.8), respectively, P = 0.01. Failure 
of IVF treatment after a mild treatment strategy may result in fewer short-term symptoms 
of depression than failure after a standard treatment strategy. These findings may further 
encourage the application of mild IVF treatment strategies in clinical practice.
Chapter 7
The objective of the current study was to determine whether pretreatment or procedural 
psychological variables in women undergoing a first IVF cycle affect their chances of 
having a live birth from that cycle. Between February 2002 and February 2004, 391 
women with an indication for IVF were recruited at two University Medical Centres in 
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The Netherlands. Pretreatment anxiety and depression were measured with the Hospital 
Anxiety and Depression Scale. The Daily Record Keeping Chart was used to measure 
negative and positive affect. Women completed the DRK daily for 1 week, starting on 
the day of the planning consultation and again daily during ovarian stimulation. Multiple 
stepwise forward logistic regression analysis was performed with term live birth as the 
dependent variable. Independent variables included all psychological variables, age, du-
ration of infertility, cause of infertility and type of treatment. Women who reported low 
negative affect at baseline were less likely to have a live birth than women who reported 
a moderate level of negative affect (P = 0.03). After one IVF cycle, women who received 
a standard IVF strategy were more likely to have a live delivery than those who received 
a mild IVF strategy (P = 0.002). A male/female indication for IVF was associated with a 
higher chance of term live birth than a female-only indication (P = 0.03). In conclusion, 
expressing moderate negative emotions before starting IVF might not be always harmful 
for outcomes.
Chapter 8
In Chapter 8, the main findings of this thesis are discussed. Also, implications for future 
treatment and research are given. The results of this thesis show that the combination of 
single embryo transfer and mild ovarian stimulation can result in similar cumulative term 
live birth rates over one year of IVF treatment as standard stimulation with two embryo 
transfer, while significantly reducing multiple pregnancy rates. Furthermore, the data pre-
sented in this thesis provide the first evidence that overall, the use of a mild IVF treatment 
strategy leads to less patient distress during treatment than standard IVF treatment. This 
information might change preferences in favour of mild IVF in patients.
The results of this thesis do not support the provision of routine counselling by a 
psychosocial counsellor for all first-time IVF patients. We believe psychosocial interven-
tions should only be offered to those people who are the most vulnerable to distress and 
therefore are most likely to benefit from additional care. Fertility physicians need to be 
aware of the importance of counselling patients regarding the implications and decision-
making related to IVF treatment. Counselling should not only entail information about 
term live birth rates and medical risks associated with different IVF treatment strategies 
for both mother and child. Physicians should also educate patients about the psychologi-
cal (and social) aspects of infertility and its treatment to enable them to make educated 
treatment-related decisions. As the findings of this thesis show, the psychological conse-
quences of different treatment strategies differ during different treatment stages. There-
fore, personalised counselling by physicians should be a continuing process throughout 
all IVF stages, including treatment termination. Increased knowledge of the psychological 
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aspects of infertility in physicians might also lead to an earlier detection of psychosocial 
problems in IVF patients. Moreover, adopting the psychological consequences model of 
infertility rather than the cyclical model of stress will prevent patients from feeling shame 
or guilt about (possible) future treatment failure. Patients who feel free to express nega-
tive emotions about their infertility and infertility treatment to their physician might be 
open to a referral to a social worker or psychologist, when needed.
S
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Hoofdstuk 1
Wanneer een vrouw met een IVF-behandeling begint moet zij verschillende invasieve 
procedures ondergaan, die worden herhaald in de daaropvolgende behandelcycli. De 
behandeling is niet alleen lichamelijk belastend, maar confronteert het paar ook met het 
feit dat zij de hoop op een kind voorgoed moeten opgeven wanneer de behandeling 
niet succesvol is. Overeenkomstig het psychologische gevolgen van onvruchtbaarheid-
model blijken vrouwen een matig niveau van negatieve emoties (distress) te ervaren voor, 
tijdens en na afloop van een IVF-behandeling. Volgens een ander psychologisch model 
van onvruchtbaarheid, het cyclische stressmodel, heeft de distress die een patiënt ervaart, 
mogelijk een negatieve invloed op de zwangerschapskans na IVF. De resultaten van het 
wetenschappelijk onderzoek op dit gebied zijn echter tegenstrijdig.
Een groot aantal auteurs en deskundigen heeft beargumenteerd dat mensen die IVF 
ondergaan, standaard zouden moeten worden gecounseld op het gebied van onvrucht-
baarheid door een psychosociale hulpverlener. Deze hulpverlener zou hen op deze ma-
nier kunnen helpen omgaan met de negatieve emoties die zij ervaren als gevolg van 
hun onvruchtbaarheid en de behandeling hiervan. Hieruit volgt het eerste doel van dit 
proefschrift: het evalueren van een psychosociale counselinginterventie die werd aange-
boden aan patiënten tijdens hun eerste IVF-behandeling. In een aantal eerdere geran-
domiseerde studies bleek counseling niet tot een afname van distress te leiden. In deze 
onderzoeken werd het effect van counseling mogelijk gemist door het beperkte aantal 
distress-metingen. In tegenstelling tot deze eerdere studies werd distress in de studie die 
in dit proefschrift wordt beschreven dagelijks gemeten tijdens de IVF-behandeling.
Het doel van onvruchtbaarheidscounseling is het verminderen van negatieve emoties 
die het gevolg zijn van een stressor (d.i. IVF-behandeling). Een alternatieve manier om 
het distress-niveau te verlagen is het veranderen van de stressor. Nieuwe milde IVF-be-
handelprotocollen, waarin een mild stimulatieprotocol met het terugplaatsen van één em-
bryo (SET) wordt gecombineerd, bieden mogelijk een patiëntvriendelijk alternatief voor 
standaard behandelprotocollen. Milde ovariële hyperstimulatie met GnRH-antagonisten 
leidt waarschijnlijk tot minder lichamelijke en psychologische klachten dan standaard 
ovariële hyperstimulatie met GnRH-agonisten. Aan de andere kant zou het gebruik van 
milde behandelprotocollen stressvol kunnen zijn voor patiënten voor wie de zwanger-
schapskans per behandelcyclus belangrijk is. Zij blijken vaak de voorkeur te geven aan 
het terugplaatsen van twee embryo’s in plaats van één embryo vanwege de hogere zwan-
gerschapskans per behandelcyclus. Door het terugplaatsen van één embryo met milde 
ovariële hyperstimulatie te combineren kan mogelijk een hoger aantal behandelcycli met 
bijbehorende zwangerschapskansen per tijdseenheid worden bereikt in vergelijking met 
een standaard IVF-behandeling, dit vanwege een kortere cyclusduur. In dit proefschrift 
wordt de eerste gerandomiseerde gecontroleerde studie gepresenteerd waarin niet alleen 
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de klinische en economische uitkomsten, maar ook de psychologische gevolgen voor 
patiënten van het gebruik van milde behandelprotocollen werden bestudeerd.
Het derde doel van dit proefschrift was het exploreren van de relatie tussen distress en 
de kans op een levend geboren kind na IVF. Er wordt vaak gedacht dat distress de resul-
taten van een IVF-behandeling negatief beïnvloedt, wat schaamte en schuldgevoelens kan 
oproepen bij die mensen die niet zwanger raken door middel van IVF. Meer duidelijkheid 
over deze relatie draagt mogelijk bij aan de emotionele verwerking van mensen die een 
IVF-behandeling ondergaan. In tegenstelling tot eerdere studies, waarin de relatie tussen 
distress en zwangerschapskans werd bestudeerd, wordt in dit proefschrift de relatie tus-
sen distress en de kans op een levend geborene onderzocht.
Hoofdstuk 2
Het doel van de studie die in dit hoofdstuk wordt besproken, was het evalueren van 
een psychosociale counselinginterventie voor paren die aan hun eerste IVF-behandeling 
beginnen. In dit hoofdstuk wordt de invloed onderzocht die deze interventie heeft op de 
distress die vrouwen ervaren tijdens de behandeling. 265 paren die waren doorverwezen 
naar een IVF-kliniek werden gevraagd deel te nemen aan deze studie. 84 paren stemden 
hiermee in en werden gerandomiseerd in A) een routine zorg controlegroep, versus B) 
een interventiegroep. Deze interventie bestond uit drie gesprekken met een maatschap-
pelijk werker die is getraind in de Ervaringsgerichte Psychosociale Therapie. De gesprek-
ken vonden plaats voor, tijdens en na afloop van de eerste IVF-behandelcyclus. Distress 
werd gedurende de behandelcyclus dagelijks gemeten met behulp van de Daily Record 
Keeping Chart. Depressieve en angstige gevoelens werden zowel voor als na afloop van 
de behandelcyclus vastgesteld met de Hospital Anxiety and Depression Scale. Op geen 
enkele van de psychologische uitkomstmaten werden significante verschillen gevonden 
tussen de twee groepen. De resultaten van deze studie lijken het standaard aanbieden 
van onze interventie tijdens de eerste behandelcyclus niet te rechtvaardigen. Het lage 
responspercentage lijkt er bovendien op te wijzen dat paren weinig behoefte hebben aan 
aanvullende psychosociale counseling vlak voor hun eerste behandelcyclus.
Hoofdstuk 3
Dit hoofdstuk beschrijft het design van een studie waarin een evaluatie plaatsvindt van de 
effectiviteit, de kosten en de patiëntvriendelijkheid van twee IVF-behandelprotocollen, 
die verschillen in zowel het stimulatieprotocol als het terugplaatsingsbeleid. Het betreft 
een gerandomiseerd gecontroleerd onderzoek, dat is uitgevoerd in twee grote IVF-centra 
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in Nederland. De twee onderzochte strategieën waren: A) milde ovariële hyperstimulatie 
(met GnRH-antagonist) samen met het terugplaatsen van één embryo, versus B) een 
conventioneel ovarieel hyperstimulatieprotocol (met een lang GnRH-agonist protocol) en 
het terugplaatsen van twee embryo’s. De primaire studie-eindpunten waren: (1) zwanger-
schap binnen een jaar na randomisatie resulterend in een à terme levend geborene, (2) 
de totale kosten per paar en kind tot zes weken na de uitgerekende datum, en (3) het 
totale patiëntenongemak binnen een jaar na randomisatie. Bij de powerberekening van 
deze studie is er uitgegaan van een overall cumulatieve zwangerschapskans van 45% met 
de conventionele behandelstrategie en non-inferioriteit van de milde behandelstrategie 
(gedefinieerd als een verschil van gelijk aan of kleiner dan 12,5% in de ondergrens van 
de kans op een levend geborene in vergelijking met de conventionele behandelstrate-
gie). Voor een power van 80% en een alpha = 0,05 moesten 400 deelnemers worden 
geïncludeerd. Volgens plan werden tussen februari 2002 en maart 2004 410 patiënten 
geïncludeerd in de studie.
Hoofdstuk 4
De doelstelling van de studie in hoofdstuk 4 was het vaststellen van de psychologische 
gevolgen van milde ovariële stimulatie in combinatie met het terugplaatsen van één 
embryo tijdens een eerste IVF-behandelcyclus. Er werd een gerandomiseerde gecon-
troleerde studie uitgevoerd in twee IVF-centra. 391 paren werden gerandomiseerd voor 
behandeling met: A) milde ovariële hyperstimulatie (met GnRH-antagonist) in combinatie 
met het terugplaatsen van één embryo (n = 199), versus B) conventionele ovariële hyper-
stimulatie (met een lang GnRH-agonist protocol) en het terugplaatsen van twee embryo’s 
(n = 192). De deelneemsters vulden op de volgende tijdstippen een aantal vragenlijsten 
in: 1) op de dag van de intake, 2) op de dag dat zij met de ovariële stimulatie begon-
nen en 3) op de eerste dag na het terugplaatsen van het embryo of de embryo’s. De 
volgende vragenlijsten werden afgenomen: de Hospital Anxiety and Depression Scale, 
de Hopkins Symptom Checklist en de Subjective Sleep Quality Scale. Vanaf de eerste dag 
dat de deelneemsters met de ovariële stimulatie begonnen tot en met de eerste dag 
waarop de uitkomst van de behandelcyclus bekend was, werd ook dagelijks hun stem-
ming gemeten met behulp van de Daily Record Keeping Chart. De deelneemsters in de 
conventionele behandelgroep rapporteerden tijdens downregulatie meer lichamelijke en 
depressieve klachten in vergelijking met de deelneemsters in de milde behandelgroep, 
die geen downregulatie ondergingen. Op de dag dat de punctie plaatsvond, scoorden 
de deelneemsters uit de eerste groep echter hoger op positieve stemming en lager wat 
betreft negatieve stemming dan de milde behandelgroep. Vergeleken met de milde groep, 
bleek in de conventionele groep het voortijdig staken van de eerste behandelcyclus met 
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lagere scores voor positieve stemming en hogere scores voor negatieve stemming samen 
te hangen. Uit deze resultaten kan worden geconcludeerd dat milde ovariële hypersti-
mulatie (met GnRH-antagonist) in combinatie met het terugplaatsen van één embryo 
gemiddeld niet tot meer psychologische en lichamelijke klachten leidt tijdens de eerste 
IVF-behandelcyclus dan het gebruik van een conventioneel behandelprotocol.
Hoofdstuk 5
Het doel van dit hoofdstuk was om vast te stellen of een milde IVF-strategie eenzelfde 
kans op een à terme levend geborene tot gevolg heeft binnen een jaar in vergelijking met 
de standaardstrategie, en of deze strategie leidt tot minder meerlingzwangerschappen, 
minder kosten en minder psychologische en lichamelijke klachten. Er werd een gerando-
miseerde en gecontroleerde effectiviteitstudie uitgevoerd met twee onderzoeksgroepen. 
404 patiënten werden gerandomiseerd voor behandeling met: A) milde ovariële hyper-
stimulatie (met GnRH-antagonist) in combinatie met het terugplaatsen van één embryo, 
versus B) conventionele ovariële hyperstimulatie (met een lang GnRH-agonist protocol) 
en het terugplaatsen van twee embryo’s. De primaire studie-eindpunten waren: (1) zwan-
gerschap binnen een jaar na randomisatie, resulterend in een à terme levend geborene, 
(2) de totale kosten per paar en kind tot zes weken na de uitgerekende datum, en (3) 
het totale patiëntenongemak binnen een jaar na randomisatie. De cumulatieve kans op 
een zwangerschap leidend tot een à terme levend geborene binnen een jaar was 43,4% 
in de milde groep en 44,7% in de standaardgroep. De kans op een meerlingzwanger-
schap per paar was respectievelijk 0,5% versus 13,1% (P < 0,001) en de totale kosten 
bedroegen € 8.333 versus € 10.745 (P = 0,006). Binnen een jaar was er geen verschil in 
de oppervlaktes onder de curve voor angst, depressie, lichamelijke klachten en kwaliteit 
van slaap. Milde ovariële stimulatie in combinatie met het terugplaatsen van één embryo 
resulteert in een gelijke cumulatieve kans op een à terme levend geborene en een gelijke 
hoeveelheid patiëntenongemak na een jaar in vergelijking met de standaardstimulatie in 
combinatie met het terugplaatsen van twee embryo’s. Daarnaast leidt het gebruik van de 
milde strategie tot minder meerlingzwangerschappen en lagere totale kosten.
Hoofdstuk 6
In deze studie werd onderzocht wat de psychologische impact is van het mislukken van 
een IVF-behandeling op vrouwen die meer dan één behandelcyclus hebben ondergaan 
volgens een mild of een standaard behandelprotocol. De deelneemsters werden gerando-
miseerd voor behandeling met: A) milde ovariële hyperstimulatie (met GnRH-antagonist) 
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samen met het terugplaatsen van één embryo (n = 197), versus B) een conventioneel 
ovarieel hyperstimulatieprotocol (met een lang GnRH-agonist protocol) en het terug-
plaatsen van twee embryo’s (n = 194). Vóór hun eerste behandelcyclus en één week na 
afloop van hun laatste behandelcyclus vulden de deelneemsters de Hospital Anxiety and 
Depression Scale in. De gegevens van de deelneemsters die meer dan één behandelcyclus 
ondergingen, werden geanalyseerd (n = 253). De deelneemsters die volgens het stan-
daard behandelprotocol waren behandeld, rapporteerden meer depressieve symptomen 
nadat hun behandeling was mislukt dan vrouwen die volgens het milde protocol waren 
behandeld (P = 0,01). De depressieve gevoelens die samenhangen met het mislukken 
van een IVF-behandeling, lijken te worden beïnvloed door de aard van het gebruikte 
behandelprotocol.
Hoofdstuk 7
De doelstelling van deze studie was het vaststellen van de invloed van psychologische 
factoren op de slagingskans van een eerste IVF-poging. Hierbij werd rekening gehou-
den met de psychologische gesteldheid van de deelneemsters vóór en tijdens de IVF-
behandeling. Tussen februari 2002 en februari 2004 werden 391 vrouwen die voor IVF 
in aanmerking kwamen, geworven in twee universitaire medische centra in Nederland. 
Symptomen van angst en depressie voorafgaand aan de behandeling werden gemeten 
met de Hospital Anxiety and Depression Scale. Negatieve en positieve stemming werden 
dagelijks gemeten gedurende één week na de intake en tijdens de ovariële hyperstimu-
latie met behulp van de Daily Record Keeping Chart. Er werd een multipele stapsgewijze 
voorwaartse regressieanalyse uitgevoerd met de kans op een à terme levend geborene 
als de afhankelijke variabele. De onafhankelijke variabelen waren: de eerdergenoemde 
psychologische variabelen, leeftijd, duur van de onvruchtbaarheid, oorzaak van de on-
vruchtbaarheid en het soort behandelprotocol. Deelneemsters die bij aanvang van de 
studie weinig negatieve gevoelens rapporteerden, hadden een kleinere kans op een à 
terme levend geborene dan deelneemsters die een zekere mate van negatieve gevoelens 
rapporteerden (P = 0,03). Daarnaast bleken deelneemsters die tijdens de eerste behan-
delcyclus waren behandeld volgens een standaardprotocol, een grotere kans te hebben 
op een à terme levend geborene dan deelneemsters die volgens een mild protocol waren 
behandeld (P = 0,002). Wanneer de oorzaak van de onvruchtbaarheid door zowel manne-
lijke als vrouwelijke factoren kon worden verklaard, was de kans op een à terme levend 
geborene groter dan wanneer alleen vrouwelijke factoren de onvruchtbaarheid konden 
verklaren (P = 0,03). De belangrijkste conclusie uit dit onderzoek is dat het uiten van 
negatieve gevoelens niet altijd tot slechtere IVF-resultaten blijkt te leiden.
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Hoofdstuk 8
In hoofdstuk 8 worden de belangrijkste bevindingen uit dit proefschrift besproken. Daar-
naast worden de implicaties van deze resultaten voor de praktijk en voor toekomstig 
onderzoek uiteengezet. Uit het onderzoek dat in dit proefschrift is beschreven, blijkt 
dat een behandeling die bestaat uit de combinatie van milde ovariële hyperstimulatie 
(met GnRH-antagonist) en het terugplaatsen van één embryo, na één jaar in een gelijke 
cumulatieve kans op een à terme levend geborene resulteert als standaardstimulatie in 
combinatie met het terugplaatsen van twee embryo’s. Tegelijkertijd blijkt het gebruik van 
de milde strategie tot minder meerlingzwangerschappen te leiden. Daarnaast wordt in dit 
proefschrift voor het eerst wetenschappelijk onderbouwd dat het gebruik van een mild 
behandelprotocol tijdens en vlak na de behandelperiode minder distress bij patiënten 
veroorzaakt dan het gebruik van het standaardprotocol.
De resultaten van dit proefschrift ondersteunen niet het routinematig aanbieden van 
adviesgesprekken met een maatschappelijk werker aan alle paren die aan hun eerste 
IVF-behandelcyclus beginnen. Dergelijke psychosociale interventies zijn slechts geïndi-
ceerd voor echtparen die kwetsbaar zijn en die om deze reden werkelijk baat hebben bij 
aanvullende zorg. Er is voor fertiliteitsartsen een belangrijke rol weggelegd wat betreft 
patiëntenvoorlichting met betrekking tot de implicaties van de verschillende behandel-
keuzen waar patiënten zich voor zien gesteld. Idealiter heeft deze voorlichting niet alleen 
betrekking op de zwangerschapskansen en de medische risico’s voor moeder en kind van 
bepaalde behandelingen, maar ook op de psychologische (en sociale) gevolgen van on-
vruchtbaarheid en de verschillende behandelingen. Op deze manier worden patiënten in 
staat gesteld om weloverwogen behandelingskeuzen te maken. Aangezien dit proefschrift 
laat zien dat de psychologische gevolgen van de verschillende behandelingen kunnen 
verschillen per behandelstadium, lijkt geïndividualiseerde voorlichting tijdens alle stadia 
van de behandeling op zijn plaats. Artsen die op de hoogte zijn van de psychologische 
aspecten van onvruchtbaarheidsbehandelingen, zullen mogelijk ook eerder psychosoci-
ale problemen bij patiënten signaleren. Wanneer artsen bij hun voorlichting bovendien 
uitgaan van het psychologische gevolgen van onvruchtbaarheid-model in plaats van het 
cyclische stressmodel, voorkomen zij wellicht dat patiënten schuld- en schaamtegevoelens 
ontwikkelen als gevolg van het mislukken van hun behandeling. Wanneer patiënten zich 
vrij voelen om hun negatieve gevoelens te uiten met betrekking tot hun onvruchtbaar-
heid en de behandeling hiervan, staan zij mogelijk ook meer open voor doorverwijzing 
naar een psychosociale hulpverlener wanneer dit nodig blijkt te zijn.
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